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Many studies investigate the seasonality of onset of diseases over the year, with a 
view to this being an indication of their aetiology. Seasonal data are usually presented 
in 12 monthly counts gathered over years with no individualised information on either 
exact date of onset or characteristics provided. For this format several statistical tests 
have been devised for the investigation of potential seasonal influences on onset.  
The main objective of this thesis is to describe the statistical methods for 
situations where seasonality can be summarised by a single peak or by peaks 
determined by patient characteristics or external influences. The circular nature of 
date variables over a year means that the Normal distribution is replaced by the von 
Mises distribution for statistical inference. An angular regression approach, analogous 
to that used routinely in other areas of clinical research, potentially allows a more 
systematic and detailed investigation of possible seasonal patterns in patient 
subgroups. However, the application of this extension of the angular methods is 
seldom found in the medical literature, possibly because computer software is not 
readily available for such analysis. To enable clinical researchers to make use of the 
angular method, I have developed a computer program as part of this work.  
The thesis also refers to our published work associated with angular 
regression. This includes the presentation of childhood cancers in the United States of 
American (USA), breast cancer in Singapore, the cases of methicillin-resistant 
staphylococcus aureus in Spain, and attempted suicides in Singapore. 
I use the angular method to re-examine the evidence for seasonality of acute 
lymphoblastic leukaemia (ALL). The summary data from published papers provided 
the essential components for an appropriate meta-analysis. Despite summarising 20 
studies, the overview provides no clear message with respect to seasonality of onset of 
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ALL. Nevertheless none of these studies used individual dates of onset of ALL for 
analysis. 
In the final section of this thesis, I use ALL data for which individualised date 
and characteristics are available for analysis from Singapore, the USA and Central 
Sweden. No strong peak of onset was observed in either Singapore or the 11 distinct 
locations in the USA. In contrast, a strong peak (early January) was found in Sweden 
but the 95% confidence interval (November 17 through January 01 to February 10) 
was wide due to a small sample size (N = 79). Different seasonal patterns between 
children and adults and between genders are only observed in Sweden and the only 
ethnic group to show a significant peak are Black Americans from Detroit, USA who 
presented in early December (Winter). Angular regression was suggestive that the 
peak presentation of ALL depended on latitude, with these from the South (latitude < 
40°) presenting 7 months later than the North (p = 0.004). 
Some suggestions for standardised reporting of seasonality studies are made.  
Recommendations for further work are proposed, specifically (i) case studies on 
angular regression with three or more explanatory variables; (ii) angular regression 
with independent variables which take an angular form (such as latitude), (iii) for 
ALL an international and prospective study of date of onset of symptoms. 
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As judged from the extensive literature, there is considerable interest in medicine in 
the seasonal pattern of onset of disease. The object of such interest has usually been to 
seek some clue to the presence of some underlying aetiological factor that may be 
predisposing for the particular disease or condition. For example, Cave and Freedman 
(1975) suggest that in the United Kingdom (UK) Crohn's disease has peak onsets in 
January and July, whereas ulcerative colitis (UC) has a single peak onset in 
December. As a consequence, the authors suggested that Crohn's disease could be a 
transmissible condition, but that Crohn's disease and UC may not be aetiologically 
related. In this study the presence of a seasonal variation led to hypotheses which may 
in turn lead to a better understanding of the diseases in question. However, and in 
contrast, Sonnenberg et al (1994) from the United States of American (USA), albeit 
not referring to the Cave and Freedman (1975) study, concluded that neither Crohn’s 
nor UC showed any clear-cut seasonality. A second, and now a well established 
example of seasonal influences, is that observed in sudden infant death syndrome 
(SIDS), or 'cot' deaths in the UK, as first reported by Carpenter and Emery (1974) and 
subsequently confirmed by others including Harris et al (1982). These studies clearly 
identify the increased risk of SIDS in the winter months and have led to detailed 
studies of the influence of ambient temperatures (Murphy and Campbell, 1987). In 
other examples, Stolwijk et al (1997) review the published evidence from 20 articles 
concerned with the seasonal variation in the prevalence of Down’s syndrome at birth 
in the Northern and Southern hemispheres while Alabi and Akinsanya (1981) 
investigates the seasonality of onset of cutaneous lichen planus in tropical Africa. 
Seasonal variation has also been studied for some chronic diseases or 
conditions, notably cancer. For example, Lee (1963) found seasonality of leukaemia 
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with a summer peak (June) usually associated with acute lymphoblastic leukaemia 
(ALL) in England and Wales. This pattern is not restricted to England and Wales as 
data from New Zealand and Australia also suggested that the summer peak 
(December) is present in the occurrence of leukaemia (Lee, 1964; Lee and Gardner, 
1965). Some details of Lee (1964) are given in Appendix E. However, in a more 
recent study, Gilman et al (1998) found little evidence of seasonality in the 
presentation of leukaemia in Great Britain (England, Scotland and Wales). In the solid 
tumours, Kirkham et al (1985) noted a summer peak (June) in the presentation of 
breast cancer in Southampton, England. Also more thyroid cancer cases are 
presenting during the late autumn and winter from October to December in Norway 
(Akslen and Sothern, 1998).  
The investigation of the seasonal onset of disease critically depends on a 
clearly established date of onset. Thus in the SIDS example, the onset and date of 
death coincide and will be determined for most cases very precisely. This is also the 
case for testicular torsion investigated by Kirkham and Machin (1983) amongst others 
(Table 1.1). In contrast, the onset of uveal melanoma of the eye (Schwartz and Weiss, 
1988) is poorly established due to the natural history of the disease. Uveal melanomas 
most often come to diagnosis as a result of pain or loss of vision (Shields, 1983). 
Another example is the onset of breast cancer investigated by us (Gao et al, 2001) 
where there is an uncertain relationship between date of diagnosis and date of onset of 
symptoms. As a consequence, there may be considerable and variable times from 
onset to diagnosis so that, if the latter is utilised as an indicator, a false impression of 
seasonality (or lack thereof) may result.  
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Table 1.1 Examples of diseases with clear and unclear onset 
 
Onset Disease First author  Onset delay 
    
Clear  Testicular torsion Kirkham (1983) 1 day 
    
Clear  Sudden infant death syndrome Carpenter (1974) A few hours 
    
Unclear  Breast Cancer Gao (2001) Possibly 1 year 
    
Unclear  Uveal melanomas Schwartz (1988) Uncertain  
    
Seasonal data are usually presented and analysed in the form of a series of 12 
monthly totals, these being the numbers of persons presented with the disease of 
interest in a given month of the year. Often the data of onset have been gathered over 
a number of years and monthly totals are obtained by summing over the individual 
years. Several statistical tests are available to analyse this kind of data. The standard 
χ2 test for heterogeneity with df = 11 has been widely used, even though it is often 
inappropriate and strong reservations have been made concerning its uncritical use 
(Edwards, 1961; Newcombe, 1983). Edwards (1961) proposed a method to test the 
hypothesis of uniform distribution throughout the year against a particular hypothesis 
− namely that the frequencies follow a sinusoidal curve of period 12 months. This test 
has been applied to a wide variety of epidemiological investigations.  
However, using grouped monthly totals when the individual dates are 
available may miss some important aetiological clues. Despite this, an example 
arguing for grouping before analysis is provided by Badrinath et al (1997) who state: 
“We divided the year into summer (May − October) and winter (November − April) 
….. to facilitate comparison with published studies from the UK. ….. This apparently 
crude approach, being based on a specific prior hypothesis, is more powerful than the 
application of more complex tests for seasonality”. Although this may indeed be the 
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case, such a dichotomy between summer and winter implies an underlying step-
change in the number of cases between seasons. This is unlikely to truly reflect the 
pattern of diagnosis of, in this case, ALL (see also Gilman et al, 1998). 
In addition, many authors have not provided a precise estimate of the date of 
the peak onset, with the associated confidence interval (CI), but rather a general 
estimate perhaps of a particular season (Bounameaux et al, 1996; Allan and Douglas, 
1996; Badrinath et al, 1997) – the meaning of which will be highly dependent on the 
geographical location of the particular studies. Such coarse groupings may also lead 
to incorrect conclusions when comparing published studies.  
One situation in which using the individual dates, rather than grouped data, 
might have lead to a clearer conclusion is that described by Allan and Douglas (1996). 
They cite four groups of studies, representing 23 series, investigating the variation of 
deep vein thrombosis presentation over the four seasons of the year. They test for 
seasonality using χ2 each with df = 3 (see §2.2) and quote 3.8, 11.8, 10.4 and 21.4 
respectively. The corresponding tests of the absence of seasonality yield exact p-
values (not quoted in their note) of 0.284, 0.008, 0.015 and 0.00009. Thus, the latter 
three of these four studies are strongly suggestive of the presence of seasonality. 
However, two of these three suggest the peak is winter, while the third suggests 
autumn, as does the one which was not statistically significantly different from a 
uniform distribution of events over the four seasons (Allan and Douglas, 1996, Figure 
1). These conflicting peak onsets reported as autumn and winter may not be truly so 
inconsistent if the peak onset is in late autumn or early winter. Clearly, it would have 
been useful if each of these studies had identified and reported a date of peak 
incidence.  
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One problem in the investigation of seasonality is that of missing values or 
incomplete years of observation. For example, a study by Miller et al (1992) 
described the presentation of cases of pneumocytis carinii pneumonia over the 2 years 
and 5 months from September 1989 to January 1992. These data are therefore 
incomplete in terms of whole years of observation and so standard angular summary 
measures cannot be applied. 
As with other types of epidemiological studies confounding factors may be 
present. One way to adjust for confounding effects is by means of stratification so that 
insight can be gained into whether seasonal variation differs between, for example, 
gender or age groups. For example, in the leukaemia study of Lee (1963), they 
examined the age effect by dividing patients into 0 − 19 and 20 − 44 years and 
concluded that the summer peak is evident in children and adults. 
The methods associated with circular statistics, the von Mises distribution and 
angular regression models were first suggested by Batschelet (summarised somewhat 
later in Batschelet, 1981) and detailed by Mardia (1972), Machin and Chong (1998) 
and Mardia and Jupp (2000, Chapter 3). This methodology has been used in many 
diverse applications, such as crystallography and vectorcardiography (Downs and 
Mardia, 2002). However, they do not seem to have been utilised in epidemiological 
studies. This may be because the statistical techniques have been described in 
publications not routinely accessed by medical researchers and epidemiologists. 
Perhaps the important factor however is the lack of core programs in standard 
statistical packages to implement the methodology. This contrasts with the methods 
described by Bliss (1958, 1970) and Stolwijk et al (1999) who described the use of a 
regression model using sine and cosine functions, although still utilising accumulated 
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monthly data. Such models can make use of standard multiple regression packages 
which are readily available. 
In a medical context, the angular method was probably first used in the 
investigation of seasonal variation in the sudden infant death in Southampton (Harris 
et al, 1982). Subsequently, it was used to investigate the presentation of the testicular 
torsion (Kirkham and Machin, 1983) and of breast cancer (as determinated by the date 
of biopsy) in Southampton, England (Kirkham et al, 1985). Machin and Chong (1998) 
have described and illustrated some of methods in detail. They investigated the 
presentation of corneal ulceration (Chong and Machin, 1998) and thyroid cancer 
(Machin and Chong, 1999) and we have investigated suicides in Singapore (Parker et 
al, 2001). However, none of these studies has used angular regression. We have 
published some of the preliminary work associated with angular regression (Gao et al, 
2002) and applied the angular regression technique to several studies on the 
presentation of cancer: childhood cancers in the USA (Machin and Gao, 2000) and 
breast cancer in Singapore (Gao et al, 2001), non-cancer disease: methicillin-resistant 
staphylococcus aureus (MRSA) in Spain (Gao and Machin, 2004).  
Although we have focused here on seasonal variation over a year (365 days), 
there are other applications where the time frame would be different. Thus, Patel et al 
(1985) studied the times that women attended an Accident and Emergency clinic, 
relative to the phase of their menstrual cycle. In this situation, the menstrual cycle 
length for each woman was first standardised to a 28 day cycle. They also recorded 
the number of symptoms of premenstrual syndrome experienced by the women. Their 
analysis suggested that the peak menstrual cycle day for accident risk was dependent 
on the number of premenstrual symptoms reported. Another application is to sleep-
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related vehicular accidents investigated by Horne and Reyner (1995) (also see §3.8) 
for which the time frame is the 24 hour over day. 
For purposes of this thesis we only consider circumstances in which the 
underlying population varies minimally over time and so assume that the presentation 
of the disease under investigation is not affected by the population-at-risk 
denominator. However, significant seasonality could be the result of an effect induced 
by the general birth seasonality (Torrey et al, 1997) and so Walter and Elwood (1975) 
modified the Edwards (1961) test to deal with the “population at risk” that is itself 
seasonally variable. They analysed seasonality of anencephalus adjusted for varying 
frequency of total births for Canada in the period 1954 − 1962. Symonds and 
Williams (1976) and Walter (1977a) also used this method to allow for the fluctuating 
monthly pattern of total hospital admissions in an analysis of the seasonal trend in 
mania admissions.   
The first objective, therefore, of this thesis is to describe an appropriate 
statistical methodology for situations where seasonality can be summarised by either a 
single peak or peaks possibly determined by patient characteristics or external 
influences. Following a review of statistical methods commonly used in practice in 
Chapter 2, I investigate the application of the angular methodology in a medical 
context in Chapter 3. The second objective is to describe in detail the angular 
regression technique (Chapter 4). In order to enable clinical researchers to make use 
of this methodology I develop a computer program for the application of the angular 
methods. As a final, but primary objective, I use the angular method to re-examine 
findings from previous studies on the seasonality of ALL. I also examine the seasonal 
component of ALL (both in children and adults) amongst cases presenting in widely 
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different geographical areas: Singapore, the USA and Central Sweden, using patient 
specific dates of onset of the disease and their individual demographic characteristics.   
All of the analysis of examples was carried out in S-PLUS (2001, version 6.0). 
The particular functions used in Chapters 2 to 4 are discussed in Appendix H. The 
data used are detailed in Appendix I.  
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2 Methods for grouped data 
 
2.1 Introduction 
Seasonal data are often presented in the format of the number of occurrences of the 
disease per calendar month that are usually obtained following summation over a 
number of complete years. For this format several statistical tests have been devised 
for the investigation of potential seasonal influences on the presentation of disease. 
Early methods for detecting seasonality in epidemiological data relied almost 
exclusively on two statistical tests: the Pearson χ2 test for heterogeneity and the test 
devised by Edwards (1961). However, both methods have been criticised; the former 
for its failure to utilise information in neighbouring months, and the latter for poor 
performance with small samples (Edwards, 1961; Hewitt et al, 1971; Freedman, 
1979). For example, the Pearson χ2 test would not distinguish the case of 3 months in 
which the numbers are raised in (say) January, May and September from numbers 
raised in neighbouring months of April, May and June. The latter suggest a single 
peak, the former not. Edwards’ method has been extensively studied, and many 
modifications to the test have been suggested, both to extend its generality and to 
improve its small sample properties (Walter and Elwood, 1975; St Leger, 1976; 
Roger, 1977). Many of the latter modifications have assumed a multinomial 
distribution, modelling the probability of monthly occurrence by a sinusoidal function 
(Halberg et al, 1972; Roger, 1977). In most published reports in which statistical 
analysis has been carried out, Pearson c2 tests have been applied to monthly, 
quarterly, or biannual totals of presentation of the disease. However many early 
investigators did not employ formal statistical tests of seasonal variation, and instead 
relied on visual inspection of monthly tabulations or graphs (Little and Elwood, 
1992). 
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In this chapter, (see however, part §2.8) we discuss the commonly used 
statistical methods in terms of monthly counts ignoring (for ease of exposition) 
variation in the number of days between months of a year and leap years. A single 
year of data commencing January is assumed. Further we assume that there are N1, 
N2, …, N12 occurrences in the m = 12 successive months, and .g
g
N N= ∑  For 
simplicity, we will suppose that the only temporal effect is seasonal, with no long-
term trend. We use monthly births of anencephalics to primiparous women in 
Birmingham (1940 – 1947) described and used by Edwards (1961) as an illustrative 
example (Table 2.1).  
Table 2.1 Monthly births of anencephalics in Birmingham (data from Edwards, 1961) 
 
 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov  Dec Total 
              
N 10 19 18 15 11 13 7 10 13 23 15 22 176 
              
 
2.2 Pearson χ2 
In our situation, the standard Pearson χ2 test has degrees of freedom (df) = m – 1 = 11 
and tests the compound null hypothesis of a uniform distribution of cases over the 
year, 
 : 0 1 2 12...H π π π= = = . (2.1) 
Thus 
 





N E N N
T
E N
− −= =∑ ∑ , (2.2) 
where the expected number of observations per month is Eg = N/12 for all g (= 1, 2, 
…, 12).  
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 Variations of equation (2.2) have been used, for example, if there is thought to 
be a broad ‘seasons’ effect between spring, summer, autumn and winter. In which 
case three months of data are grouped into each of the four seasons and are then tested 
with df = 3. 
 The χ2 test for heterogeneity of equation (2.2) only tests for departures from a 
uniform distribution of cases throughout the year and not specifically for the presence 
of a single peak or any other pattern. As a consequence, as Newcombe (1983) pointed 
out in a similar context: “… such a test is insensitive as an indicator of seasonal trend, 
…” and it is therefore not recommended. This same point had been made more than 
20 years earlier by Edwards (1961) who stated (with some change in notation): “This 
is an extremely bad test for detecting a cyclic trend : of the (m – 1) df only one or two 
are likely to be necessary to specify any biologically meaningful type of trend, and the 
remaining (m – 2) or (m – 3) will produce a cloud of uncertainty over any 
interpretation, and can easily lead to errors of both kinds”. Thus there is a strong 
possibility that single peaks (should they exist) would not be (statistically) identified 
and of the converse situation.  
The function Pearson has been written to calculate TP. Using Pearson for the 
data of Table 2.1 gives TP = 18.727, df = 11, p = 0.066.  
 
2.3 Edwards 
Nevertheless, in certain circumstances, it will be useful to examine differences 
between observed frequencies and those expected under the uniform hypothesis of 
equation (2.1). Such an exploratory analysis may suggest appropriate models for 
describing the data. Models for the seasonal pattern of disease have usually been 
based on the sine wave and this was first suggested by Edwards (1961). According to 
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his model, every month has an angle of 30º (p/6 radians), and the whole year 
corresponds to 360º (2p radians). Edwards (1961) placed a sequence of weights 
g gw N=  around a unit circle at directions θg = (2g – 1)π/12 radians from the origin 
of the North pole. For example, February is centred at 45∞ (p/4 radians) and this 
model can be visualized geometrically (Figure 2.1).  
 
Figure 2.1 Basis of the calculation of the Edwards (1961) test. 








S x w W






∑  (2.3) 
and N g g
g g
W w N= =∑ ∑ . The distance of COG from the geometric centre of the 
circle is 
2N
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 2 2Ed S C= + . (2.4) 
The direction of COG with respect to the geometric centre of the circle, is then 
determined by solving the equation 
 0 arctan( / )S Cθ = . (2.5) 
The precise method of solution is detailed in Chapter 3 (see Equation (3.3)). This lead 




( sin ) ( cos )
8











which under the null hypothesis of no seasonality has approximately a χ2 distribution 
with df = 2.  
 On the other hand, if a particular kind of seasonal variation, such as, the 
simple cyclic trend following a sine wave of period 12 months, is postulated as an 







α θ φ+ −= , (2.7) 
where α is the amplitude of the sine curve and φ is the phase angle which determines 
the position of the peak and is estimated by 0θ  of equation (2.5).   
The shape of the model (2.7) is illustrated in Figure 2.2 for φ = 0, α = ½ and 
1. The curve has a single peak and one trough during the year. The peak and trough 
are exactly 180° (π radians) apart. If α = 0, then Pg = 1/12 and the distribution of 
counts is uniform over the year. Thus a test of the hypothesis given by equation (2.7) 
against the hypothesis given by expression (2.1), is achieved by testing whether the 
amplitude α of the fitted 12-month sine curve is different from zero. 
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Figure 2.2 Edwards (1961) model for φ = 0, α = ½ and 1.  
Assuming φ = 0, Edwards (1961) placed 12 equal weights of WN / 12 at 
directions θg = (2g – 1)π/12 radians from the origin and at respective distances 




d r θ= ∑ . (2.8) 
Assuming α to be reasonably small, then rg ≈ 1 + 2
α  cosθg. Thus, a, the estimate of 
the amplitude α, can be derived as 
 4 Ea d= . (2.9) 
To implement this estimation procedure the function Edwards in S-PLUS has 
been written to calculate TE, determine the peak and estimate the amplitude, α. Using 
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Edwards for the data of Table 2.1 without the adjustments of §2.8 gives TE = 6.973 
(p = 0.031), 0θ  = 0.532∞ (January 01) and a = 0.282. Note that TE differs from that 
quoted by Edwards (1961) of 6.4. We assume the latter is a typographical error. If the 
data is adjusted (see §2.8) before Edwards is used, we obtain TE = 7.295 (p = 0.026), 
0θ  = 2.619∞ (January 03) and a = 0.282. The distribution of the data of Table 2.1 and 
the fitted sine model is shown in Figure 2.3.  
 
Figure 2.3 Monthly births of anencephalics in Birmingham with the fitted sine model. 
The statistic TE has been quoted as the “statistical test which has been widely 
used” (Walter, 1977b) for the investigation of seasonal variation in epidemiology. 
However several issues, such as choice of weights, sample size and specificity in 
detecting sinusoidal variation, have been raised in relation to the Edwards test. 
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Choice of weights 
According to Edwards (1961), using the weight g gw N=  can partially remove 
sudden disturbance which may cause an increase or decrease in count in a particular 
month. Edwards (1961) stated without further explanation: “It may also conceivably 
happen that there will be an increase or decrease in one month due to a sudden 
disturbance, which is not repeated in other years. It is not possible to eliminate the 
effect of such disturbances completely, but the use of a square root transformation 
may help to reduce them”. However, Roger (1977) criticized the use of the square 
root. He showed that the statistic TR (see equation (2.15)), with wg = Ng, has, under the 
null hypothesis, a better approximation to the χ2 distribution with df = 2. In this study, 
he used 10,000 simulations for sample sizes of 20, 50, and 100. He also proved that 




Edwards (1961) did not suggest a minimal or desirable sample size for the use of this 
approach but gave a worked example based on N = 176 observations of first-born 
anencephalics (Table 2.1). Hewitt et al (1971), using simulation methods, showed 
that the application of the Edwards test gave an excess of apparently significant 
results for samples of less than 46 observations. St Leger (1976) and Roger (1977) 
also showed by simulations that TE gave a poor approximation to the χ2 distribution 
under the null hypothesis when sample sizes are small. Both advocated maximum 
likelihood methods (§2.4, 2.5), rather than the geometric methods suggested by 
Edwards (1961) for estimating the probability that the pattern of seasonal variation 
corresponded to a sinusoidal trend.  
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Specificity of Edwards’ test 
Scotto and Nam (1980) considered Edwards’ test when describing the seasonality of 
monthly incidence of skin melanoma among Caucasians by age, gender, anatomical 
site and geographic area. They applied TP first to determine the validity of the 
sinusoidal model and calculated Edwards test statistics TE only if the TP test did not 
reject (p > 0.05) the model. For example, they tested the skin melanoma pattern 
among females in the face, head and neck first using TP and since p < 0.05 (the exact 
probability was not given) indicates that the pattern departs significantly from the sine 
curve model they considered TE inappropriate. However, Marrero (1981) 
recommended that the test of TP should follow (not precede) the test for seasonality, 
such as TE, and both of these tests should be included in a seasonality study. Indeed, 
Walter (1982) claimed that both tests are informative, and that the results of one 
should not be allowed to preclude the use of the other. Both argued that TE test may 
be used to detect variation other than that arising from a simple sinusoidal pattern. But 
Nam and Scotto (1981, 1982) have maintained their position that the TE is only 
capable of detecting departure from uniformity of the sinusoidal form. No clear 
resolution of this point appears to have been made.  
 
2.4 Maximum likelihood 
To test the same hypothesis as stated for Edwards test in §2.3, the likelihood of the 
monthly occurrences is, under the alternative hypothesis, 
 ( !/ !) gNg g
g g
l N N P= ∏ ∏ . (2.10) 
Thus the log likelihood is 






    log







C N α θ φ
=
= +




where 1 log ! log !g
g
C N N= − ∑  and 1 log(1/12)C C N= +  are constant. Under the null 
hypothesis a = 0 and Pg = 1/12 for all g, equation (2.11) reduces to L0 = C. As a 
consequence St Leger (1976) proposed the test statistic TSL for seasonal variation 
given by 
 0 12( )SLT L L= − − . (2.12) 
Under the null hypothesis, TSL is distributed asymptotically as a c2 with df = 2. 
However, the likelihood equations are not tractable to analytic solution, so numerical 
estimation for α and φ is used.  
 
2.5 Roger’s 
Roger (1977) used the fact that cos(θ − φ) = cosθ cosφ + sinθ sinφ to propose a model 
in which the probability Pg that any disease onset occurs in the g-th month is given by 
 (1 cos sin ) /12g g gP β θ γ θ= + +  (2.13) 
where b (= αcosφ) and γ (= asinφ) are parameters of the model and are to be 
estimated. This is equivalent to Edwards’s model (2.7). Model (2.13) is illustrated in 
Figure 2.4 for values of the parameters corresponding to the (b, γ) pairs (½, ½), (1, 0) 
and (0, 1). 
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Figure 2.4 Roger (1977) model for the (β, γ) pairs (½, ½), (1, 0) and (0, 1). 
By substituting (2.13) in equation (2.11), the corresponding log likelihood function is  
 1 log(1 sin cos )g g g
g
L C N β θ γ θ= + + +∑  (2.14) 









β β θ γ θ










γ β θ γ θ
∂ =∂ + +∑ . The derivatives of the likelihood function with 
respect to each of the parameter  (b, γ) are evaluated under the hypotheses 
0 1: 0,      : 0 or 0.H H ββ γ γ= = ≠ ≠  
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The test statistic was derived based on the efficient score vector ( 1 1,L Lβ γ
∂ ∂
∂ ∂ )β = 0, γ = 0 = 
( sin , cosg g g g
g g
N Nθ θ∑ ∑ ) (see Cox and Hinkley, 1974, page 107) and can be written 
as 




θ θ= +∑ ∑  (2.15) 
Roger (1977) showed for large samples that TR is nearly equivalent to TE. 
The function Roger has been written to calculate TR. Using Roger with the 
data of Table 2.1 gives TR = 6.636, p = 0.036. The p-value calculated using Roger is 
slightly larger than that by use of Edwards (p = 0.031).  
 
2.6 Non-parametric methods 
David and Newell test 
David and Newell (1965) proposed a test based on the maximum difference in the 
number of cases in all possible pairs of 6-month divisions of the year. Assume Sg be 
the total number of occurrences for the six months beginning with month g. David 
and Newell (1965) defined TDN by 
 61 6
1 maxDN j jjT S SN +≤ ≤
= − . (2.16) 
A more general format of TDN is given when the year is divided into any even number 
of periods. The upper percentage points for test size a = 0.05 and 0.01 and 2, 3, 4, 5 
and 6-month divisions are provided in David and Newell (1965, Table 1). For the 6-
month divisions the upper percentage points for statistic TDN when a = 0.05 and 0.01 
are 2.53 and 3.09. 
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An assumption of the test is that monthly case frequencies are approximately 
normally distributed, so the test is strictly a compromise between a parametric and 
non-parametric method. The calculations need not begin in January. For the data in 
Table 2.1, the calculations using Dn illustrated in Table 2.2 give TDN = 38/ 176  = 
2.864 and reference to the percentage points given in David and Newell (1965, Table 
1) gives 0.05 > p > 0.01.   
Table 2.2 The David and Newell (1965) method (data from 
Edwards, 1961) 
 
Month  Ng Sg | Sj – Sj+6 | 
  
Jan 10 86 4 
Feb 19 83 10 
Mar 18 74 28 
Apr 15 69 38 
May 11 77 22 
Jun 13 81 14 
Jul 7 90 - 
Aug 10 93 - 
Sep 13 102 - 
Oct 23 107 - 
Nov  15 99 - 
Dec 22 95 - 
  
Total 176 1056  
    
 
Hewitt’s test 
Hewitt et al (1971) described a non-parametric test dependent only on the ranking of 
monthly frequencies. This method avoids the problem of specifying a particular 
algebraic version of the alternative hypothesis. Unfortunately the test lacks the power 
of parametric methods for moderate sample sizes (Walter and Elwood, 1975).   
The method is based on assignment of ranks to the number of disease onsets 
for each month, with rank 12 assigned to the month with highest occurrence, 11 to the 
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next highest, and so on down to rank 1 for the month with the lowest. We assume that 
the ranks obtained from the 12 successive month totals N1 to N12 of January to 
December are N(1), …, N(12). In the situation a prior hypothesis specifying a six-month 
period of higher expected occurrences, for example summer from May to October, is 
available for testing, the rank-sum of six successive months is distributed 
symmetrically over the range: 21 (= 1 + 2 + … 6) to 57 (= 7 + 8 + … + 12). Hewitt et 
al (1971, Table 2) provided the exact distribution and cumulative probabilities for all 









= ∑  equal or greater than 50 would be regarded as significant at the 
conventional 5% level. Walter (1980) suggested that the approach would be unlikely 
to be used in practice. Our review of the literature did not reveal its use even once!  
 When no prior hypothesis exists it is necessary to locate the six-month 
segment which yield the highest value of the rank-sum. The test statistic TH is the 










= ∑  (2.17) 
where N(i) = N(i−12) when i > 12. Equation (2.17) is an easily computed test for 
seasonality although the distribution of TH is unknown (Walter, 1980). Hewitt et al 
(1971) generated and tested 5,000 random permutations of the numbers 1 to 12 using 
simulation. A significance of 5% could be achieved only when TH = 55, 56 and 57. 
Walter (1980, Table) provided a tabulation of the exact distribution of TH when TH = 
53, 54, 55, 56 and 57. The discrepancies between the simulated and the exact values 
are modest.  
The test of Hewitt et al (1971) requires that there are no ties in the ranking of 
the monthly frequencies. For the data in Table 2.1, the calculations using Hewitt 
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illustrated in Table 2.3 give the maximum value of the rank-sum as TH = 52 
corresponding to October to March. The p-value is not available because of the ties in 
Ng (January and August; April and November; June and September). These same ties 
remain even when using the corrected frequencies (§2.8).  
Table 2.3 Calculation of TH for the data of Table 2.1 
 
Month  Ng Corrected 
frequency
 N(g) Rank-sum 
     
Jan 10 9.7932  2.5 38.5 
Feb 19 20.4184  10 37.0 
Mar 18 17.62779  9 29.5 
Apr 15 15.1795  7.5 26.0 
May 11 10.7725  4 30.5 
Jun 13 13.1556  5.5 34.0 
Jul 7 6.8553  1 39.5 
Aug 10 9.7932  2.5 41.0 
Sep 13 13.1556  5.5 48.5 
Oct 23 22.5244  12 52.0 
Nov  15 15.1795  7.5 47.5 
Dec 22 21.5451  11 44.0 
      
Total 176     
      
 
Kuiper’s statistic 
Freedman (1979) described a non-parametric method based on a Kolmogorov-
Smirnov type statistic. The method may be used either with individual dates of onset 
or with monthly grouped totals. Under the assumption that there is a uniform seasonal 
distribution the cumulative probability distribution F(g) at the end of January is 
31(1)
365
F = ; at the end of February, 59(2)
365
F = , etc. Similarly, the sample 
cumulative probability distribution function FN(g) is FN(1) = N1 / N at the end of 
January, FN(2) = (N1 + N2) / N at the end of February and so on. Thus the test statistic 
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 ( ) ( )
1 12
max{ } min{ ( ) ( )}K N NggT F g F g F g F g≤ ≤= − + −1£ £12  (2.18) 
is a Kolmogorov-Smirnov type statistic. This statistic (2.18) was first suggested by 
Kuiper (1962) and can be used when there is no specific parametric alternative to the 
null hypothesis. However, no analytical methods are available for deriving the 
distribution of TKS under the null hypothesis. As a consequence, Freedman (1979) 
performed ten thousand simulations and estimated percentiles of the distribution of 
KT N . Some percentiles of KT N  suitable for sample sizes greater than 50 are 
given in Table 2.4  
Table 2.4 Selected percentiles for the statistic KT N (from 
Freedman, 1979, Table 2) 
 
Percentile  90% 0.95% 99% 
    
KT N  1.29 1.41 1.66 
    
The calculation of KT N  for the monthly births of anencephalics in 
Birmingham is shown in Table 2.5. The frequencies and cumulative frequencies are 
shown in the columns 2 and 3, while columns 4 and 5 give the values of the functions 
FN and F. The final column shows the difference between them. Further, one obtains 
from the final column, ( ) ( )max{ } 0.0231Ng F g F g− =1£ £12 , 1 12min{ ( ) ( )} 0.0890Ng F g F g≤ ≤ − =  
and substituting these into equation (2.18) gives TK = 0.0231 + 0.0890 = 0.1121. The 
value of KT N  = 1.4872 lies between the 95% and 99% points of the asymptotic 
distribution of Table 2.4. Thus the deviation from a uniform seasonal variation is 
significant at the 5% but not the 1% level (0.05 > p > 0.01). The calculations 
illustrated in Table 2.5 are made with Kuiper. 
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Table 2.5 Calculation required to test seasonal variation of data of Table 2.1 using 
Kuiper’s statistic 
 
Month Frequency  Cumulative  
Frequency 
FN F FN – F 
      
Jan 10   10 0.0568 0.0849 –0.0281 
Feb 19   29 0.1648 0.1622   0.0026 
Mar 18   47 0.2670 0.2471   0.0200 
Apr 15   62 0.3523 0.3292   0.0231 
May 11   73 0.4148 0.4141   0.0007 
Jun 13   86 0.4886 0.4962 –0.0076 
Jul   7   93 0.5284 0.5811 –0.0527 
Aug 10 103 0.5852 0.6660 –0.0808 
Sep 13 116 0.6591 0.7481 –0.0890 
Oct 23 139 0.7898 0.8330 –0.0432 
Nov 15 154 0.8750 0.9151 –0.0401 
Dec 22 176 1.0000 1.0000   0 
      
 
Summer to Winter ratio 
Suppose that S1 is the total number of occurrences for the 6-month period termed 
summer, for example from May to October in the Northern Hemisphere. Similarly, S2 
is the total number of occurrences for the second 6-month period of winter 
(November to April). On the null hypothesis that the occurrence in summer is the 
same as the winter, then following equation (2.2), the statistic 
 






/ 2 / 2
/ 2 / 2
       
Ratio








has c2 with df =1. 
Since S1 follows a binomial distribution with sample size N and parameter p 
estimated by S1/N. For large samples, the 95% CI for p is  
 1 1 2 1 1 2/ 1.96 /  to / 1.96 /S N S S N S N S S N− + . (2.20) 
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From this, since the ratio φ = p/(1 – p) is estimated by S1/S2, the 95% CI for φ is 
 1 1 2 1 1 2
1 1 2 1 1 2
/ 1.96 / / 1.96 /
 to 
1 ( / 1.96 / ) 1 ( / 1.96 / )
S N S S N S N S S N
S N S S N S N S S N
− +
− − − + . (2.21) 
For the data in Table 2.1, S1 = 77 and S2 = 99. The corrected total numbers of 
occurrences are 76.35 and 99.65, respectively (§2.8). The function Ratio gives the 
ratio φ = 0.766, TRatio = 3.439 (p = 0.064) and the 95% CI for the ratio is from 0.5639 
to 1.0285. 
 
Lorenz curve and Gini index 
To construct the Lorenz curve (Lee, 1996), the monthly incidences are first ranked 
from the lowest to the highest. These monthly incidences are calculated by dividing 
the monthly number of cases by the number of days in each month. Thus, the months 
are also reordered according to the ranked monthly values. The Lorenz curve plots the 
cumulative percentage of cases against the cumulative percentage of days during the 
study period. The Gini index (G) is defined as twice the area between the Lorenz 
curve and the 45° diagonal line. Clearly, 0 < G < 1. Lee (1996) used data from 
Edwards (1961) (Table 2.1) to illustrate the methodology. The function Gini plots the 
Lorenz curve and calculates G. By applying Gini to the Edwards (1961) data set, the 
Lorenz curve of Figure 2.5 agrees with that of Lee (1996), but G = 0.1904 differs 
from that quoted by Lee (1996) of 0.1881. 
A large G means that the cases are more concentrated in particular months, 
while a smaller index or a flatter curve indicates a more uniform distribution. 
However, it is not straightforward to test if this figure is statistically larger than zero 
as G does not have a theoretical reference distribution (Lee, 1994). To determine 
whether G = 0.1881 is statistically larger than zero, Lee (1994) performed 10,000 
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simulations, each with sample size of 176.  He found the 99th and 95th percentiles of 
the simulated sampling distribution to be 0.2072 and 0.1843. Therefore, the null 
hypothesis: G = 0 can be tested to give p ≈ 0.05 as 0.1881 is very close to 0.1843. 
 
Figure 2.5 The Lorenz curve for the birth of anencephalics to primiparous women in 
Birmingham, England during 1940 – 1947 (data used by Edwards, 1961 and Lee, 
1996). 
 
G can be also interpreted as a probabilistic measure of temporal clustering. 
Lee (1994) shows that the clustering probability (cp) that a randomly selected case 
arrives from a month whose incidence of disease occurrence is higher than a 
randomly selected month is cp = (1 + G)/2. For the data in Table 2.1, cp = (1 + 
0.1881)/2 = 0.5941. Therefore, we can infer that the cases of anencephalics are not 
very concentrated in particular months even though the seasonality test is suggestive 
of a significant temporal variation (p ≈ 0.05). 
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Gini tests are able to deal with calendar effects, such as the variation in month 
length, the irregular number of weekend days in each month, and the occurrence of 
holidays. The calendar effects can produce spuriously significant seasonal effects if 
they are not taken into account properly in the analysis (Walter, 1994). For control of 
the calendar effect, one needs only to plot the cumulative percentage of cases against 
the cumulative percentage of relevant denominators. The others remain the same. 
Edwards and Roger tests can also be modified to cope with the problem of calendar 
effects, however the modification is not so straightforward as they destroy the 
symmetry of θg over the whole year.  
 
2.7 Periodic regression  
Bliss (1958, 1970) provides a detailed description, under the term periodic regression, 
of the use of sinusoids in the analysis of the biological cycles. The simplest sine curve 
is a generalization of Roger’s method of the form  
 0 1 1cos sin  Y α β θ γ θ ε= + + +  (2.22) 
where Y is the dependent variable, α0 is a constant, β1 and γ1 are regression 
coefficients, θ is time of year expressed in radians and ε is an error term. The 
coefficients in the fitted sine curve can be computed using least squares fitting 
programs in the standard computer software. These can be found using the least 
squares fitting function ‘lsfit’ from S-PLUS. Russell et al (1993) applied such an 
analysis to births in Scotland over the years 1938 – 1987 and Douglas et al (1999) has 
applied this method to data on the presentation of leukaemia and Non-Hodgkin’s 
lymphoma in England and Wales during the years 1984 – 1993. They name such 
analysis cosinor analysis. It is possible to extend the cosinor model (2.22) by adding 
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more cosine terms thereby creating rather complex models and ones which are then 
more difficult to interpret.  
  
2.8 Adjustments for unequal month length and leap years  
In the preceding sections of this Chapter, we have usually assumed the 12 months of 
the year to be of equal length (days). We now assume that the onset of disease in a 
patient is ascribed to a particular date and this has been recorded.  
 Each calendar year consists of either 365 or 366 days depending on whether or 
not the year is a leap-year. Clearly if we give the onset of a particular disease a date, 
for example 16 March 2000, then convention defines this as the 76th day of the year 
since 2000 was a leap-year. Thus the date is converted to a day, d, which in turn can 
then be converted into an angle, θ, measured in degrees for standard and leap-years 
by:  
 360 360 or 
365 366
d dθ θ= = .    (2.23) 
 Thus 16 March 2000 corresponds to [(31 + 29 + 16)/366] × 360 = (76/366) × 
360 = 74.75° and, in the case of 16 March 2001, this is [(31 + 28 + 16)/365] × 360 = 
(75/365) × 360 = 73.97°. This angle is measured in a clockwise direction starting from 
01 January. 
If the date of onset for each subject is given then this allows the individual 
event to be allocated to one of 12 ‘standard’ months of duration 365/12 = 30.42 days 
or 366/12 = 30.50 days for a leap year, counting from 01 January of each year. These 
standardised months can then be labelled as January to December. 
In many studies of the seasonal onset of disease, monthly (grouped) data, 
rather than individual daily data are presented and analysed. Thus the actual date of 
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onset itself is not utilised. In these circumstances many authors, for example, 
Bounameaux et al (1996) and Badrinath et al (1997), appear to overlook the fact that, 
if monthly counts are made, some adjustment is necessary as the 12 calendar months 
are not all of equal duration. For example, January has 31 days while February, in 
non-leap-years, has 28. Thus one would expect, on the basis of a uniform distribution 
of events over the year, that 10% [(31/28) × 100] more events would therefore occur 
in January than February. If no account of such differences in the number of days per 
month is taken, then the true pattern of underlying seasonal variation may be obscured 
(Tomkinson, 1996). Walter (1994) also points out that special considerations may 
have to be made for weekends and public holidays in some contexts. 
 If monthly counts are made, although some adjustment is really necessary as 
the 12 calendar months are not all of equal duration, each month has an angle of 30°, 
sometimes termed ‘bins’, and the whole year corresponds to 360°. Therefore, the 
angular mid-point of corresponding month is utilised in the subsequent analysis.  
 If individual dates are not available for the individual subjects, then one makes 
the following adjustments. The first adjustment reduces the frequency in those months 
of 31 days by 30/31 = 0.96774, leaves those of 30 days unchanged and increases the 
February count in a manner dependent on the number of leap-years included in the 
study.  For 2 leap-years in 8 years the divisor will be (6 × 28 + 2 × 29) / 8 = 28.25 and 
the February adjustment will be 30/28.25 = 1.06195. The sum of these adjusted 
frequencies is N′ and is less than N. As a consequence, each of the 12 adjusted 
frequencies has to be further adjusted by multiplication by N/N′ to preserve the total 
number of subjects.  
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For the data of Table 2.1, the adjustment process clearly increases the 
February count from 19 to 20.42 (Table 2.6) while decreasing those of January, May, 
July, August, October and December, albeit the modal month remains as October.  
 Almost equivalently, one can first calculate the average number of days per 
‘standard’ month taken over the duration of the study. For example, for monthly 
births of anencephalics (Table 2.1) there are two leap–years and so there are (6 × 365 
+ 2 × 366) = 2922 days in total and therefore the ‘standard’ month has 2922 / (8 × 12) 
= 30.4375 days. Thus the numerator of 30 used for the correction described above, is 
replaced by 30.4375. Finally an adjustment of the form N/N′ is required. The final 
frequencies obtained by the two methods are numerically equal to several decimal 
places. We have adopted the latter approach in our calculations.  
Adjustments can be made for seasons (3 months of accumulated data) using a 
similar approach, although the definitions of the month to include in a ‘season’ often 
differ between studies. In this situation the second method of adjustment is more 
flexible. In one year, the number of days from March to May is 92, from June to 
August is 92 also, and from September to November is 91. The days from December 
to February are 90 for non-leap years or 91 for a leap-year. The length and hence 
number of ‘seasons’ may also differ depending on the geographical location of the 
study in question. 
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Table 2.6 Calculation of the frequency, by two methods, in 12 standardised months for births of anencephalics in Birmingham (data from 
Edwards, 1961) 
 
      Method I     Method II     
 Month Reported 
frequency 
(Ng) 

















               
 Jan 10   0.96774 9.68 9.79   0.98185 9.82 9.79  15  
 Feb 19   1.06195c 20.18 20.42   1.07743 20.47 20.42  45  
 Mar 18   0.96774 17.42 17.63   0.98185 17.67 17.63  75  
 Apr 15   1.00000 15.00 15.18   1.01458 15.22 15.18 105  
 May 11   0.96774 10.65 10.77   0.98185 10.80 10.77 135  
 June 13   1.00000 13.00 13.16   1.01458 13.19 13.16 165  
 July 7   0.96774 6.78 6.85   0.98185 6.87 6.85 195  
 Aug 10   0.96774 9.68 9.79   0.98185 9.82 9.79 225  
 Sep 13   1.00000 13.00 13.16   1.01458 13.19 13.16 255  
 Oct 23   0.96774 22.26 22.52   0.98185 22.58 22.52 285  
 Nov 15   1.00000 15.00 15.18   1.01458 15.22 15.18 315  
 Dec 22   0.96774 21.29 21.55   0.98185 21.60 21.55 345  
                
 Total N = 176    N′ = 173.94 176.00    N′′ = 176.45 176.00    
                
a Obtained from previous column after multiplying by N/N′ = 176/173.94 = 1.01184. 
b Obtained from previous column after multiplying by N/N′′ = 176/176.45 = 0.99745. 
c Including 2 leap-years – adjustment factor (8 × 30)/(6 × 28 + 2 × 29) = 1.0619 
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2.9 Comparisons of the alternative tests 
For comparison purposes we have applied the statistical tests for seasonality 
summarised in this Chapter to the data reported on ALL which we discuss later in 
Chapter 5 and list in Appendix I7. We conducted a reanalysis for the respective total 
samples from each study and not for any sub-group. The calculations using Tp, TE and 
TR are given in Table 2.7 and those from the non-parametric tests, TDN, TH, KT N , 
TRatio and G in Table 2.8. The studies in these two tables are listed in the same order 
(the study names are omitted in Table 2.8). When it is necessary, the monthly counts 
are first corrected to the standard month length before the tests are applied. Because 
the studies in Harris et al (1987) were conducted in 9 different locations in the USA, 
and the study period in each location is different, we first correct the monthly counts 
in each location and then combine them before analysis. These analyses are compared 
with the corresponding analysis conducted using the Mardia test of Chapter 3, which 
are summarized in Tables 5.7 to 5.10.  
Ties occur frequently in the monthly counts or corrected monthly counts. 
Hence TH is not applicable to most of the studies (Table 2.8). Consequently we are 
unable to make comparisons with the other tests. For ease of description, we take a p-
value of < 0.05 to indicate ‘statistical significance’ but are aware that this simple 
dichotomy will not be relevant in all cases. Tables 2.7 and 2.8 provide examples of 
inconsistent results with respect to the p-value, and hence statistical significance, 
obtained from the different tests. For example, applying Tp to the data of Karimi and 
Yarmohammadi (2003) gives p = 0.037 (statistically significant) in contrast to TE (p = 
0.679), TR (p = 0.572), TDN (p > 0.05). TK N  (p > 0.1), TRatio (p = 0.356) and G (p > 
0.05) all of which are not significant. In fact they reported a significant peak in 
October stating p < 0.05 (despite the value given in their Table 1 of p = 0.3254) using 
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a χ2 test. They did not specify if Tp or TE was used. Our analysis shows a non-
significant peak of October 31 (pMardia = 0.565). Similarly the data of Douglas et al 
(1999) give a Tp (p = 0.039) which is significant in contrast to TE (p = 0.775), TR (p = 
0.810), TDN (p > 0.05), TDN (p > 0.1), TK N  (p > 0.1), TRatio (p = 0.895) and G (p > 
0.05) which are not. In their paper a non-significant peak in April (p = 0.630) using 
periodic regression was reported (see §2.7). This peak is close to our estimate (March 
25) but with a dissimilar test result (pMardia = 0.806). The conclusion re significance 
would be different had Tp (p = 0.039) been used. The data from Hayes et al (1961) 
shows a significant peak by TE (p = 0.017), TR (p = 0.024) and some non-parametric 
tests: TDN (0.01 < p < 0.05) and G (0.01 < p < 0.05) but not with Tp (p = 0.447), 
TK N  (0.05 < p < 0.1) and TRatio (p = 0.351). Hayes et al (1961) reported absence of 
seasonal variation by using Tp (p < 0.5), a finding inconsistent with ours (pMardia = 
0.022).  A significant peak would also be identified if either TE, TR, TDN or G were 
applied. In contrast, data from Badrinath et al (1997) identifies a significant peak by 
all but one test: Tp (p = 0.042), TE (p = 0.005), TR (p = 0.005), TDN (p < 0.01), TK N  
(p < 0.01) and TRatio (p = 0.0003) but G (p > 0.05). Thus the summer peak reported, 
using TRatio, is consistent with pMardia = 0.004, and is detected by most of the tests 
available. 
We note that TE and TR always give similar results. A significant peak is 
detected in the three studies of Lee (1963), Badrinath et al (1997) and Gilman et al 
(1998) using Tp, TE, TR, TDN, KT N  and TRatio. However, the corresponding G remain 
small ranging from 0.075 to 0.113 with all the corresponding p–values > 0.05.    
The diversity of possible p-values provided by the individual tests used, 
suggests that the conclusions drawn with respect to seasonality, or the lack thereof, 
may depend on the particular analytical method adopted. Some of these differences 
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are substantial whilst others are small and may not change the interpretation a great 
deal. The differences suggest that a common analytical approach would be desirable. 
 
2.10 Comments 
As already mentioned, the most widely used tests for seasonal variation in studies of 
presentation of the disease have been Tp and TE. Although I have not done an 
exhaustive search TDN, TH, KT N  and G do not appear to be prominent in the 
medical literature. In the 16 studies we reviewed (Tables 2.7 and 2.8), Tp has been 
used twice, TE 5 times and TRatio (more precisely φ) 5 times (Tables 5.3 to 5.6) 
although Tp testing for heterogeneity is inappropriate for the seasonal variation. No 
studies have used individual date of onset in the analysis. 
An important practical problem is the performance of these tests for detecting 
seasonality in monthly data. Marrero (1983) using simulation compared TE, TR, TSL, 
TH, TK, TDN and two other tests which are not discussed in this thesis. One is harmonic 
analysis (Pocock, 1974) and the other an extension of TE, with an underlying 
sinusoidal model with two peaks and two troughs (Cave and Freedman, 1975). 
Marrero (1983) considered various sample size of N = 25, 50, 100, 500 and 1000 and 
type I and type II error rates of these tests at nominal significance level, α = 0.01 and 
0.05. Three models were used for the variation: annual sinusoidal with one peak and 
one trough; semi-annual sinusoidal with two peaks and two troughs; and a curve 
which is constant in all but three consecutive months of the year, when it exhibits a 
constant increase (a “one-pulse” model). Marrero (1983) concluded that  
(i) if the data appear to follow a sinusoidal curve with one peak and one trough, 
any one of the tests of TE, TR, TDN, TSL and TK would be appropriate in larger 
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sample sizes. For smaller sample sizes, the type I error rates associated with TE 
are too high.   
(ii) if the data appear to follow a model other than a sinusoidal curve with one 
peak and one trough, or two peaks and two troughs, then it is unclear whether 
any one of the tests under consideration is adequate for statistical testing of 
seasonality. 
In general, he suggested that it is good idea to first plot the data. Such a plot would 
indicate which model might be more appropriate to the data under consideration.  
The performance of G was compared with TP, TE, TR and TK by Lee (1996). 
Although Lee (1996) does not specifically identify the von Mises distribution (see 
§3.4), he describes 5 different models for seasonality with a brief description of 
situations in which they may be useful. These include a simple sinusoidal curve with 
essentially one peak and one trough (the cosinor model) and a sinusoidal curve but 
with two peaks and two troughs within a year. There is a one-peak model that he 
states reflects, for example, the situation when the particular disease occurs 
predominantly in some of the hottest months of the year. The one trough model, 
which, for example, may happen when the infectivity of a transmissible disease is 
greatly reduced in some months, perhaps because of specific climatic conditions in 
these months. A one-peak one-trough model, which simulates an epidemic (the peak) 
that wipes out the pool of susceptibles and/or builds up herd immunity, hence a trough 
follows. These alternatives emphasise how important it is to take note of the possible 
underlying mechanisms for the disease onset before selecting a model.    
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Table 2.7 Re-analysis of previously published studies on the presentation of ALL using grouped methods  
 
No. Study N  Age TP p-value TE  a 0θ  p-value TR  p-value 
             
 Onset            
             
1 Lee (1963) 674  0 − 44 25.437 0.008 10.029  0.173 Jul 20 0.007 10.496  0.005 
             
2 Meighan (1965) 214  0 − 14 11.639 0.391 1.404  0.115 Jul 01 0.496 1.508  0.471 
             
3 Harris (1984) 101  0 − 14 17.261 0.100 2.272  0.212 Apr 25 0.321 2.677  0.262 
             
 Symptom            
             
4 Till (1967) 372  0 − 9 10.429 0.492 0.004  0.005 Jan 22 0.998 0.006  0.997 
             
5 Westerbeek (1998) 1055  0 − 14 17.463 0.095 2.231  0.065 Mar 07 0.328 2.251  0.325 
             
6 Karimi (2003) 211  0 − 15 20.698 0.037 0.773  0.086 Nov 04 0.679 1.116  0.572 
             
 Diagnosis            
             
7 Hayes (1961) 86  0 − 78 10.954 0.447 8.175  0.436 Mar 29 0.017 7.451  0.024 
             
8 Walker (1982) 1783  All 8.910 0.630 0.395  0.021 Mar 17 0.821 0.388  0.824 
             
9 van Steensel-Moll (1983) 233  0 − 14 9.521 0.574 0.533  0.068 Jan 16 0.766 0.657  0.720 
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(Continued)            
No. Study N  Age TP p-value TE  a 0θ  p-value TR  p-value 
             
10 Harris (1987) 1221  0 − 19 19.914 0.047 3.595  0.077 Mar 02 0.166 3.298  0.192 
             
11 Badrinath (1997) 515  All 20.214 0.042 10.715  0.204 Jul 25 0.005 10.590  0.005 
             
12 Westerbeek (1998)* 1070  0 − 14 13.032 0.291 3.919  0.086 Jul 04 0.141 3.762  0.152 
             
13 Douglas (1999) 1369  0 − 14 20.533 0.039 0.510  0.027 Mar 29 0.775 0.421  0.810 
             
14 Ross (1999) 5532  0 − 19 14.056 0.230 9.292  0.058 Jul 09 0.010 9.184  0.010 
             
15 Timonen (1999) 64  16 + 17.319 0.099 8.249  0.508 Jan 28 0.016 8.416  0.015 
             
 Registration             
             
16 Gilman (1998) 1340  All 25.515 0.008 9.125  0.117 Aug 06 0.010 8.524  0.014 
             
* Note ‘symptom’ given above.
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Table 2.8 Non-parametric analysis of previously published studies on the presentation of ALL  
 
No. TDN p-value TH p-value KT N p-value φ TRatio 95% CI p-value G p-value 
             
1 3.347 < 0.01 53 − 1.773 < 0.01 1.297 11.242 1.115 to 1.513 0.001 0.099 > 0.05 
             
2 1.909 > 0.05 48 − 0.942 > 0.1 1.102 0.505 0.843 to 1.446 0.447 0.128 > 0.05 
             
3 1.404 > 0.05 45.5 − 1.225 > 0.1 0.858 0.594 0.573 to 1.267 0.441 0.218 < 0.01 
             
4 0.529 > 0.05 43.5 − 0.794 > 0.1 0.975 0.061 0.795 to 1.195 0.805 0.093 > 0.05 
             
5 2.437 > 0.05 50.5 − 1.218 > 0.1 0.932 1.292 0.826 to 1.052 0.256 0.070 > 0.05 
             
6 1.089 > 0.05 42.5 − 1.039 > 0.1 1.136 0.853 0.867 to 1.495 0.356 0.162 > 0.05 
             
7 2.614 0.05 > p > 0.01 55 − 1.335 0.1 > p > 0.05 0.817 0.868 0.526 to 1.247 0.351 0.201 0.05 > p > 0.01 
             
8 1.012 > 0.05 48 > 0.05 0.827 > 0.1 0.986 0.088 0.899 to 1.082 0.767 0.043 > 0.05 
             
9 1.192 > 0.05 45 − 0.745 > 0.1 0.866 1.204 0.667 to 1.119 0.273 0.108 > 0.05 
             
10 1.605 > 0.05 45 > 0.05 1.392 0.1 > p > 0.05 0.920 2.140 0.822 to 1.029 0.134 0.072 > 0.05 
             
11 3.539 < 0.01 55 − 1.787 < 0.01 1.374 12.810 1.156 to 1.642 0.0003 0.113 > 0.05 
             
12 2.099 > 0.05 50 > 0.05 1.073 > 0.1 1.140 4.579 1.011 to 1.286 0.032 0.062 > 0.05 
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(Continued)            
No. TDN p-value TH p-value KT N p-value φ TRatio 95% CI p-value G p-value 
             
13 1.378 > 0.05 45.5 − 0.820 > 0.1 1.007 0.017 0.906 to 1.120 0.895 0.073 > 0.05 
             
14 3.069 0.05 > p > 0.01 55.5 − 1.538 0.05 > p > 0.01 1.057 4.319 1.003 to 1.115 0.038 0.024 > 0.05 
             
15 2.789 0.05 > p > 0.01 51 − 1.398 0.1 > p > 0.05 0.516 6.522 0.289 to 0.840 0.011 0.300 < 0.01 
             
16 2.935 0.05 > p > 0.01 51 > 0.05 1.465 0.05 > p > 0.01 1.158 7.163 1.040 to 1.290 0.007 0.075 > 0.05 
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3 Angular methods – univariate 
 
3.1 Introduction 
To identify the seasonal patterns, a variety of statistical methods often based on the 
monthly or quarterly frequencies have been used and not therefore using the 
individual patient specific dates directly. Some potential problems associated with 
grouping onsets into monthly or arbitrary seasonal periods are, as Tomkinson (1996) 
indicated, the months of the year are not of equal length, and wide variations in 
weather conditions may occur within any given month; this is a particular problem in 
the UK. Freedman (1979) also points out that compressing the data into monthly 
totals, if individual dates are available, can only be used in the absence of a long-term 
trend in the data. He states: “… , if there is a long-term decline in the incidence of a 
disease and no seasonal variation, then combining months …. will result in an 
apparently steady decrease in the numbers from January to December and perhaps the 
erroneous conclusion that some type of seasonal variation is present”. The object of 
this chapter is to describe an approach for use with individual dates, first suggested by 
Batschelet (summarised somewhat later in Batschelet, 1981) and detailed by Mardia 
(1972), Machin and Chong (1998) and Mardia and Jupp (2000, Chapter 3).  
Although some of the techniques described here have been long established, 
indeed Florence Nightingale (1820 − 1910) introduced the rose diagram format. Her 
example presented the changing mortality in hospitals in the Crimea, Ukraine over a 
one-year period from 01 October, 1854 including before-and-after the commencement 
of sanitary improvements in the military hospitals of the Crimean War at Scutari and 
Kulali. The diagram also indicated the much lower mortality in military hospitals near 
London, England (see Crichton, 1998). However, they have not been widely used in 
the medical literature. The method is based on regarding the calendar year as a circle 
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and identifying each date of onset as a point on that circle. On the assumption of a 
peak onset for a disease, this circular or angular methodology then identifies the point 
on the circle corresponding to this (single) peak and estimates its magnitude. By using 
the actual date, rather than say month, of occurrence it is thus more sensitive than 
some of the common methods used.   
 
3.2 Data display 
Angular 
As we have indicated, many investigators group their data into monthly bins and so 
do not always use the full information provided by the data in their analysis of 
seasonal effects. The simplest representation of the individual dates of disease onset is 
to plot each observation as a point on the unit circle at the corresponding angle.  
 
Figure 3.1 Circular plot of the dates of onset of APACG (part data from Seah et al, 
1997). 
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Figure 3.1 shows the dates of onset of acute primary angle-closure glaucoma 
(APACG) for 132 persons with a single eye affected in the complete year 1995 in 
Singapore. Full details of the study are given by Seah et al (1997). They found that 
attacks were more frequent on hotter days. The individual data for these 132 cases is 
given in Appendix I1. In this plot a bin of 5° is used, that is the points in the same bin 
have angles that are the same or similar. Figure 3.1 is suggestive of two rather flat 
peaks, one in the interval 45° − 180° and a second between 230° and 305°. More 
details of the angular analysis are given in §4.5. 
 
Histogram 
When investigating seasonality, it is common practice to sum the monthly data over 
the years and plot these in histogram format, usually beginning with January. In 
addition, the summated year representing the 12 groups may be repeated once to 
emphasise the circular nature of the calendar. If the summated year is not repeated, 
then a superficial examination of such a histogram may, for example, suggest two 
peaks. One peak at the beginning of the year and a second towards the end, whereas 
there is, in reality, only a single peak somewhere over the December to January 
period.  
 Bounameaux et al (1996) described seasonal variation in suspected and 
confirmed deep vein thrombosis over the period January 1989 to December 1994 
inclusive. They used counts accumulated on a seasonal basis and presented confirmed 
deep vein thrombosis graphically by season: autumn (September, October, 
November), winter (December, January, February), spring (March, April, May) and 
summer (June, July, August). They conclude: “ ... , there is no seasonal variation in 
the incidence of suspected and confirmed deep vein thrombosis”. However, the 
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corresponding monthly counts have been made available to us (Appendix I2) and 
these have been accumulated for the confirmed deep vein thrombosis cases into 
adjusted monthly totals in Figure 3.2. This ‘repeated’ histogram shows there is weak 
evidence for a single peak over the September to January period.  
 
Figure 3.2 Repeated histogram of the monthly onset of confirmed deep veined 
thrombosis during 1989 − 1994 in Geneva, Switzerland (data provided by 




The observed device of repeating the data for a second year in Figure 3.2 can 
(visually) mislead, as there appears to be much more data (the repeated year) than is 
really the situation. To avoid this difficulty, grouped frequency data can be plotted on 
polar coordinate paper in the form of the Nightingale rose diagram, with each month 
covering an arc of 360/12 = 30°. Clearly, if the data were, for example, weekly 
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counts, this arc would be 360/52 = 6.92°. However, the area of each segment (petal) 
of the rose increases with the distance from the centre. In view of this, the square root 
of the count per month is plotted to preserve equal areas for each unit of frequency as 
for a conventional histogram. This is the same as the suggestion of g gw N= of 
Edwards (1961). Figure 3.3 shows the rose diagram for the data used in Figure 3.2 
and illustrates some evidence of a peak in December/January as we have indicated. 
Notice that the January mode is less pronounced in the rose diagram than the 
histogram presentation.  
 
Figure 3.3 Rose diagram on the confirmed deep veined thrombosis during 1989 − 
1994 in Geneva, Switzerland (data provided by Bounameaux et al, 1996). 
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3.3 Summary statistics 
Mean direction 
Each date of onset within a calendar year can be expressed as an angle. The angle θ 
represents a point on a circle of radius 1 that has corresponding coordinates sinθ and 
cosθ. In view of this, to estimate the peak day, which is termed the mean direction as 
early examples of its use related to directions of flight after release of homing 
pigeons, for the N subjects observed at θ1, θ2, …, θN, it is first necessary to calculate 









= =∑ ∑ . (3.1) 
 The mean direction, µ, is then estimated by first solving the equation 
 0 0cos , sin
C SR R
N N
θ θ= = , (3.2) 
where R is the mean resultant defined in equation (3.4). Hence   
 0 arctan( / )S Cθ = , (3.3) 
where the solution for 0θ  is confined to the range − π/2 to + π/2. The estimated mean 
direction is then (i) 0θ  itself, if S > 0 and C > 0, (ii) 0θ + π, if C < 0 or (iii) 0θ + 2π, if 
S < 0 and C > 0. 
 Once, the mean direction in radians is obtained, it can be converted back into 
days of a 365 day year and the corresponding date for the peak determined. 
 
Magnitude of the peak 
Although the calculations described will, in most practical circumstances, identify a 
single date for the peak, it is also necessary to establish the associated magnitude. The 
magnitude is measured by the length of the mean resultant, R, given by 





+= . (3.4) 
 Values of R range between 0 and 1. Although R = 1 corresponds to all onsets 
occurring on the same calendar day in all years, a value R = 0 does not necessarily 
imply, as Fisher (1993) points out, a uniform distribution of disease onset over the 
year. For example, if onset dates actually occur in two clusters p radians (180°) apart, 
then R = 0 although the distribution of onset dates is far from uniform. In this case, a 
calculated value of R close to zero may suggest that a distribution with more than one 
peak is appropriate rather than that the distribution is uniform over the circle. An 




Fisher (1993, pages 75 − 76), see also Fisher and Lewis (1983, page 334), describes 
how a CI for the mean direction µ, may be derived. The 95% CI suitable for sample 
sizes of N ≥ 25, is 
 2 20 02 2
(1 ) (1 )arcsin 1.96  to arcsin 1.96
2 2NR NR

















The equation (3.5) can be written as 
 ( ){ } ( ){ }0 0 0 0arcsin 1.96  to arcsin 1.96SE SEθ θ θ θ− + , (3.6) 
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where ( ) 20 212σ SE NRθ −= = r  is termed the circular standard error of 0θ  and δ = Nσ2 
is the circular dispersion. Although not stated explicitly by Fisher and Lewis (1983, 
page 334), this only applies in the case of the product NR being not too small.  
 
Small samples 
In the case of N small (< 25), and also if NR is small, Fisher (1993) suggests a 
bootstrap technique to obtain a CI. The bootstrap methodology proceeds (with the use 
of some details of Appendix A, which contains the corresponding algorithms) in the 
following way: 
Step 1: Re-sampling 
Generate all required B bootstrap samples using a balanced re-sampling technique. 
Create a vector of length B × N consisting of the sequence θ1,…,θN repeated B times: 
1 2
1 1 1,..., , ,..., ,..., ,...,
B
N N Nθ θ θ θ θ θ
  
. 
Then apply a random permutation to this vector, obtaining  
1 2
* * * * * *
1 1 2 1,..., , ,..., ,..., ,...,
B
N N N BN N BNθ θ θ θ θ θ+ − +
  
. 
The result is B bootstrap samples which altogether contain equal numbers of the 
original θ1,…,θN. 
Step 2: Bootstrap estimate 
For the first bootstrap sample, * *1 ,..., Nθ θ , calculate the vector Z1 (Algorithm A1), the 
2 × 2 matrix V1 (Algorithm A2), the 2 × 2 matrix W1 (Algorithm A3), and finally, the 
bootstrap estimate of the mean direction for this bootstrap sample (Algorithm A4). 
Label this estimate *1ˆθ .  
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Step 3: Repetition 
Repeat Step 2 until the B bootstrap estimates * *1ˆ ˆ,..., Bθ θ  of the mean direction are 
obtained. 
Step 4: Confidence Interval 
To obtain a 100(1 − α)% CI for the unknown mean direction, µ, sort the B bootstrap 
estimates * *1ˆ ˆ,..., Bθ θ  together with estimated mean direction of the original sample 0θ  
into increasing circular order to obtain ( ) ( ) ( )1 1,..., ,...,l Bγ γ γ + , where ( ) 0lγ θ= . These are 
then reordered so that ( ) 0lγ θ=  is in the centre, that is, they are circular ranked so that 
B/2 are anticlockwise from 0θ  and B/2 are clockwise from 0θ . The 100(1 − α)% CI 
then cuts this ranking at the integer part of (Bα + 1)/2 in each tail, so that, L, the 
corresponding rank observations is L = int{(Bα + 3) / 2} from each tail end.  
For example, for B = 200 and assuming l = 107, 0θ  corresponds to g(107) will 
be in the centre of  
 ( ) ( ) ( ) ( ) ( ) ( )(12) 0 (108)7 107 201 1 2 6,..., , ,..., , , ...,γ γ γ θ γ γ γ γ γ=,..., . 
Thus for the 95% CI of µ, L = int{(200 × 0.05 + 3) / 2} = int(6.5) = 6. The 95% CI 
will be from γ(12) through 0θ  to γ(1).  
 
Very small samples 
Very small sample sizes (N < 9) tend to produce poor coverages for bootstrap CIs, 
regardless of which method is used to produce them (Fisher, 1993, page 207). This is 
due to the difficulties in the estimating covariance matrices from resamples containing 
a high degree of replication of data values. I have encountered this problem in 
Chapter 5 when calculating 95% CI in each ethnic group.  Fisher (1993, page 207 − 9) 
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suggests an iterated bootstrap method by estimating the relationship between nominal 
coverage and actual coverage and then selecting a nominal coverage which will 
produce the actual coverage we want. Again, this can only be done very 
approximately.  
A key question faced by anyone using the bootstrap is how large should B be. 
Ducharme et al (1985) and Fisher and Hall (1989) studied bootstrap analysis of 
directional data. Fisher and Hall (1989, page 1000) using simulation suggest that B = 
2,000 gave far less conservative confidence regions than B = 200. They also found 
that small numbers of samples (e.g., B = 200) can result in an erratic performance of 
the bootstrap. In all the actual examples we have studied, CIs are generated by the 
bootstrap technique using B = 2,000 bootstrap samples of the same sample size as the 
number of patients under consideration. Quite skewed CIs can result when the sample 
size N is small.    
 
3.4 Statistical models 
Since the distribution of onset dates is on a circle, rather than along a line, the use of 
the Normal distribution to describe their distribution is no longer appropriate. Several 
models have been proposed to describe seasonal data with a single peak. 
 
von Mises distribution 
Fisher (1993) termed the von Mises (von Mises, 1918) distribution as the ‘natural’ 
analogue of the Normal distribution for seasonal data with a single peak. 
A circular random variable θ, expressed in radians, which ranges from 0 to 2π 
(radians), has a von Mises distribution with parameters µ and κ, VM(µ, κ), if it has the 
following probability density function 
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θ κ θ µπ κ= −  (3.7) 
where  κ > 0 and 












 =   ∑k . (3.8) 
Here, I0(κ) is the modified Bessel function of the first kind and order zero.  
 
Figure 3.4 Probability density functions of the von Mises distribution with µ = 0°, for 
κ = 0.5, 1, 2, 4. 
 
When κ = 0 then I0(0) = 1 and equation (3.7) reduces to the uniform 
distribution on a circle. For small κ, I0(κ) ≈ 1, exp{κ cos(θ − µ)} ≈ 1 + κ cos(θ − µ) 
and 1( ) {1 cos( )} 
2vonMises
g θ κ θ µπ≈ + − tends to the Cardioid distribution. Mardia 
(1972) shows that, for large κ, the von Mises distribution is approximately Normal 
with mean µ and standard deviation κ−½. The proof is outlined in Appendix B. 
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The shapes of the corresponding VM(µ, κ) with µ = 0° for various values of κ 
are shown in Figure 3.4. The larger the value of κ, the greater is the clustering around 
the mode µ = 0°. 
The estimates of µ and κ are obtained using maximum likelihood. Thus the log 
likelihood function of a random sample θ1, …, θN is  
 01
0 0
cos( ) log 2 log ( )




L N N I
N R I
κ θ µ π κ
κ θ µ π κ
=
= − − −
= − − −
∑  (3.9) 
Since cosx has its maximum at x = 0, the maximum likelihood estimate of µ is 0θ  of 
equation (3.3). Differentiating (3.9) with respect to κ gives 








∂ = − −∂  (3.10) 
where I1(κ) = I0′(κ), the first derivative of I0(κ), is the modified Bessel functions of 
the first kind and first order. Then the maximum likelihood estimate κˆ  of κ is the 
solution of  







κκ κ= . The mean resultant R is obtained from equation (3.4) as 
described earlier.  
Limited tables of A−1 are given by Mardia (1972, page 298) and Mardia and 
Jupp (2000, page 363) based on those in Gumbel et al (1953) and Batschelet (1965). 
Mardia and Zemroch (1975) give a computer algorithm for calculating several 
circular statistics including κ which is obtained iteratively. The computer algorithm 
Newton for κ using Newton’s iteration method is given in Appendix H6. The κ agrees 
with the tables given by Mardia (1972, page 298) and Mardia and Jupp (2000, page 
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363) except when R = 0.94, 0.95, 0.96, 0.97, 0.98 and 0.99 is close to unity; situations 
which are unlikely to arise in practice (Table 3.1). However, the difference is not so 
great, the largest discrepancy is 0.01 when R = 0.99.  
Table 3.1 Comparing the maximum likelihood estimate of 
concentration parameter κ (reproduced from Mardia, 
1972, page 298) with that obtained by iteration when R is 
close to unity  
 
R κ a κ b 
   
0.94 8.6104 8.6103 
0.95 10.2716 10.2717 
0.96 12.7661 12.7668 
0.97 16.9266 16.9289 
0.98 25.2522 25.2579 
0.99 50.2421 50.2538 
   
a Reproduced from Mardia (1972, page 298). 
b Calculated by Newton. 
 The function A(κ) has the following power series expansions (Mardia and 
Jupp, 2000, page 40), (i) for small κ, 
 2 4 61 1 11( ) {1 }
2 8 48 3072
A …κκ κ κ κ= − + − +  (3.12) 
(ii) for large κ,  
 32 3
1 1 1( ) 1 ( )
2 8 8
A Oκ κκ κ κ
−= − − − + . (3.13) 
When R is small, we have from expansion (3.12) 
 2 41 1 1(1 )
2 8 48
R κ κ κ≈ − +  
and on inverting this series (Abramowitz and Stegun, 1965, page 16),  
2 41ˆ (12 6 5 )
6
R R Rκ ≈ + + . 
When R is large, we have from expansion (3.13) 





R κ κ κ≈ − − − . 
Again on inverting the series, we have 
2 3
2 3
1 2(1 ) (1 ) (1 )
ˆ
    3 4 .
R R R
R R R
κ ≈ − − − − −
= − +
 
By fitting a multiple linear regression to tabulated values of A−1(R) when 0.53 ≤ R ≤ 
0.85, an approximate method for solving equation (3.11) is described by Fisher (1993, 





2 5 / 6                       0.53
ˆ 0.4 1.39 0.43/ 1   0.53 0.85.
1/ 4 3                     0.85
R R R R
R R R
R R R R
κ
 + + <= − + + − ≤ ≤ − + >
 (3.14) 
In all the actual examples we have studied, these are very close to the exact 
(iterative) solutions for κ. 
Since A(κ) is a non-linear function, κˆ  is a biased estimator of κ. Fisher (1993, 
page 88) points out that the estimate of κ from (3.11) may be very biased and over 
estimate the true value if R is small (< 0.45). For small κ, equation (3.12) gives A(κ) ≈ 
κ/2, hence (3.11) gives κˆ  ≈ 2R. Thus E(κˆ ) ≈ 2E(R). Stephens (1969) states 
1( ) ( )
2
E R A κ
Nκ
≈ + . Hence, an approximation to the bias is 
 1ˆ( )E κ κ
Nκ
− ≈ . (3.15) 
This bias may become large when κ is small. For example, when N = 100 and κ = 0.1, 
the bias is approximately 0.1.   
If the data are assumed to have the von Mises form, then the CI for the mean 
direction is given by use of equation  (3.6) but with 
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 ( )0 1 .SE NRθ κ=  (3.16) 
A test for the presence of seasonality, as expressed by a single peak, is 
proposed by Mardia (1972) which is 
 2 22Mardia NRχ =  (3.17) 




As previously indicated, another distribution that has been proposed to describe 
seasonal variation is the Cardioid distribution (see Fisher, 1993, page 44) which takes 
the form 
 ( ) ( ){ }1 1 2 cos
2Cardioid
g θ θ µπ= + −r  (3.18) 
where µ is the mean direction and the mean resultant ρ is constrained to be ≤ ½ to 
ensure gCardioid(θ) ≥ 0. 
 The Cardioid equation (3.18) is equivalent to cosine distribution used in 
Edwards’s model (2.7). Edwards (1961) used it as the basis for his test of cyclic 
trends. Bastchelet (1981) points out that for the same value of the mean resultant, that 
is with the same degree of concentration around the mean, the points of inflection of 
the von Mises are closer to the peak than those of the Cardioid distribution. In 
general, the Cardioid distribution is more restrictive in the context of a single peak, as 
it requires the associated trough to be of equal magnitude and to occur at exactly 6 
months from this peak.  
 
 




Figure 3.5 Comparison of the probability density functions of the Cardioid (µ = 0° 
and ρ = 0.217) distribution and the von Mises distribution (µ = 0°, κ = 0.4 and 3). 
____ von Mises distribution, …….. Cardioid distribution 
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In addition, since ρ ≤ ½, the cosine distribution cannot be fitted to a sample 
with R (= ρ) > ½. This is illustrated in Figure 3.5 where, for κ = 0.4, there is almost 
no difference between the two distributions. However, for larger κ (shown = 3) the 
model extends to situations in which there is a clear peak around which presentations 
are lower but approximately constant for the remainder of the year. Such a situation, a 
strong peak over a limited period, cannot be described by Cardioid equation (3.18) or 
cosine distribution (2.7), as there is a restriction on the size of ρ but not κ.  
 
3.5 Pooled estimate of peak  
In §5.5 of this thesis, the pooled estimate of the peak date of ALL presentations from 
11 locations in the USA is obtained. The corresponding methodology required is 
summarised here.  
For each of i (i = 1, 2, … 11) locations the corresponding sample size, ni, 0,iθ , 
Ri, ki, di and si as defined in §3.3, are calculated (Table 5.13).  
Further we denote dmin, dmax respectively, as the minimum and maximum 
values of di. When the di differ substantially as defined by dmax / dmin > 4 as is the case 
with our example, Fisher (1993, page 120 – 121) gave the following method to 
calculate the pooled estimate 0θ . First define the quantities 




v v= ∑  (3.20) 
Then the weights   
 / ,i iw v v=  (3.21) 
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to give a pooled R as  
 .Pool i i
i
R w R= ∑  (3.22) 
Furthermore in an obvious notation   
 cos /w i i i i i i
i i
C w R w C nµ= =∑ ∑  (3.23) 
and 
 sin /w i i i i i i
i i
S w R w S nµ= =∑ ∑ . (3.24) 
A pooled estimate of the common peak 0θ  is then given by (3.3) using Cw and 
Sw in place of C and S. The associated circular standard error s is defined by  
 2 2 2 2 2/Pool i i i Pool
i
w R Rσ σ= ∑ . (3.25) 
Finally the 95% CI for 0θ  is 
 0 arcsin(1.96 )Poolθ σ± . (3.26) 
This expression is used to calculate the pooled estimate of the peak date of ALL 
presentations in the USA in Chapter 5. 
  
3.6 Grouped data  
If the data are grouped into a single year, then the grouped frequency version of 
equation (3.1) must be used, that is: 
 cos , sing g g g
g g
C N S Nθ θ= =∑ ∑  (3.27) 
Here Ng are the corrected (monthly) counts (see §2.8) and θg = (2g − 1)π/12 are the 
angular mid-point values of the corresponding bins, here petals. The remainder of the 
calculation follows as for equation (3.3). 
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 However, when the data are grouped into bins of width h°, a modification has 
to be made to equation (3.4), which becomes (Fisher, 1993, page 35; Mardia and 
Jupp, 2000, page 23) 





π= , where h is the arc width of the bin in radians, is termed the 
correction for grouping. If the data are grouped in bins of one month h = π/6, a(π/6) = 
1.0115 and this does not materially affect the calculation. However, if the data are 
grouped into bins of a season each of 3 months, then h = π/2, a(π/6) = 1.1107. If the 
data are not grouped then h = 0 and a(0) = 1. 












χ  + =    
× 
 (3.29) 
where C and S are from (3.27) and R is from (3.4).  
  
3.7 Illustration 
To test the variation in suspected and confirmed deep vein thrombosis in Geneva, 
Switzerland over the period from January 1989 to December 1994 inclusive 
(Bounameaux et al, 1996), we apply the Mardia analysis Peakgp to the (grouped) 
monthly data (Appendix I2).  
For suspected cases, Peakgp gives N = 7303, 0θ  = 342.14°, RGroup = 0.0105, 
χ2Mardia = 1.61 and p = 0.45, which confirms the absence of a peak. However, a similar 
analysis for the confirmed cases, gave N = 1905, S = −35.3820, C = 59.4392 and, 
since S < 0 and C > 0, equation (3.3) gives 0θ  = 329.24° or day 334 which is 30 
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November. In addition, from equation (3.28) RGroup = 0.0367 and equation (3.29) 
gives 2Mardiaχ  = 5.2497. Further, ρ2 = −0.0084, σ = SE( 0θ ) = 0.4429 and substituting 
these into equation (3.5) gives an approximate 95% CI for 0θ  as 268.99° (day 273) to 
29.48° (day 30). These can then be converted into dates as 30 September through to 
30 January. This analysis is suggestive of the presence of a rather flat peak centred at 
30 November. While, Bounnameux et al (1996) concluded that: “… there is no 
seasonal variation in the incidence of suspected and confirmed deep vein thrombosis”. 
 Fitting the corresponding von Mises distribution of equation (3.7) to the 
confirmed cases gives κ = 0.0735 from the first expression of equation (3.14). In this 
case use of the first term alone of this approximate solution, that is 2R only, gives κ = 
0.0734. Solving equation (3.11) using Newton gives the exact solution as κ = 
0.073449. For this example, there is very close agreement between these. From κ = 
0.0734 equation (3.16) gives SE( 0θ ) = 0.4414 and substituting into equation (3.6) 
gives an approximate 95% CI for 0θ  as 269.34° to (389.14 – 360) = 29.14°. These 
angles can then be converted into dates as 01 October through to 30 January, giving 
almost the same 95% CI as calculated earlier which did not assume the von Mises 
distribution form. 
 The CI is very wide in view of only a weak suggestion of a peak onset. 
Nevertheless, it may be important for the investigators to conclude an absence of any 
discernible pattern in clinical onset. 
 The fits of the von Mises and Cardioid distribution to these data by function 
Hist are illustrated in Figure 3.6 and are so close as to be essentially superimposed on 
each other. Again it is clear from this that there is little evidence of any strong 
seasonality.  
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Figure 3.6 The von Mises and Cardioid distributions fitted to the monthly onset of 
confirmed deep veined thrombosis during 1989 − 1994 in Geneva, Switzerland (data 
provided by Bounnameux et al, 1996). 
 
3.8 Technical problems 
Missing values 
One problem is that of missing values or incomplete years of observation. For 
example, a study involving incomplete years by Miller et al (1992) was briefly 
described in Chapter 1. They retrospectively reviewed the numbers of patients with 
pneumocystis carinii pneumonia presenting to the Middlesex Hospital, London, 
England from September 1989 to January 1992. Therefore the data from February 
1989 to August 1989 are missing. To circumvent this problem, a simple approach is to 
commence the calculations as from February 1990 (It is not essential to start the 
observation period as from 1 January), thereby having 2 complete years of 
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observation until January 1992. However, this ignores the information from the earlier 
months. Thus, if the years are incomplete, Machin and Chong (1998) recommend 
calculating in several stages. Firstly, starting from the beginning of the series, only 
include data in the calculations for the subsequent full years. The second calculation 
excludes the first month of this first calculation, but includes the (final) next month to 
make completed years. This process continues until the data comprise the completed 
years, backwards in time from the final month available. The results from these 
calculations are then averaged to give the estimated mean peak. An abbreviated 
approach is just to do the calculations for the first and last of these. 
 Clearly if there is a missing or an incomplete month of observation, within a 
series of monthly counts extending over many years, then replacing the missing count 
by the average for that month calculated from the remaining years will be satisfactory. 
However, it should be recognised that the N, of equation (3.17), remains to the 
recorded total count. This, and also expressions used in calculating CIs, should not 
include the missing month count that has just been estimated.  
 In order to calculate, for example, a CI for the mean direction when the month 
and year but not day of an individual presentation is available, a value corresponding 
to the mid-month (16 – 31 day month, 15 − 30 day month) can be given as the onset 
date. Alternatively, we could calculate the monthly counts in each year, then a random 
sample with replacement of the same sample size as the corresponding monthly 
counts between 1 and length of the corresponding month is selected. We used the 
latter method in the analysis of data from the Surveillance, Epidemiology, and End 
Results (SEER) Program in Chapter 5. 
No theoretical work on the potential influence of missing values on inferences 
drawn appears to have been conducted. 
    63
 
More than a single peak 
More care is needed when the onset of disease appears to have two or more peaks in a 
year. For example, Horne and Reyner (1995) investigated sleep-related vehicular 
accidents over the 24 h day. In their study there appeared to be three vulnerable times 
of the day. These were from 0200−0259 and from 0600−0659 in the morning and in 
the mid-afternoon from 1600−1659. The corresponding rose diagram (Figure 3.7), 
has each petal of arc 360/24 = 15°, to illustrate the hourly variation and indicates the 
three peaks. The data are listed in Appendix I3.  
 
Figure 3.7 Rose diagram for the data on sleep-related vehicular accidents 
(reproduced from Horne and Reyner, 1979, Figure 1). 
Except for the graphical aspects, the angular methodology we describe is not 
directly applicable to variation in count data with more than a single peak. Thus it is 
not directly applicable to the sleep related vehicular accident data. However, Mardia 
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(1972) described how the angular approaches might be adapted to some situations of 
multiple peaks by the multi-modal von Mises distribution 
 
0
cos{ ( )}1( )  0 2 ,0 2 /
2 ( )
κ l µ
vonMisesg e µ lI κ
θθ θ π ππ
−= < ≤ < ≤ . (3.30) 
Here l is the number of modes of the distribution situated 2π/l radians apart with the 
first mode at θ = µ. Figure 3.8 shows the probability density function of the bimodal 
von Mises distribution with µ = 90° and κ = 1. 
 
Figure 3.8 Probability density function of the bimodal von Mises distribution with µ 
= 90° and κ = 1. 
   
3.9 Applications 
The clinical publications concerned with seasonal variation are dominated by the 
Edwards test (Edwards, 1961). While there are many good reasons for this, at least 
part of the domination is due to the fact that Edwards test is easy to compute in 
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standard statistical software. Although the angular methodology is now long 
established (see Mardia, 1972; Batschelet, 1981; Fisher, 1993; Mardia and Jupp, 
2000), they do not seem to have been utilised in the medical literature to any extent. 
This may be because the techniques described here (and in Chapters 4) are not 
routinely accessed by medical researchers and epidemiologists.  
 
Sudden infant death  
Harris et al (1982) performed a retrospective review of 68 infants dying suddenly and 
unexpectedly between 1 July 1975 and 31 December 1979 in Southampton, England. 
Note the study period is incomplete years. In their study, they have used the rose 
diagram to show the seasonal distribution of these 68 sudden infant deaths. This rose 
diagram suggested clearly the excess of deaths in the winter months around January 1, 
but no formal estimate of the peak date, its magnitude or CI are given. The Mardia 
test for the presence of a single peak, gives 2Mardiaχ  = 13.7, df = 2 and p = 0.001. We 
are not able to confirm these calculations as the data are no longer available. 
 
Testicular torsion 
Kirkham and Machin (1983) reviewed the details of 42 patients from Southampton, 
England who had an orchidectomy for testicular torsion and for whom the date of 
onset of symptoms had been recorded. The symptoms of the disease manifest 
themselves rapidly and patients usually present within 1 day. The Mardia test was 
used in the testing for seasonal variation. Contrary to what had been suggested by 
other studies, they concluded: “In Southampton at least testes do not seem to be at risk 
from cold weather”. They used the individual dates of onset of symptoms in their 
analysis and these are listed in Appendix I4.  
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The individual data of Kirkham and Machin (1983) gives by Peak, for N = 42, 
0θ  = 305.06° which is equivalent to November 6, and the length of the mean resultant 
R = 0.0358. The results are the same as those given in Machin and Chong (1998) 
except they quote November 5.  
In all our reporting we use the convention of, for example, November 6 rather 
than 6 November, using the day as analogous to a figure after a decimal point, and the 
month as one preceding the decimal point.   
 Although N = 42 is greater than 25, NR = 42 × 0.0354 = 1.5 is small, so that 
equation (3.5) is not applicable to calculate the corresponding CI. Using Boots with N 
= 42 and sampling 2000 times gave a 95% CI for the mean direction from 144.63° to 
111.51°. The corresponding dates are May 27 through to Apr 24. The CI has a width, 
therefore, of 11 months, which reflects the lack of evidence for seasonality of onset of 
the torsion. This agrees with the calculation given in Machin and Chong (1998) in 




Gonzales et al (1996) reported that a higher incidence of corneal ulceration in the first 
three months of the years in Madurai District of South India. These corneal 
ulcerations are defined as a central stromal infiltrate with an overlying epithelial 
defect with or without a hypopyon, diagnosed clinically. They have tested the 
presence of seasonality by using χ2 test with df = 11 to the observed monthly 
frequency, not the adjusted frequency. Chong and Machin (1998) applied angular 
methods to these 1144 presentations with corneal ulceration. First they corrected 
unequal monthly frequencies to the 30 days and used a rose diagram to illustrate the 
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distribution of corneal ulceration. They calculated the peak to be February 11 with 
95% CI February 7 to 16. Further the Mardia test gave 2Mardiaχ  = 12.02, df = 2 and p = 
0.0025. Although the angular methodology used did not materially affect the 
conclusions, it did identify the peak onset more precisely.     
 Utilising Peakgp to the same grouped data (Appendix I5) gives 0θ  = 41.637 
(February 12), 2Mardiaχ  = 12.297, df = 2 and p = 0.0021. These are close to the results 
obtained by Chong and Machin (1998). However, our calculations from equation (3.5) 
yield the 95% CI to be from January 09 to March 17, while Boots gave from January 
07 to March 31. 
 
Thyroid cancer 
Akslen and Sothern (1998) examined seasonal variation in the presentation of 2627 
thyroid cancer cases diagnosed in Norway during 1970 – 1985. They noted: 
‘…significantly more cases presenting during the late autumn and winter’. However  
χ2 = 119.3 with df = 11 and p < 0.00001 obtained in Akslen and Sothern (1998) does 
not imply that there is therefore a (single) peak of presentation. The definitions of the 
seasons used in Akslen and Sothern (1998) are the four quarters of the year with 
winter as January, February and March. Thus the ‘seasons’ differ from those defined 
by Bounameaux et al  (1996) where winter begins in December. Machin and Chong 
(1999) pointed out the difference in season definition is one difficulty that arises if 
data are grouped for analysis and presentation. It also makes comparison between 
different studies difficult.  
Machin and Chong (1999) re-examined Akslen and Sothern (1998, Figures 1A 
and B) and identified a single peak at December 22 with 95% CI from December 03 
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to January 10. The Mardia’s test to the (grouped) monthly data gave 2Mardiaχ  = 38.01, 
df = 2 and p < 0.00001.    
Our calculations using Peakgp to the monthly total in Machin and Chong 
(1999, Table 1) (Appendix I6) give N = 2628, 2Mardiaχ  = 38.895 and p < 0.001 and 
identify a single peak at December 23 with 95% CI from December 04 to January 11.  
 
Suicides  
Parker et al (2001) examined the seasonal pattern in 3395 suicidal deaths in Singapore 
over the 10-year period from 1 January 1989 to 31 December 1998. The monthly 
suicide data were adjusted to notional months of equal duration.  
We examined for seasonal variation across four age ranges (– 24, 25 – 39, 40 
– 59, and 60 + years) as well as within the total sample, and separately for males and 
females. The peak date of suicide for the whole group was April 20, but the Mardia 
statistic ( 2Mardiaχ  = 1.56, p = 0.46) and the wide 95% CI of December 18 to August 15 
did not identify a statistically significant peak. The same conclusion holds for both all 
males and all females (Table 3.2). 
For the gender-specific age groups, only the group of females aged 25 or more 
suggested a statistically significant peak at May 07 ( 2Mardiaχ  = 5.65, p = 0.06) but with 
small R = 0.049 and wide 95% CI of March 20 to June 27. There was also a 
suggestion that both males and females less than 25 years had somewhat different 
patterns from the remaining subjects. The male peak (August 17, 95% CI June 01 to 
October 17) preceded that for females (October 03, 95% CI June 21 to January 21) by 
a little over 2 months. For both sexes, the estimated peaks in this age group preceded 
their older counterparts by 6 and 5 months respectively. There was less consistency in 
estimated peak dates among the different male age groups (ranging over a 4-month 
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interval from December 30 to April 22) than among the females (ranging from April 
07 to May 20). However, none of these comparisons was statistically significant in 
view of the associated low magnitude of R. 
Thus we conclude ‘no clear evidence of any seasonal pattern to suicidal deaths 
in Singapore’.  
 
3.10 Comments 
In this Chapter I have described the angular methodology for situations where 
seasonality can be summarised by a single peak. I tested my S-PLUS function in some 
previously published studies of sudden infant death, testicular torsion, corneal 
ulceration and thyroid cancer. The numerical results agree closely with those reported 
by the studies. I have also applied this methodology to an examination of deaths from 
suicide in Singapore.   
 In angular methodology, the peak is obtained by using the associated dates for 
each case, rather than first grouping by month. This precise estimate of the date of the 
peak onset with the associated CI, may also facilitate comparisons between published 
studies and hence lead to correct conclusions. For example, the conflicting peak 
onsets reported as autumn and winter in Allan and Douglas (1996) (see also Chapter 
1) may not be truly so inconsistent if each study had identified and reported date of 
peak. These summary data, such as date of peak 0θ , together with R, κ and CI, 
provide the essential components for appropriate overviews, or meta-analyses of 
studies. I investigate this issue further in Chapter 5.   
  The methodology I described in this Chapter is appropriate to many clinical 
fields.  Although I have focused on seasonal variation over a year, there are other 
applications where the time frame is different. In addition, some difficulties may be 
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encountered in the application of the methods, such as, missing values, incomplete 
years of observations or presence of long term trend. 
On a technical note although I have described in detail the calculation of CI by 
bootstrap for small samples, the calculation is not straightforward when the sample 
sizes are very small (N < 9). In this situation the iterated bootstrap involving a second 
bootstrap experiment within the basic bootstrap is suggested by Fisher (1993, page 
207 − 9).  
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Male All 2013  0.012 Feb 16  Sep 24 to Jul 26  0.54 0.76 
 – 24 272  0.087 Aug 17 Jun 01 to Oct 17  4.09 0.13 
 25 – 39  688  0.050 Dec 30 Oct 26 to Mar 29  3.51 0.17 
 40 – 59 538  0.025 Apr 22 Nov 19 to Oct 01  0.66 0.72 
 60 + 515  0.042 Mar 25 Dec 19 to Jul 20  1.85 0.40 
 25 + 1741  0.027 Feb 16 Oct 26 to May 06  2.53 0.28 
          
Female All 1382  0.033 May 19 Mar 01 to Aug 31  3.02 0.22 
 – 24 218  0.069 Oct 03 Jun 21 to Jan 21  2.06 0.36 
 25 – 39  437  0.071 May 20 Mar 11 to Jul 23  4.37 0.11 
 40 – 59 284  0.057 May 05 Jan 09 to Sep 23  1.84 0.40 
 60 + 443  0.029 Apr 07 Nov 14 to Sep 09  0.72 0.70 
 25 + 1164  0.049 May 07 Mar 20 to Jun 27  5.65 0.06 
          
*As the data are only available grouped by month there is some spurious precision in quoting the actual day but it is included here for 
illustration. 
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4 Angular methods – regression analysis and correlation 
 
4.1 Introduction 
In certain circumstance, it may be postulated that even if seasonality is indeed present 
different patient subgroups with the disease in question may follow different patterns. 
Thus Douglas et al (1998) reported, in patients with Hodgkin’s disease in England and 
Wales, a peak occurred in March in those with nodular sclerosing histopathology but 
a peak in August in those with lymphocyte predominant disease. For such situations, 
Stolwijk et al (1999) describe and illustrate (using partially fictitious data of boys and 
girls born with anencephalus) the use of a regression model using sine and cosine 
functions although still utilising accumulated monthly data. However, the Batschelet 
methodology has been extended by Mardia (1972) (see also Mardia and Jupp, 2000) 
and Fisher and Lee (1992) to include angular regression models which utilise 
individual patient dates. Apart from brief details given by us in Machin and Gao 
(2000), Gao et al (2001) and Gao and Machin (2004), applications of this extension of 
the angular methodology do not feature in the medical literature. In these three 
applications the seasonality of the presentation of the disease: breast cancer, 
childhood cancer and MRSA was investigated and the peak between patients with 
different characteristics were compared using angular regression. For example, the 
presentation of breast cancer in Singapore over the period of 1995 − 1998 was studied 
by us in Gao et al (2001). We compared seasonality between patients with respect to 
menopausal status, tumour size, estrogen and progesterone receptor (ER, PR) status. 
The angular regression suggested that the observed differences in peak between 
patients with different characteristics may be purely due to chance.  
 The primary object of this chapter is to describe this angular regression 
method using for illustration data from a study investigating the seasonality of onset 
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of APACG in Singapore (Seah et al, 1997) and the computer program I have 
developed. This regression approach, analogous to that used routinely in other areas 
of clinical research, potentially allows a more systematic and detailed investigation of 
possible seasonal patterns. Some of the work associated with this chapter is included 
in Gao et al (2002), where the first use of angular multiple regression is included but 
only involving dummy variables associated with age categories not for distinct 
covariates. However, in this chapter I include multiple angular regression with two 
covariates, age and gender. Further applications are given in Chapter 5.        
 
4.2 Estimation 
In the presence of a single covariate x of binary or continuous form, the linear 
regression model for θ is expressed as 
 ( )g xθ α β η= + + . (4.1) 
Here, α and β are the regression coefficients to be estimated, while the residual term, 
η, has a von Mises VM(0, κ) distribution. Clearly this model can be extended to 
include ν explanatory variables of any type. 
Finally, g is the link function whose role is to ‘convert’ the variable x from a 
linear to an angular variable.  Fisher (1993), see also Fisher and Lee (1992), suggests 
this should take the form g(βx) = 2arctan(βx) so that equation (4.1) becomes 
 2arctan( )xθ α β η= + + . (4.2) 
 In the situation of a binary variable, when x = 0 equation (4.2) becomes θ0 = α 
and when x = 1, θ1 = α + 2arctan(β).  Hence the angular difference is 
 1 0 2arctan( )θ θ β− = , (4.3) 
    74
 
following which 1 0tan
2
θ θβ −= . In this case, the regression model assumes that there 
are two peaks of onset for the disease in question, one for each group indicated by the 
binary variable x, but both with common κ and hence of equal magnitude, R. In these 
circumstances the model tests, through the null hypothesis H0: b = 0, for a zero 
angular distance between these peaks, that is, the two peaks corresponding to the 
levels of the binary variable coincide. 
 The corresponding maximum likelihood estimators of the parameters α, β and 
κ of equation (4.2) are values that maximise 
 0
1




L N I g xκ κ θ α β
=
= − + − −∑ . (4.4) 
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The corresponding estimates are the solutions of the following equations 
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=∑  (4.10) 
and    
 cos sin 0.NR C Sα α− + + =  (4.11) 
Equation (4.10) is the same as Fisher (1993, page 159, equation (6.57)) when a single 
covariate is considered. From equations (4.9) and (4.11), we have Rsinα = S/N and 
Rcosα = C/N, which are the same as equations (6.58) and (6.59) in Fisher (1993, page 
159). However, the definitions of C and S of equations (3.1) are first modified to 
(4.6). 
 The maximum likelihood estimates have to be found iteratively. The iteration 
begins by selecting a starting value for β set as b0. This then gives starting values for 
α = a0 and κ = k0 from equations (3.1) and (4.1). In the case of a binary variable a 
starting value is provided by b0 = tan{( 1θ  – 2θ )/2}, where 1θ  and 2θ  are the 
respective estimates of the mean directions µ1 and µ2 from the two groups being 
compared. The starting values are then used to obtain a revised estimate b1 from 





















This next iteration uses b1 in place of b0 in the right hand side of equation (4.12) and 
then uses equation (4.6), rather than (3.1) to estimate a1 and k1. The iteration continues 
until convergence and the maximum likelihood estimates a, b and k are obtained.  
This iteration procedure can be generalised for the case of multiple angular regression 
with more than a single covariate.  
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Example:  
In the binary case, suppose of the N subjects, m are observed at x = 1 and N – m at x = 




2 sin{ ( )}
1







κ θ α − ββ β
κ α αβ
=




Hence, the equation (4.10), derived from 0Lβ
∂ =∂ , is the same as (4.9) and equation 











β θ α β
=
+= + − −∑ . 
 
4.3 Confidence intervals 
















This can either lead to test of significance of the hypothesis: b = 0, through z = 
b/SE(b) or a CI for b can be derived. In the case of a binary variable, this provides a 
95% CI for δ = µ1 – µ2 as 
 { } { }2arctan 1.96 ( )  to 2arctan 1.96 ( )b SE b b SE b− × + × . (4.14) 
Alternatively, the likelihood ratio test of equation (2.12) can be used to test the 
hypothesis: β = 0 and this is the approach we have used in subsequent examples. 
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4.4 Computation 
No standard statistical computer software is commercially available for the estimation 
of the appropriate summary statistics, confidence intervals or for fitting the von Mises 
distributions although Lawson (1992) described how the latter may be fitted using 
weighted Poisson generalised linear models by using an approximation to the von 
Mises likelihood (Lawson, 1988).   
Neither is software available for fitting angular regression models. As a 
consequence, all the calculations described in this Chapter have been written and 
coded in S-PLUS for our purpose (Appendix H5).  
As a partial test of the program we have used the data from Fisher (1993, page 
252 − 3, Appendix B20). These data described the mean direction of movement of 31 
small periwinkles after they had been transplanted downshore from the height above 
water level at which they normally live. His regression model calculations yield 
estimates α = 97.0°, β = −0.0066 and κ = 3.2. Our calculations gives α = 97.039°, β = 
−0.00654 and κ = 3.187, which agree very closely. 
 
4.5 Illustration 
All ophthalmologists registered in Singapore agreed to notify a central registry of all 
new cases displaying classic signs and symptoms of APACG at their first 
examination. The physical discomfort and disturbance of vision cause the majority of 
persons to consult a primary care physician or ophthalmologist on the day they suffer 
an attack of APACG.  In a nationwide study of these self-referrals, those whose date 
of onset was established as between 01 January and 31 December 1995 were 
identified.  In addition to the estimated date of attack of APACG and the particular 
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eye, ethnicity, gender and age were recorded for each subject. Full details of the study 
are given by Seah et al (1997). 
During the study year 189 persons with APACG were seen by 
ophthalmologists and, amongst those with a single eye involved, the exact date of 
attack could be reliably determined in 132. An angular plot of these individual onset 
dates has been shown previously (Figure 3.1). These data provide an estimated peak 
of May 30 for all patients combined, although statistically significant ( 2Mardiaχ  = 
14.861, df = 2 and p = 0.0006), it is of modest magnitude (R = 0.237) (Table 4.1) with 
95% CI from May 06 to July 15. 
Peak presentation for females is approximately 4 weeks later than for the 
males (Figure 4.1), it is little affected by the (body) side of eye (1 week), but appears 
to peak later with increasing age of the patients (3 weeks per 10 years of age) – 
beginning in early May ending in late June. Thus the von Mises (single peak) 
distribution may not be a totally adequate description for the data. 
The associated univariate angular regression analyses for these patient 
characteristics are summarised in Table 4.2. As may be expected from Table 4.1, 
these analyses did not establish statistically significant differences in peak onset 
between males and females (p = 0.475) or attacks in the left or right eye (p = 0.816).  
The regression analysis for age (whether as an ordered categorical variable of 3-levels 
or a continuous variable) is also not statistically significant but is suggestive of later 
peak in the older patients. The tests of significance corresponding to the p-values of 
Table 4.2 were obtained from the corresponding likelihood ratio tests. 






Figure 4.1 Circular plot of the dates of onset of APACG with the corresponding peak 
onset date and its magnitude indicated by left or right eye involvement, age and 
gender (part data from Seah et al, 1997). 
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Table 4.1 Estimated peak date of onset and 95% confidence intervals of APACG for all patients, left or right eye involvement, age 


















           
All  132  0.237 0.489 147.82 May 30 May 06 to Jul 15 14.861  0.0006 
          
Gender Male 35  0.159 0.323 125.15 May 07 Feb 24 to Sep 16 1.778  0.411 
 Female 97  0.271 0.562 152.51 Jun 04 May 06 to Jul 07 14.220  0.0008 
          
Eye Left 71  0.281 0.586 150.39 Jun 02 May 05 to Jul 20 11.225  0.004 
 Right 61  0.187 0.381 143.31 May 26 Apr 06 to Aug 13 4.271  0.118 
          
Age – 59 44  0.288 0.601 125.98 May 08 Mar 29 to Jul 01  7.285  0.026 
 60 – 69 48  0.200 0.409 148.14 May 31 Apr 08 to Aug 18  3.857  0.145 
 70 + 40  0.275 0.571 172.89 Jun 25 May 12 to Aug 18  6.029  0.049 
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Table 4.2 Regression coefficients following univariate angular regression (part data from Seah et al, 1997) 
 
    Regression 
coefficient  
    
Difference  
Variable α° R κ β* SE (β)* 95% CI of β* p-value* (days) 
         
Gender (Male, Female) 145.21 0.2412 0.4971 0.2407 0.2915 –0.6387 to 1.3641 0.475 27 
         
Side (Left, Right) 147.12 0.2377 0.4894 –0.0618 0.2562 –1.0270 to 0.8296 0.816  7 
         
Age  148.28 0.2520 0.5208    0.375  
– 59    0 – –  –  
60 – 69    0.1959 0.2938 –0.7262 to 1.3146  22 
70 +    0.4152 0.3146 –0.3975 to 1.6021  46 
         
Age (Continuous) 150.35 0.2489 0.5140 0.0123 0.0122 –0.0232 to 0.0724 0.215  1 
         
* These estimates would usually be quoted to fewer decimal places in practical reporting situations.
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4.6 Technical details 
All the iterations to estimate the angular regression coefficients of a binary variable of 
Table 4.2 are displayed in Table 4.3. For each variable, two starting values b0 = 0 and 
b0 = tan{( 1θ  – 2θ )/2} are used. Although we have suggested starting values for the 
iterations to estimate the angular regression coefficients of a binary variable as the 
latter, we have not found in practice any advantage over commencing with b0 = 0. For 
example, Table 4.3 shows the convergence to the maximum likelihood solution is 
satisfactory with almost the same number of iterations for all comparisons of Table 
4.2.  
However the iteration does not necessarily always proceed so easily. To 
illustrate the difficulties Figure 4.2 shows the plot of the log likelihood (L), equation 
(4.4), contour for estimating the binary regression of gender (Figure 4.2a), side of eye 
involvement (Figure 4.2b) and when fitting age regarded as (essentially) a 
numerically continuous variable (Figure 4.2c). It is clear for gender and side that the 
iterations will converge with starting values chosen that are distant (between –2 and 
+2) from the maximum likelihood solution. Beyond this range the process may not 
converge. In contrast for the angular regression model to account for age, if the 
starting value for β is outside the approximate (and narrow) range –0.02 to +0.09, the 
procedure will not converge. 
This general feature was pointed out by Fisher (1993, page 160) who states 
that if the true value of β is close to zero, the likelihood can have peaks not only near 
β = 0 itself but also at infinite values of β.  This is reflected by the gradually 
increasing loglikelihood for values of |β| > 0.2. This is because any monotonic link 
function, such as that of equation (4.2), also leads to a null model with direction close 
to both a – π and a + π, which are coincident points on the circle. 
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To illustrate the likelihood surface with two covariates, Figures 4.3 and 4.4 
are the surface plots of L as a function of the angular regression coefficient vector (β) 
for gender and age for ALL in Singapore and in Central Sweden, respectively. The 
details of the multiple regression are given in Table 5.20. The only difference 
between plots (a) and (b) is a rotation so that the direction of viewing differs: the axes 
for gender and age are interchanged. In Singapore (Figure 4.3) L will reach its 
maximum of 3.6010 when the angular regression coefficient vector (β1, β2) for gender 
and age = (–0.6188, 1.1234). However, the iterations on gender and age will converge 
to coefficient (–1.2099, –5.1038) with starting values for gender and age = (–1.5, –
1.5) and hence L will reach its maximum of 3.3675. However, convergence do not 
occur with starting values for gender and age = (10, 2). Similarly, L will reach its 
maximum of 9.1946 when the angular regression coefficient vector (β1, β2) for gender 
and age = (1.2901, –1.2720) in Central Sweden. 
In §5.5 for gender the iterations converge to different values depending on the 
starting value chosen (Figure 5.4). This is because L has a bi-modal distribution with 
equal maximum values at two values of β.  
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Table 4.3 Iterations required to estimate the parameters of the regression model for 
date of onset of APACG in Table 4.2 
 
Iteration β µ° R κ L 
      
Gender      
0 b0 = 0     
1 0.1761 148.01 0.2373 0.4885 7.5391 
2 0.2237 146.10 0.2409 0.4965 7.7764 
3 0.2363 145.60 0.2411 0.4971 7.7935 
4 0.2395 145.47 0.2412 0.4971 7.7947 
5 0.2404 145.44 0.2412 0.4971 7.7948 
6 0.2406 145.43 0.2412 0.4971 7.7948 
7 0.2407     
      
0 b0 = –0.2434     
1 0.1116 151.08 0.2258 0.4637 6.8206 
2 0.2064 146.58 0.2401 0.4946 7.7209 
3 0.2317 145.57 0.2411 0.4969 7.7896 
4 0.2383 145.30 0.2412 0.4971 7.7944 
5 0.2401 145.23 0.2412 0.4971 7.7947 
6 0.2405 145.21 0.2412 0.4971 7.7948 
7 0.2406 145.21 0.2412 0.4971 7.7948 
8 0.2407 145.21 0.2412 0.4971 7.7948 
      
Side      
0  b0 = 0     
1 –0.05760 147.82 0.2373 0.4885 7.5391 
2 –0.06153 147.16 0.2377 0.4894 7.5651 
3 –0.06180 147.12 0.2377 0.4894 7.5652 
4 –0.06182 147.12 0.2377 0.4894 7.5652  
      
0  b0 = 0.06186     
1 –0.05383 148.52 0.2360 0.4858 7.4581 
2 –0.06127 147.21 0.2377 0.4894 7.5657 
3 –0.06178 147.12 0.2377 0.4894 7.5662 
4 –0.06182 147.12 0.2377 0.4894 7.5662 
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(Continued)      
Iteration β µ° R κ L 
      
Age *      
0 b0 = (0, 0)     
1 0.2279, 0.4707 147.82 0.2373 0.4885 7.5391 
2 0.1927, 0.4084 148.38 0.2517 0.5203 8.5024 
3 0.1963, 0.4160 148.27 0.2520 0.5208 8.5195 
4 0.1958, 0.4151 148.28 0.2520 0.5208 8.5198 
5 0.1959, 0.4152 148.28 0.2520 0.5208 8.5198 
      
0 b0 = (–0.1958, –0.4339)     
1 0.3451, 0.6925 146.82 0.1933 0.3940 4.9771 
2 0.1718, 0.3672 148.69  0.2461 0.5078 8.1188 
3 0.1987, 0.4205  148.22 0.2518 0.5204 8.5067 
4 0.1956, 0.4146  148.28 0.2520 0.5208 8.5200 
5 0.1959, 0.4153  148.28 0.2520 0.5208 8.5200 
6 0.1959, 0.4152 148.28 0.2520 0.5208 8.5200 
      
* Age group is expressed by 2 dummy variables. 
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Figure 4.2 Plot of the log likelihood surface as a function of the angular regression 
coefficient (β) for the comparisons of left or right eye involvement, gender and age in 
APACG (data of Table 4.2).  
 




Figure 4.3 Plot of the log likelihood surface as a function of the angular regression 





Figure 4.4 Plot of the log likelihood surface as a function of the angular regression 
coefficient (β) for gender and age for the ALL study in central Sweden (data of Table 
5.20). 
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4.7 Angular – angular correlation  
In §5.5, the correlation between the 13 peaks estimated from 13 locations and the 
corresponding latitudes is calculated. The corresponding methodology required is 
summarised here. 
In the presence of two circular random variables θ (= peak date) and φ (= 
latitude), the association between θ and φ can be expressed as a signed rank 
correlation coefficient (Mardia and Jupp, 2000, page 252; Fisher, 1993, page 146 – 
50). This association between θ and φ corresponds to monotone association of real 
variables as measure by Kendall’s τ or Spearman’s ρ.  
If  γ1,…,γl and e1,…,el are the circular rank of q1, …, ql and φ1, …, φl (l = 13 is 
used in §5.5) respectively, defined by 
 [ ] [ ]
2 2
,        ,i ii iγ εl l
πθ πφ= =  (4.15) 
where θ[i] and φ[i] are the rank of θi among q1, …, ql and φi among φ1, …, φl, regarding 
the circular variable θ and φ as linear (rank 1 being the smallest). Fisher and Lee 
(1983) showed that the signed rank correlation coefficient r could be written as  
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= ∑ , then they give a useful formula for computing r is   
 4 ( )r AB CD
l
= − . (4.17) 
The statistic r takes values in [−1, 1]. Values of r near 1 indicate positive dependence, 
while values of r near –1 indicate negative dependence. Under independence, r ≈ 0. 
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However, small values of r need not indicate independence. The null hypothesis that 
two measurements are independent is rejected if r differs too much from zero. Some 
quintiles of the statistics |(l – 1) r| are tabulated in Fisher (1993, Appendix A13). As 
this method is applied to calculate the correlation between the peak date and the 
corresponding latitude from l = 13 locations, some percentiles for this situation are 
given in Table 4.4. 
Table 4.4 Selected percentiles for the statistic |(l – 1) r| (from Fisher, 1993, Appendix 
A13) 
 
α  0.10 0.05 0.025 0.01 0.005 
      
|(l – 1) r|  1.72 2.45 3.15 4.03 4.73 




Seasonality in the presentation of breast cancer cases has been claimed in countries 
with distinct climatic seasons. For example, Kirkham et al (1985) studied seasonal 
variation in patients with breast cancer and benign breast disease in Southampton, 
England. They noted that the seasonality is more pronounced in premenopausal 
women and peaked in June 3 months later than post-menopausal women. They also 
suggested that the small tumours (< 3 cm diameter) were diagnosed 1 to 2 months 
earlier than the larger ones. 
We investigated seasonality in the diagnosis of new cases of malignant breast 
carcinoma reported between 1995 − 1998 in Singapore (Gao et al, 2001). In our study, 
individual dates of diagnosis were available and so these were used.  
In total 3219 women were diagnosed with breast cancer over the 4-year 
period. Figure 4.5 shows the frequency distribution of the date of diagnosis, 
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presented as a rose diagram on a half monthly basis. There is no clear cut seasonal 
pattern although somewhat fewer cases are diagnosed in January and February (close 
to the Western and Chinese New Year festivals) and they appeared more numerous 
approximately 6 months later over the June to August period. The estimated peak 
(Table 4.5) of August 27 (95% CI July 11 to October 05) is statistically significant (p 
= 0.015) but of small magnitude (R = 0.036). 
 
Figure 4.5 Rose diagram of the frequency of diagnosis of female malignant breast 
cancer patients (data from Singapore Breast Cancer Registry 1995 − 1998). 
 
The bootstrap technique was used to obtain the 95% CIs for the peak date 
using B = 2,000 bootstrap samples of the same size as the number of patients under 
consideration. 
Table 4.5 also shows the estimated peaks for ethnicity (Chinese, Malay, 
Indian, Others), ER and PR status, Menopausal status (pre, uncertain, post) and 
tumour size (< 1, ≥ 1 cm). It is clear, for example, that the peaks within the 4 ethnic 
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groups are far from strong, and while those for the Chinese and Others coincide in 
August, that for the Malays is 3 weeks earlier in July whereas for the Indians, it is 2 
months later in October. Only that for the Indian women is statistically significant (p 
= 0.036) but, with R = 0.160, this is not very marked. 
There is only a 4-day difference in the peak dates for pre- and post-
menopausal women.  The peaks for ER and PR negative women essentially coincide 
in late August and early September respectively and both precede the peaks for the 
positive tumours by 1 month. These are all statistically significant but of relatively 
low magnitude. In fact Gao et al (2001) observed that the close agreement in the 
results for ER and PR status arise since the status (negative or positive) is the same for 
each in 78% of the women for which they are both observed. 
The date of peak diagnosis for the women who have large sized tumours (≥ 1 
cm) is late August in contrast to early December in those with the small tumours. 
However, the only statistically significant peak is for those with the larger tumours (R 
= 0.049, p = 0.002) but again this is of low magnitude.  
Apart from Stage 0 patients who have an estimated peak in early July, the 
higher the stage the earlier the peak in diagnosis although only that for Stage IIA 
disease at September 25 is statistically significant (R = 0.061, p = 0.034). 
Table 4.6 summarises the associated regression analyses for the patient and 
tumour characteristics that are binary in nature. However, these analyses did not 
establish any statistically significant differences between the corresponding 
subgroups. For example, the observed 3-month difference in the peak dates of 
diagnosis for the different sized tumours is not established as other than due to chance 
(θ1 − θ2 = 2arctan(0.998) = 90°, 95% CI −45° to 134°, p = 0.166). 
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Table 4.5 Seasonal variation by patient and tumour characteristics at presentation for 














        
All  3219  Aug 27 0.036 Jul 11 to Oct 05 8.412 0.015 
        
Ethnicity        
Chinese 2743  Aug 21 0.031 Jun 21to Oct 10 5.309 0.070 
Malay 307  Jul 30 0.060 Apr 04 to Oct 21  2.215 0.330 
Indian 130  Oct 28 0.160 Sep 09 to Dec 13 6.652 0.036 
Others 39  Aug 20 0.130 Mar 30 to Dec 06 1.313 0.519 
        
Menopause        
Pre 1557  Aug 19 0.026 May 22 to Jan 24 2.099 0.350 
Uncertain 264  Sep 16 0.106 Jul 11 to Nov 02 5.922 0.052 
Post 1398  Aug 23 0.036 Jun 13 to Nov 04 3.594 0.166 
        
ER        
Negative 1061  Sep 01 0.084 Jul 27 to Sep 30 14.858 0.0006 
Not done 732  Apr 23 0.090 Mar 18 to May 29 11.756 0.003 
Positive 1426  Oct 02 0.056 Aug 26 to Nov 15 8.979 0.011 
        
PR        
Negative 1308  Aug 31 0.071 Jul 27 to Oct 02 13.069 0.002 
Not done 779  Apr 20 0.093 Mar 17 to May 21 13.497 0.001 
Positive 1132  Oct 04 0.076 Sep 03 to Nov 15 12.955 0.002 
        
Tumour (cm)        
< 1  338  Dec 06 0.030 Jul 10 to May 21 0.599 0.741 
≥ 1 2572  Aug 30 0.049 Jul 30 to Oct 07 12.203 0.002 
Not done 309  May 05 0.061 Jan 30 to Aug 12 2.263 0.323 
        
Stage        
0 276  Jul 05 0.036 Jan 31 to Nov 25 0.699 0.705 
I 770  Sep 12 0.042 Jun 15 to Dec 05 2.684 0.261 
IIA 922  Sep 25 0.061 Aug 03 to Nov 08 6.759 0.034 
IIB 662  Aug 04 0.034 Apr 06 to Dec 10 1.517 0.468 
III 208  Jun 18 0.039 Jan 10 to Nov 15 0.630 0.730 
IV 199  Apr 16 0.026 Nov 02 to Sep 26 0.265 0.876 
Not done 182  Jul 21 0.069 Apr 21 to Nov 27 1.716 0.424 
        
  
A clear drawback of this study (and most others in this area) is the uncertain 
relationship between date of diagnosis and date of onset of symptoms of breast cancer 
(I alluded to this problem in Chapter 1). The latter is more likely to be aetiologically 
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important as the variable delays from first symptom to presentation and eventual 
diagnosis may depend on many factors. In Singapore, the delay between onset of 
symptoms and presentation is uncertain but that between presentation and diagnosis is 
not likely to be great. 
Table 4.6 Regression coefficients for differences in peak date of diagnosis for selected 
patient and tumour characteristics at presentation for all women (data from 














       
Menopause  Pre Aug 19 1557 0   
 Post Aug 23 1398 0.030 0.425 0.94 
       
ER Negative Sep 01 1061 0   
 Positive Oct 02 1426 0.270 0.215 0.205 
       
PR Negative Aug 31 1308 0   
 Positive Oct 04 1132 0.295 0.201 0.140 
       
Tumour size (cm) ≥ 1 Aug 30 2572 0   
 < 1 Dec 06 338 0.998 0.719 0.166 
       
 
The overall health care system in Singapore is ranked very highly (World 
Health Organization, 2000) and provides relatively open access to care although 
individuals are less likely to self refer during the span of the New Year (December to 
February) festivities. In addition, the tropical climate is of an essentially unchanging 
pattern over the year.  For both these reasons a major seasonal component in the 
diagnosis of breast cancer (whether induced by climatic changes or referral) was not 
anticipated. However, Gao et al (2001) noted that the observed fewer cases in January 
and February and the peak (of small magnitude) in August indeed reflected self-
referral patterns, and not the presence of an aetiological determinant. Likewise, the 
corresponding seasonality reported in other studies of breast cancer (Table 4.7) may 
be enhanced (or obscured) by local referral characteristics, perhaps leading to a false 
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indication of an underlying climatic component, or the influence of hormonal activity 
as has been conjectured by Cohen et al (1983) and Holdaway et al (1990).  
When seasonality between patients with different characteristics are 
compared, our findings do not always appear consistent with previous studies.  Thus 
while Kirkham et al (1985), also using angular methodology although not regression, 
reported peak presentation for pre-menopausal women was 3 months earlier than for 
post-menopausal, they differed by only 4 days in Singapore (Table 4.5).  
In this study, angular regression suggested observed differences between 
groups in peak dates of presentation might be no more than chance. This will not 
necessarily be the case in other geographical locations.  
If a climatic component played a major role in the development of breast 
cancer, then one might anticipate some gradient between studies ranging from 
Northern (or Southern) latitudes to the equator and perhaps similarities between those 
of common latitude but differing longitude. We investigate aspects of this topic when 
discussing ALL in Chapter 5. One would anticipate little effect at the equator as we 
have observed (Table 4.7). Such a gradient may manifest itself despite different 
health care delivery systems and other confounding variables distorting individual 
studies.  Studies reported to date show no such gradient but the lack of standardisation 
in the identification of case presentation dates and reporting details make the true 
position unclear.  
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Table 4.7 Summary of studies on the seasonal variation of presentation of breast cancer 
 
Study Location Latitude* Method of 
dating 
N Peak reported R 95% CI Mardia 
(χ2) 
p-value 
        
Galea 
(1991) 
Nottingham, England 52.97N Detection 1944 None  − − − − 
Kirkham 
(1985) 
Southampton, England 50.92N Biopsy 866 Jun 14 0.068  May 01 to Jul 29 8.04 0.020 
Jacobsen 
(1977) 
USA 38.92N Diagnosis 11825 May − − − − 
Cohen 
(1983) 
Israel 32.08N Detection 1944 Spring (May 07) 0.083 Apr 18 to Jun 03 26.52 < 0.001 
Gao 
(2000) 
Singapore 01.33N Surgery 3219 Aug 27 0.036 Jul 11 to Oct 05 8.41 0.015 
Holdaway 
(1990) 
Auckland, New Zealand 36.92S Detection 2244 Summer (Dec) − − − − 
          
* Taken as the latitude of the capital city (Washington DC, USA, Tel Aviv, Israel) if no more precise information is available.
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Childhood cancer 
Ross et al (1999, Table 1) describe the seasonal variation in the diagnosis of 12 
childhood cancers in the USA. They concluded that there was a statistically 
significant seasonal variation for ALL (summer), rhabdomyosarcoma 
(spring/summer) and hepatoblastoma (summer). We (Machin and Gao, 2000) re-
examined these data using the angular techniques. The calculations are summarised in 
Table 4.8.  For ease of presentation the results are presented in the calendar order of 
the respective estimated peak days. Although we have quoted the day of the peak, 
because the data are only available grouped by month, there is spurious precision in 
quoting the actual day. In all the childhood cancers of Table 4.8 R is small (ranging 
from 0.016 to 0.140) and CIs rather wide, giving little support for important 
aetological effects. 
We questioned whether it is truly meaningful to summarise the ‘overall’ 
pattern by summing the monthly counts of the k = 12 cancers and using these 20,949 
as one group to calculate TR as Ross et al (1999) have done. The more common 
tumours will dominate such totals and this process also assumes that there is indeed a 
common peak for these cancers. We suggested that it may be better to summarise this 
information by calculating the ‘overall’ peak from the 12 individual disease specific 
peak dates of Table 4.8, Column 3. These peaks are presented in an angular plot 
(Figure 4.6). However, this made little difference to the peak date of 08 June (pooled) 
and 14 June (stratified) but the latter approach clearly results in a relatively strong 





Table 4.8 Peak date of presentation of 12 childhood cancers (data from Ross et al, 















Ross et al (1999) 
CNS 3855 Jan 18 Oct 13 to Mar 06 0.026 0.073 
NB 1495 Feb 26 Nov 08 to Jul 01 0.024 0.417 
RD   861 Apr 18 Mar 07 to Jun 19 0.065 0.026 
WT 1245 Jun 11 Apr 19 to Aug 09 0.045 0.077 
ES   437 Jun 17 Jan 25 to Nov 06 0.030 0.669 
NHL 1325 Jun 23 Jan 25 to Nov 23 0.016 0.735 
AML 1153 Jul 03 Mar 26 to Oct 24 0.031 0.329 
ALL 5532 Jul 09 May 17 to Aug 14 0.029 0.009 
HB   228 Jul 09 May 29 to Aug 19 0.140 0.012 
OS   776 Sep 13 Jun 16 to Jan 09 0.037 0.342 
HD 1142* Nov 27 Jun 20 to Apr 28 0.015 0.78* 
Rb   402 Dec 27 Jul 22 to Jun 11 0.026 0.763 
Overall N = 20949 Jun 08 Apr 15 to Aug 14 0.010 0.134 
 K = 12 Jun 14 Jan 19 to Oct 19 0.273 0.409 
Westerbeek et al (1998) 
NHL 189 Feb 19 Sep 05 to Aug 09 0.020 0.927 
      
* Given as 1135 and 0.62 respectively by Ross et al (1999) 
a ALL = acute lymphoblastic leukaemia; AML = acute myeloid leukaemia; HD = 
Hodgkin’s disease; NHL = non-Hodgkin’s lymphoma; NB = neuroblastoma; Rb = 
retinoblastoma; WT = Wilm’s tumour; RD = rhabdomyosarcoma; OS = 
osteosarcoma; ES = Ewing’s sarcoma; CNS = central nervous system; HB = 
hepatoblastoma 
 
The peak dates of Table 4.8 facilitate comparisons to be made between 
studies. As an illustration, we compared the peak in children with NHL in USA with 
the peak reported by Westerbeek et al (1998, Table 3) for England. The peak for USA 
is indicated as June 23 (more sensibly the June/July period) (95% CI January 25 to 
November 23) and this contrasts rather markedly with the estimate of February 19 
(95% CI September 05 to August 09) for those reported in UK (Table 4.8). However, 
the wide CIs and small R both suggest little support for any distinct peak. Thus the 
observed 4-month difference in peak presentation may merely be a chance difference. 
However, these two dates may be compared using the regression technique for 
directional data. This estimates the interval between these two observed peaks, which 
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can then be tested under the null hypothesis of a common date. The estimated 
difference in peak dates is 122 days (β = −1.73, SE(β) = 3.74, 95% CI −2.92 to 2.79). 
Not surprisingly, this lead to a non-statistically significant difference (R = 0.019, p = 
0.56) for this comparison. 
 
Figure 4.6 Distribution of the estimated peak date of presentation of 12 childhood 
cancers (data from Ross et al, 1999). 
 
Ross et al (1999, Table 2) also list 19 other studies that have explored 
childhood cancer and seasonality. We review these 19 studies further in Chapter 5. 
From their Table 2, one can see that a wide range of statistical approaches have been 
used to summarise these. However the synthesis of these studies is made in purely 
descriptive terms. They conclude, for example, “ ... provides some modest support for 
a summer excess in the diagnosis of childhood ALL”. However, in other situations, 
particularly in the context of randomised trials, overviews of studies using formal 
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meta-analytical techniques have provided a more useful synthesis of the data than the 
purely descriptive. 
 
Leukaemia and non-Hodgkin’s lymphoma. 
Douglas et al (1999) describe a population based study seeking evidence of 
seasonality in leukaemia and non-Hodgkin’s lymphoma. They summarise in a month-
by-month tabulation, by gender and two age groups (0 − 14 and 15 − 79), the number 
of cases presenting over a 10-year period. They then apply cosinor model in the form 
Y = β0 + β1cos(t) + β2sin (t), as described by Halberg et al (1972) (see §2.7), to 
investigate seasonal patterns. From these they concluded that the ‘results were mainly 
negative’ in that evidence for seasonality in the presentation of the diseases was not 
established.  
However, as the authors themselves indicate, this form of statistical modelling 
implies a rather artificial situation that the peak and trough are constrained to be 6 
months apart. Applying the angular regression methodology to their grouped data on 
ALL (Appendix I7) gave the results of Table 4.9.  
Table 4.9 Estimated peak date of presentation, with 95% confidence interval, for 
patients with ALL by gender and age group (Douglas et al, 1999, Table II) 
 
Gender Age (y) N κ Peak date 95% CI p-value 
       
Male 0 – 14 423 0.10 Mar 21 Dec 22 to Aug 08 0.34 
 15 – 79 370 0.12 Mar 19 Nov 18 to Jun 29  0.30 
       
Female 0 – 14 366 0.11 Aug 08 May 18 to Oct 09 0.32 
 15 – 79 210 0.15 Nov 09 Jun 27 to Feb 25 0.31 
       
 
For males of both age groups the peak date of presentation is in mid-March 
whereas those for the females are later in the year and in the latter there is a difference 
between the age groups.  However, for each of the 4 gender by age groups R is small 
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and 95% CIs of the peak date estimated rather wide, providing little support for 
important seasonal effects. 
The univariate angular regression models comparing males and females, and 
the two age groups are summarised in Table 4.10. Thus the model for gender, 
estimates that peak presentation for females occurs 126 days (4 months) later than in 
the males (z = 2.49, p = 0.013). In contrast, the 108 days (3.5 months) later peak for 
the younger age group is not statistically significant (z = −1.03, p = 0.303). The 
angular multiple regression model confirms the gender difference in presentation time 
with a minor revision of the estimate to 132 days. This is the first known use of 
angular multiple regression in a medical context.  
Table 4.10 Regression coefficients for gender and age following univariate and 
multiple angular regression of date of presentation for patients with ALL (data from 





















Univariate angular regression 
       
Gender (Male, Female) 0.10 1.89 0.76 0.77 to 2.57 0.013 126 
       
Age (0 – 14, 15 – 79) 0.04 1.35 1.31 −1.77 to 2.64   0.30 108 
 
Multiple angular regression 
       
Gender (Male, Female)  2.15 0.88 0.80 to 2.64 0.015 132 
 0.10      
Age (0 – 14, 15 – 79)  0.65 0.86 −1.60 to 2.33   0.45   67 
       
 
Although our analysis confirms that of Douglas et al (1999) with respect to the 
lack of a strong seasonal effect in ALL (see also §5.4), this is because there is little to 
choose between the cosinor and von Mises models in this situation (Figure 3.5).  
However the regression approach does provide some indication that there is a real 
difference between peak presentations in males and females. 
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Methicillin-resistant staphylococcus aureus (MRSA) 
Sopena et al (2001) characterized the pheonotype and molecular pattern of MRSA 
strains isolated in Spain in 1996 and compared the epidemiological, clinical and 
evolutionary characteristics of patients infected or colonized by gentamicin-sensitive 
MRSA (GS-MRSA) and gentamicin-resistant MRSA (GR-MRSA). They summarised 
the monthly number of infected cases in their Figure 1. Gao and Machin (2004) 
reported the estimated peaks for GR and GS are early March (March 09) and 7 
months later in late October (October 27) respectively (Table 4.11). Both are 
statistically significant (χ2 = 13.03, p = 0.002, χ2 = 13.704, p = 0.001) using the 
Mardia test. A comparison of these two peak dates using angular regression methods 
suggests that there is a real (rather than chance) difference between them (p < 0.001, 
95% CI of difference 107 to 132 days).    
Table 4.11 Peak date of presentation and its magnitude, for cases of MRSA (data 
















       
GS 50 0.370 Oct 27 Sep 30 to Nov 22 13.704 0.001 
       
GR 41 0.399 Mar 09 Feb 04 to Apr 11 13.030 0.002 
       
 
 
4.9 Comments  
In this Chapter I have described angular regression and applied this methodology to 
the presentation of diseases including breast cancer, childhood cancer, ALL and 
MRSA. I have explored the application of the regression with one or two explanatory 
variables, which are continuous or ordered categorical with 2 or 3-levels. These 
applications are the first attempt to apply angular regression in an epidemiological 
context. The S-PLUS codes for the regression are given in Appendix H5. The plots of 
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L as a function of the angular regression coefficients of one or two explanatory 
variables (Figures 4.2 to 4.4 and Figure 5.4) have shown the potential difficulties in 
the estimation of the regression coefficients. The iteration for estimation of regression 
coefficients does not necessarily always converge nor converge to the same L if 
different starting values are chosen. For example, in Figure 4.2c, no converge with 
starting value of β = −2, while converge to 7.8 with β = 0. This suggests that a plot L 
before commencing the iteration may provide useful insight for the regression 
estimation process. More applications on a larger dataset are given in Chapter 5. 
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5 Acute lymphoblastic leukaemia (ALL) 
 
5.1 Introduction 
Many infectious and some chronic diseases have characteristic seasonal onsets (Linet, 
1985) and, in certain cases, these seasonal rhythms can be related to aetiological 
precipitating factors (Douglas et al, 1998). Thus, demonstration of seasonal variation 
in the onset of leukaemia may provide insight into potential risk factors (Badrinath et 
al, 1997). The first published interest in the seasonality of leukaemia appears to be the 
study by Lambin and Gerard (1934) (see Allan, 1964) in Belgium and reported a 
November – February peak of acute leukaemia. Since then there have been numerous 
reports concerned with investigating seasonality of leukaemia. While many of these 
studies have not identified an obvious seasonal pattern (Douglas et al, 1999), others 
have found significant seasonal variation (Lee, 1963; Badrinath et al, 1997). The 
inconsistency between the results may itself be informative, perhaps reflecting various 
levels of between population heterogeneity and different patterns of seasonality 
induced by possible causative agents. It is also possible that seasonality may be more 
pronounced within subtypes of leukaemia or within particular age groups. Gilman et 
al (1998) noted little evidence of seasonality in a national dataset from Great Britain, 
but have noted seasonality in a regional dataset from the West Midlands. They 
suggest: “further work on seasonality needs more sophisticated analysis, controlling 
for broad geographical heterogeneity”. However, no formal synthesis of published 
reports has been attempted to date. As a consequence, the aetiology of leukaemia in 
this respect, both in children and in adults, still remains virtually unquantified.  
As non-causal factors may be important in explaining the inconsistencies 
between investigations of possible seasonal variation, methodological issues relating 
to the detection of seasonal variation have been discussed in Chapters 2 − 4. In this 
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chapter we focus on ALL, provide a summary overview of some epidemiological 
features of the disease, review the previous publications on seasonality, reanalyse 
wherever possible and synthesise these using angular methodology. Possible patterns 
underlying some inconsistencies are explored.   
Although the seasonal pattern in the presentation of ALL has been 
investigated in many studies, the effect of gender, age and ethnicity has been 
relatively little studied. For example, the SEER data set has been used in several 
studies (Walker and van Noord, 1982; Harris et al, 1987), but none has examined 
seasonal variation by ethnicity in the investigation and the latitude effect was only 
examined by Harris et al (1987). However, patient data is available in Singapore 
(latitude 1.16°N) which coincidently also provides data from a country very close to 
the equator. Thus if there was indeed an influence of season on the date of peak 
presentation of ALL it should be weakest here as there are no marked seasonal 
weather patterns. In contrast, and through a personal contact, we were also able to 
obtain individual dates from ALL cases in Central Sweden (latitude 58.24°N) where 
seasons are markedly different between winter with few daylight hours and 
temperatures below 0°C and summer with almost continual daylight and temperatures 
ranging from 25° to 30°C. Thus one would expect to identify a seasonal pattern for 
ALL if indeed one exists. The SEER programme from the USA provides individual 
(but month and year only) dates and case-specific characteristics over a range of 
latitudes lying within the extremes of Singapore and Sweden. Thus in this Chapter I 
will also examine the seasonal component of ALL in these three countries using 
patient specific dates of onset of their disease. The effect of age, gender, ethnicity and 
geographical location (latitude, longitude) are studied in detail.   
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5.2 Clinical features 
Disease 
Leukaemia is a cancer of the white blood cells which are produced by the bone 
marrow. The four main types of leukaemia are ALL, acute myeloid leukaemia 
(AML), chronic lymphoblastic leukaemia (CLL) and chronic myeloid leukaemia 
(CML) (Xie et al, 2003). Each disease subtype has its own unique characteristics and 
so treatments differ between them. 
ALL is a cancer of immature lymphocytes, or lymphoblasts (blast cells). 
Normally, white blood cells repair and reproduce themselves in an orderly and 
controlled manner but in leukaemia the process gets out of control and the cells 
continue to divide, but do not mature. These immature cells fill up the bone marrow 
and prevent it from making blood cells properly. As the leukaemia cells do not 
mature, they cannot do the work of normal white blood cells, leading to an increased 
risk of infection. Further because the bone marrow is overcrowded with immature 
white cells it cannot make the right numbers and quality of red cells and platelets.  
 
Symptom and diagnosis  
The main symptoms of ALL are caused by the increased number of blast cells in the 
blood which hence reduces the number of normal blood cells. The most common 
symptom is the unusual bleeding caused by a reduction in the number of platelets. 
This may include: bruising (bruises may appear without any apparent injury), 
bleeding gums, frequent nose bleeds, heavy periods in women. Feeling very tired 
(even breathless at the slightest effort), looking pale, aching joints and bones and 
feeling generally unwell and run down are also common symptoms. Occasionally, a 
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person will have none of these symptoms and the disease is discovered during a 
routine blood test.  
The latent period for the majority of paediatric ALL is very short, but can be 
clinically silent for months or even years in some cases (Greaves, 1993). Clinical 
symptoms of ALL in children usually antedate a diagnosis by only a few weeks. 
A number of tests are involved in the diagnosis of ALL. A blood test usually 
shows low numbers of normal white blood cells and the presence of abnormal cells. A 
sample of bone marrow is then required to confirm the diagnosis. Chest X-rays are 
taken to show if there are any enlarged glands in the chest. Other tests may be 
required depending on the presenting symptoms.  
 
Incidence 
Leukaemias are the most common of the childhood cancers (Ross et al, 1994) and 
ALL accounts for about 75% of childhood leukaemias (Ross et al, 1994; Lehtinen et 
al, 2003).  
The geographical variation in incidence has been studied extensively. Parkin 
et al (1988) reported on the incidence of cancer in childhood obtained from cancer 
registries in more than 50 countries over the period 1970 – 1979 although several 
centres provided more recent data. The age-standardized incidence rates of childhood 
ALL varied with the lowest rates being recorded in Kuwaiti natives (less than 12 per 
million) and highest rates in Costa Rica (44.7 cases per million). Costa Rica, although 
not as economically developed as some Western countries, is modernized with respect 
to many societal characteristics, including education and literacy levels.  
In Singapore ALL is not common with less than 50 cases diagnosed annually 
and with no notable differences in overall incidence between the major ethnic groups 
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(Chinese, Malay and Indian). However, the incidence is increasing gradually (Chia et 
al, 2000). 
The overall incidence of childhood leukaemia in Sweden is comparatively 
high; it is considerably higher than in Britain (a relatively close neighbour) and is 
amongst the highest in the world (Parkin et al, 1998). The age standard incidence rate 
for ALL is 27.0 cases per million in children aged 0 – 14 years (Parkin et al, 1988).  
In the USA there is a similar pattern to Sweden and again ALL is the most 
common childhood cancer (McNeil et al, 2002).  
The evidence for an increasing trend in ALL has been reported, although there 
is wide variation between countries (Magnani et al, 2003). The incidence in the USA 
has increased from 1973 – 1998. This increase was particularly notable in the two 
middle age groups, 20 – 44 and 45 – 64, but did not increase in the oldest group (65 + 
years) (Xie et al, 2003). Hjalmars and Gustafsson (1999) also reported an increasing 
trend for ALL incidence with both increasing population density in parishes and 
increasing degree of urbanity in municipalities in Sweden in the study period 1973 – 
1994. The reported increase in incidence of ALL presumably reflects changes in 
exposure to environmental agents (Ries et al, 1991) and suggests that some 
environmental factors associated with high population density, such as infectious 
agents, may be of etiological importance for childhood ALL. 
Indeed, higher socio-economic status has been associated with an increased 
risk of childhood ALL (Pinkel and Nefzger, 1959; Browning and Gross, 1968; Fasal 
et al, 1971; Sanders et al, 1981). Gurney et al (1995) reported that white children in 
the USA have a much higher rates than do those of African-American origin. The 
incidence rates for childhood ALL in developed countries occurs at from two to four 
times the rates of less developed countries (Swensen et al, 1997). 
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In addition to the geographical variation, the peak incidence of childhood ALL 
occurs at 2 – 5 years when more children are succumbing to common infectious 
diseases such as chickenpox, mumps and measles.  
  Although the actual cause of ALL is still unknown. It has been speculated as 
to whether ALL in children is virus-related (MacMahon, 1992). While Greaves et al 
(1993) has suggested that most cases of childhood ALL may be the consequences of 
an abnormal response to common infections occurring in early life. Early, perhaps in 
utero, mutational events may contribute to this. A large study on the offspring of 
550,000 mothers in Finland and Iceland indicates reactivation of maternal Epstein-
Barr virus infection is probably associated with childhood ALL (Lehtinen et al, 2003).  
ALL is more common in children, although adults do also get the disease. In 




The aim of treatment for ALL is to destroy the leukaemia cells and allow the bone 
marrow to work normally again. Chemotherapy is the first and main form of treatment 
given, including injections of cytotoxic agents into the spinal fluid to destroy any 
remaining leukaemia cells in the fluid around the brain and spinal cord. Cranial 
irradiation is often introduced for the same reason. Adolescents usually fare less well 
than younger patients on conventional therapy. 
 
Prognosis 
Male gender, increased age, a high leukocyte count, non-T-cell immunophenotype 
and Ph-positive genotype are the poor prognostic features of ALL (Cortes and 
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Kantarjian, 1995; Imbach et al, 1995). They influence response to treatment and 
ultimate survival. These clinical features change progressively with age. The SEER 
program 1973 – 1998 indicates inferior survival for adolescents (median survival 3.5 
years) compared with children under 15 years of age (median survival > 10 years) 
(McNeil et al, 2002). The possible reasons why outcomes are inferior in this age 
group have been ascribed to different biological characteristics of the leukaemia, the 
use of different treatment strategies, and treatment outside of clinical trials (Davies 
and Ross, 2002).  
Sixty percent to 80% of adults with ALL can be expected to attain complete 
remission status following induction combination chemotherapy and effective 
supportive care during induction therapy (appropriate early treatment of infection, 
hyperuricemia, and bleeding) and approximately 35% to 40% of adults with ALL can 
be expected to survive 2 years. A few studies suggest that the use of intensive multi-
agent approaches achieves a 50% 3-year survival in selected patients (Gaynor et al, 
1988). 
 
5.3 Published studies 
Literature search 
To identify all published studies concerned with seasonality in ALL the distinction 
between the different cell types of leukaemia was not made initially. We began with 
the bibliography of Allan and Douglas (1994) which lists forty-five articles published 
between 1934 and 1987 on aspects of seasonality of leukaemia. However one article 
appeared twice (Knox, 1964) and 24 of these 44 were not relevant to our aims for the 
various reasons listed in Appendix D.  
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The next stage was a further comprehensive literature search (and this was 
repeated systematically over time until 01 June 2003) using the PubMed database. 
The terms used in the searching were: seasonality AND leukaemia, seasonal AND 
variation* AND leukaemia. A total of 31 articles were found of which 4 were 
duplicated, 3 studied animals (Barajas-Rojas et al, 1993; Cattanach et al, 1998; 
Kagley et al, 2003) and 4 (Walker and van Noord, 1982; Harris and AL-Rashid, 1984; 
Janicki and Gurda, 1965; Ramenghi et al, 1983) were included in the list given by 
Allan and Douglas (1994). Of the remaining 20 articles, 9 were not included in our 
review for the reasons listed in Appendix D.  
Amongst the references in those identified by Ross et al (1999, Table 2) one 
additional article was identified (van Steensel-Moll et al, 1983). Further hand 
searching of reference lists identified Browning and Gross (1968) and Paul (1968). 
Copies of all the articles identified were obtained and pertinent data retrieved. 
Unpublished work was not reviewed. 
In total 34 studies of leukaemia were identified and these are listed in 
Appendix C.  
 
Findings 
The essential features of the 34 studies identified by the literature search are 
summarised in Appendix E (Leukaemia – non ALL) with some brief comments on 
the studies. Those for ALL are collected together in Table 5.1 for later convenience.  
Among the identified studies (Appendix E and Table 5.1), most report 
seasonal variation of leukaemia either in the USA or UK. Because the leukaemias are 
rare, results in some studies are based on a small number of cases. As in many other 
epidemiologic investigations, the case group is often a selected series derived from 
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admission or clinical visits to one or more hospitals or death certificate series, rather 
than a population-based identification of all incidence cases. No study data had been 
collected with a planned objective to investigate seasonality but were rather more 
investigations of the data available. For example, the SEER database used by Walker 
and van Noord (1982), Harris and AL-Rashid (1984) and Harris et al (1987) for 
investigation of seasonality of leukaemia appears to have been established merely to 
count cases as only the year and the month of the diagnosis are reported and not the 
actual day.   
In addition, some studies (Lee, 1964) combined all leukaemias without taking 
account of histology or age. The majority of cell types involved are acute leukaemia 
(AL), ALL, AML and acute monocytic leukaemia (AMNL). Lee (1963) and Fraumeni 
(1963) studied acute lymphatic leukaemia and Badrinath et al (1997) and Harris and 
Al-Rashid (1984) studied acute lymphocytic leukaemia. Although there are some 
histological differences dependent on maturity of the cells, for our purpose, we 
consider both as ALL. For the same reasons we classify acute myeloblastic leukaemia 
and acute myelocytic leukaemia as AML.  
As for many infectious and some chronic diseases, the leukaemias often have 
somewhat insidious onsets and the data of onset may be hard to pinpoint. In the 
studies identified, investigators used different ‘event’ types: onset of symptoms; onset 
of clinical signs; date of registration; and date of diagnosis (Table 5.1). For exposition 
purposes I term these as the ‘start’.  None of the studies have used the individual start 
dates of the leukaemia in their analysis whatever the ‘start’ definitions. All reports 
utilised data in the form of the number of occurrences per calendar month or quarter.  
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Table 5.1 Published studies identified on the seasonality of ALL 
 
 
Study   
 






Source of data * 
Age 
(years) N





1943 – 58 Onset 
Diagnosis   
Hospital  0 – 78 86
      
Lee 
(1963) 
England and Wales 1946 – 60 Onset   National Cancer Registration 
Scheme  
0 – 44 674
      
Fraumeni 
(1963) 
USA 1958 – 61 Onset  National Co-operative Leukaemia 
Survey – 12 centres  
0 – 15 237
      
Lanzkowsky 
(1964) 
Capetown, South Africa  Not given Onset  Paediatric Teaching Unit, 
University of Capetown  
0.1 – 13 27
      
Meighan 
(1965) 
Oregon, USA 1950 – 61 Onset Death certificate review and 
University of Oregon Medical 
School Hospital 
0 – 14 214
      
Mainwaring 
(1966) 
Liverpool, England 1955 – 64 Symptom  
Diagnosis 
Medical charts at Children’s 
Hospitals, death certificates  
0 – 14 52
      
Till 
(1967) 
Greater London, England 1952 – 61 Symptom  Death certificates 0 – 9 372
      
Walker 
(1982) 
USA 1969 – 77 Diagnosis  TNCS and SEER  All 1783
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(Continued)      
 
Study   
 






Source of data * 
Age 
(years) N
      
van Steensel-Moll 
(1983) 
The Netherlands 1973 – 80 Diagnosis  Morbidity registry of the Dutch 
Childhood Study Group 
0 – 14 233
      
Harris 
(1984) 
Eastern Nebraska, USA 1971 – 80 Onset   Tumour registries – 18 paediatric 
medical institutions 
0 – 14 101
      
Harris USA 1973 – 80 Diagnosis  SEER 0 – 19 1132
(1987) Nebraska, USA 1973 – 80 Diagnosis  Survey 0 – 19 89




and Norfolk, England 
1971 – 94 Diagnosis East Anglian Cancer Registry All 515
      
Gilman 
(1998) 
West Midlands, England 1971 – 94 Registration West Midlands Cancer Intelligence 
Unit  
All 1340
      
Thorne 
(1998) 
South-West, England 1976 – 95 Diagnosis Childhood Cancer Registry  0 – 14 420
      
Westerbeek 
(1998) 
Greater Manchester and 
Lancashire, England 
1954 – 96 Symptom  
Diagnosis 
Manchester Children’s Tumour 
Registry 
0 – 14 1070
      
Douglas 
(1999) 
England and Wales 1984 – 93 Diagnosis Data Collection Study 0 – 79 1369
      
Ross 
(1999) 
USA 1989 – 91 Diagnosis Children’s Cancer Group, Pediatric 
Oncology Group 
0 – 19 5532
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Study   
 






Source of data * 
Age 
(years) N
      
Timonen 
(1999) 
Northern Finland 1972 – 86 Diagnosis  University Hospital, Oulu and the 
other central hospitals  
16 + 64
      
Sorensen 
(2001) 
Denmark 1950 – 94 Diagnosis  Danish Cancer Registry 0 – 3 458
      
Karimi 
(2003) 
Shiraz, Iran Apr 96 – Mar 00 Symptom Hospitals of Shiraz University of 
Medical Sciences 
0 – 15 211
      
* SEER = Surveillance, Epidemiology, and End Results, TNCS = Third National Cancer Survey. 
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ALL 
As is indicated by Table 5.1, a total of 20 studies have examined seasonal variation in 
the presentation of ALL. The latitude and longitude of the studies listed in Table 5.1 
are summarised in Table 5.2, but ordered by their latitude (South to North) and 
further by their longitude (from West to East) for the same latitude. In several of the 
studies conducted, the precise geographical location of the study population was not 
reported. In others the whole country was included. In both these circumstances we 
have taken the capital city (of country or state) to define the latitude and longitude. 
These studies have been conducted in the South Africa with latitude 35.05°S, 
and in the Northern hemisphere with latitudes ranging from 29.37°N (Shiraz, Iran) to 
65.01°N (Northern Finland) and longitude ranging from 123.39°W (Oregon, USA) to 
52.33°E (Shiraz, Iran). Thus I identified no studies South of latitude 40°S, and none 
from Central and South American, Australasia, and most of Africa. No studies were 
identified from Eastern Europe, India, China and much of Asia.  
The findings from these studies, as summarised by the corresponding 
investigators, are reviewed in Tables 5.3 to 5.6, but ordered by the ‘start’ measure 
utilised and their abbreviated conclusions on seasonality reported. These ‘start’ 
measures include date of onset, symptom, diagnosis and registration. Within each 
‘start’ measure all studies are ordered by their latitude and longitude. There is only 
one study that examined seasonality of the date of registration. Because these data 
were from the registry in the West Midlands Cancer Intelligence Unit, I assume that 




Table 5.2 Geographic locations for published studies of ALL from Table 5.1 
 
Study Latitude  Longitude
   
Lanzkowsky (1964) 35.05S  18.00E
Capetown, South Africa   
   
Karimi (2003) 29.37N  52.33E
Shiraz, Iran   
   
Harris (1987)   
Metropolitan Atlanta, Georgia, USA 33.45N  84.23W
(Albuquerque) *, New Mexico, USA 35.05N   106.39W
   
Hayes (1961) 36.06N  80.15W
Winston-Salem, North Carolina, USA   
   
Harris (1987)   
San Francisco-Oakland, California, USA 37.47N  122.25W
   
Fraumeni (1963) 38.54N   77.02W
(Washington, DC), USA   
   
Walker (1982) 38.54N   77.02W
(Washington, DC), USA   
   
Ross (1999) 38.54N   77.02W
(Washington, DC), USA   
   
Harris (1987)   
(Salt Lake City), Utah, USA 40.46N   111.53W
(Lincoln), Nebraska, USA 40.48N  96.40W
   
Harris (1984) 40.48N  96.40W
(Lincoln), Eastern Nebraska, USA   
   
Harris (1987)   
(Iowa city), Iowa, USA 41.40N  91.32W
(Hartford), Connecticut, USA 41.46N  72.41W
   
Meighan (1965) 42.10N  123.39W
Oregon, USA   
   
Harris (1987)   
Metropolitan Detroit, Michigan, USA 42.20N  83.03W
Seattle, Washington State, USA 47.36N  122.20W
   
Thorne (1998) 50.43N  3.31W
(Exeter), South-West, England   
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(Continued)   
Study Latitude  Longitude
   
Lee (1963) 51.30N   1.62W
(London/Cardiff), England and Wales   
   
Douglas (1999) 51.30N   1.62W
(London/Cardiff), England and Wales   
   
Till (1967) 51.30N  0.10W
Greater London, England   
   
van Steensel-Moll (1983) 52.06N   4.18E
(The Hague), The Netherlands   
   
Badrinath (1997) 52.23N  0.49E
East Anglia, England   
   
Gilman (1998)   
(Birmingham), West Midlands, England 52.30N  1.50W
   
Mainwaring (1960) 53.25N  2.55W
Liverpool, England   
   
Westerbeek (1998) 53.45N  2.30W
Greater Manchester and Lancashire, England   
   
Sorensen (2001) 55.40N  12.35E
(Copenhagen), Denmark   
   
Timonen (1999) 65.01N  25.28E
(Oulu), Northern Finland   
   
* Locations in (.) refer to capital cities. 
The findings with respect to seasonal variation of presentation of ALL are 
diverse. Most of the earlier studies are based on the examination of date of onset and 
symptoms. In contrast, most of the later studies are based on the date of diagnosis. Of 
the 30 basic populations reported (some are duplicated), 7 suggested no evidence of a 
(single) peak (Tables 5.3 to 5.6). These include onset in Oregon, USA (Meighan and 
Knox, 1965) and symptoms in Greater London, England (Till et al, 1967) and 
Liverpool, England (Mainwaring, 1966). In the USA, no peak for diagnosis was 
reported in Winston-Salem, North Carolina (Hayes, 1961). An analysis of diagnosis 
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of 1738 cases identified from the USA, Third National Cancer Survey (1969 – 1971) 
and SEER (1973 – 1977), showed no evidence of seasonality (Walker and van Noord, 
1982). Further examination of the data by age and geographic location also showed no 
evidence of seasonal excess. The study on the diagnosis in the South-West, England 
showed no evidence of peak (Thorne et al, 1998) and no peak was reported from The 
Netherlands (van Steensel-Moll et al, 1983).  
For onset (Table 5.3), a summer peak in both age groups (– 19, 20 – 44 years) 
was noted in England and Wales (Lee, 1963). This peak appears to correspond with 
the findings in Eastern Nebraska, USA (Harris and AL-Rashid, 1984). However, a 
winter peak from June to August was noted in children (0.1 – 13 years) in Capetown, 
South Africa (Lanzkowsky, 1964) although the sample size is small (N = 27) and no 
statistical test is performed. This peak appears to be consistent with the winter peak 
from December to February found in the USA (Fraumeni, 1963).   
For symptoms (Table 5.4), only one study noted a statistically significant 
peak. This peak was in October in cases from Shiraz, Iran (Karimi and 
Yarmohammadi, 2003). Although some excess was noted in summer (May – October) 
in Liverpool, England (Mainwaring, 1966) and in Winter (January – March) in 
Greater Manchester and Lancashire, England (Westerbeek et al, 1998), they are not 
statistically significant.   
Among the studies that examined diagnosis (Table 5.5), there were a greater 
number during summer (May – October) compared to winter (November – April) in 
both children (0 – 14) and adults (15 +) observed in East Anglia, England (Badrinath 
et al, 1997). Children (0 – 14) in East Anglia, England gave a summer-winter ratio of 
φ = 1.40 (95% CI 1.16 to 1.64), which is consistent with the report from Greater 
Manchester and Lancashire, England by Westerbeek et al (1998) (φ = 1.16, 95% CI 
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1.04 to 1.33). However, using TE, children in Greater Manchester and Lancashire, 
England do not show a significant peak (TE = 4.68, p = 0.095). A large study of 1369 
cases by Douglas et al (1999) reported a peak in May for children (0 – 14) and a peak 
at February for adults (15 – 79) in England and Wales although these peaks are not 
statistically significant. In the USA, a summer (the actual month is not reported) peak 
for children (0 – 19) was also noted (Ross et al, 1999). However, up to 3 peaks were 
reported in each of 9 locations studied by Harris et al (1987). In other areas Timonen 
(1999) found a strong winter peak in October – December and a less pronounced 
second winter peak in January – March for adults (16 +) in Northern Finland, while 
Sorensen et al (2001) noted a peak in October for children (0 – 3) in Denmark and 
Karimi and Yarmohammadi (2003) reported a peak in November in Shiraz, Iran.       
Only one study examined registration (Table 5.6) and noted a summer excess 
in the West Midlands, England (Gilman et al, 1998). 
 
Age effect 
Several studies have examined seasonal variation for children and adults separately. 
Lee (1963) reported a summer peak of onset for both children (0 – 19) and adults (20 
– 44) in England and Wales. A similar pattern was also noted for the diagnosis in East 
Anglia, England (Badrinath et al, 1997) and registration in West Midlands, England 
(Gilman et al, 1998) although slightly different age groups (0 – 14, 15 +) were used. 
However, a large study of 1369 cases in England and Wales did not reveal any 
statistically significant peak for the age groups (0 – 14, 15 – 79) (Douglas et al, 1999). 
The study from the USA also did not reveal any differential pattern between children 
and adults (Walker and van Noord, 1982). In this study age was divided into 6 age 
categories (0 – 2, 3 – 9, 10 – 19, 20 – 49, 50 – 69 and 70 +).   
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 Some studies only found seasonal variation in very young children. For 
example, Sorensen et al (2001) reported a peak of October for cases aged 0 – 3 years 
in Denmark. Mainwaring (1966) also noted an excess in the summer (May – October) 
for cases aged 0 – 4 years in Liverpool, England although not statistically significant, 
and no peak for cases aged 5 – 15 years.  
 
Gender effect 
In the studies reviewed, only Douglas et al (1999) examined the gender effect in detail 
in the cases diagnosed from England and Wales. They analysed seasonal variation for 
males and females within 2 age groups (0 – 14, 15 – 79) and for both combined. No 
statistically significant peak was observed in any category. By using cosinor analysis 
(see also §2.7), a one month difference in peak was reported between young males 
(April) and older (March) males. In contrast, a larger difference of 4 months was 
reported between the young females (July) and older females (November). The 
difference between two genders varied by age. There was 5 months difference 
between male and female when all ages were combined, 3 months in young cases and 





Table 5.3 Findings reported by the investigators from studies listed in Table 5.1 − onset 
 
Study  Period Age (yr) N  Peak Statistical method p-value 
       
Lanzkowsky (1964) a Not given 0.1 – 13 27  Winter (Jun – Aug) Binomial  – 
Capetown, South Africa       
       
Fraumeni (1963) a 1958 – 61 0 – 15 237  Winter (Dec – Feb) Tp  0.035 
USA    Spring (Mar – May)   
       
Harris (1984) 1971 – 80 0 – 14 101  Spring (Mar – Apr) Cosinor  – 
Eastern Nebraska, USA    Summer (Aug – Sep)   
       
Meighan (1965) 1950 – 61 0 – 14 214  Absent  None – 
Oregon, USA       
       
Lee (1963) 1946 – 60 0 – 44 674  Summer Tp – 
England and Wales       
       
a Monthly data is not reported. 
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Table 5.4 Findings reported by the investigators from studies listed in Table 5.1 − symptom 
 
Study  Period Age (yr) N  Peak Statistical method p-value 
       
Karimi (2003) b Apr 96 – Mar 00 0 – 15  211  Oct TE  < 0.05 
Shiraz, Iran     φ = 0.864 – 
       
Till (1967) 1952 – 61 0 – 9 372  Absent  φ = 1 – 
Greater London, England       
       
Mainwaring (1966) a 1955 – 64 0 – 4 24  Summer (May – Oct) Tp > 0.5 
Liverpool, England  5 – 14 28  Absent  None  – 
       
Westerbeek (1998) 1954 – 96 1.5 – 8 719  Mar TE = 1.95  0.377 
Greater Manchester and   9 – 14 264  Jan TE = 1.29  0.525 
Lancashire, England  0 – 14 1055  Mar TE = 1.57  0.456 
       
a Monthly data is not reported.  
b Monthly data are obtained from their text figures.  
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Table 5.5 Findings reported by the investigators from studies listed in Table 5.1 − diagnosis 
 
Study  Period Covariate d N  Peak Statistical method p-value 
       
Karimi (2003) a, c Apr 96 – Mar 00 0 – 15 211  Nov TE  < 0.05 
Shiraz, Iran     φ < 0.001 
       
Harris (1987)  0 – 19   Cosinor   
Atlanta, USA 1975 – 80 – 60  Feb, Jun, Oct – – 
New Mexico, USA 1973 – 80 – 73  Feb, Jun, Oct – – 
       
Hayes (1961) 1943 – 58 0 – 78 86  Absent  Tp = 11.01  < 0.5 
Winston-Salem, North 
Carolina, USA 
      
       
Harris (1987) 1973 – 80 0 – 19 184  Feb, Jun, Oct Cosinor  – 
San Francisco, USA       
       
Walker (1982) 1969 – 81 All  1783  Absent  TE  – 
USA       
       
Ross (1999) 1989 – 91 0 – 19 5532  Summer  TR  0.01 
USA       
       
Harris (1987) 1973 – 80 0 – 19   Cosinor   
Utah, USA – – 114  Feb, Jun, Oct – – 
Nebraska, USA – – 89  Apr, Aug, Dec  – – 
Iowa, USA – – 211  Apr, Aug, Dec  – – 
Connecticut, USA – – 191  Feb – – 
Detroit, USA – – 172  Apr, Aug, Dec  – – 
Seattle, USA 1974 – 80 – 127  Each season  – – 
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(Continued)       
Study  Period Covariate d N  Peak Statistical method p-value 
       
Thorne (1998) a 1976 – 95 0 – 14 420  Absent  φ = 0.99, CI: 0.82 to 1.20 – 
South-West, England       
       
Douglas (1999) 1984 – 93 0 – 14  789  May   Cosinor 0.529 
England and Wales  Male 423  Apr –  0.240 
  Female 366  Jul  –  0.489 
  15 – 79  580  Feb  –  0.521 
  Male 370  Mar  –  0.165 
  Female 210  Nov  –  0.495 
  Total 1369  Apr  –  0.630 
  Male 793  Apr  –  0.080 
  Female 576  Sep  –  0.767 
       
van Steensel-Moll (1983) 1973 – 80 0 – 14 233  Absent  TE  – 
The Netherlands       
       
Badrinath (1997) 1971 – 94 0 – 14 271  Summer (May – Oct) φ = 1.40, CI: 1.16 to 1.64  < 0.01 
East Anglia, England  15 + 244  Summer (May – Oct) φ = 1.39, CI: 1.14 to 1.64  0.01 
       
Westerbeek (1998) c 1954 – 96 1.5 – 8 730  Jun  TE = 5.07  0.072 
Greater Manchester and   9 – 14 266  Mar  TE = 0.03 0.980 
Lancashire, England  0 – 14 1070  Jul TE = 4.68 0.095 
     φ = 1.16, CI: 1.04 to 1.33 –  
       
Sorensen (2001) a 1950 – 94 0 – 3 458  Oct Cosinor – 
Denmark       
       
       
       
 127
(Continued)       
Study  Period Covariate d N  Peak Statistical method p-value 
       
Timonen (1999) b 1972 – 86 16 + 64  Oct – Dec, Jan – Mar Cosinor  – 
Northern Finland       
       
a Monthly data is not reported.  
b Monthly data are obtained from their text figures.  
c Note ‘symptom’ given in Table 5.4. 






Table 5.6 Findings reported by the investigators from studies listed in Table 5.1 − registration 
 
Study  Period Age (yr) N  Peak Statistical method p-value 
       
Gilman (1998) 1971 – 94 0 – 14 805  Summer (May – Oct) φ = 1.16, CI: 1.02 to 1.30 –  
West Midlands, England  15 + 535  Summer (May – Oct) φ = 1.20, CI: 1.03 to 1.37 – 
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Latitude effect 
Harris et al (1987) studied the seasonal variation of ALL for ages 0 – 19 years in the 
USA using SEER data and data from an independent survey of a 57 county study area 
of the eastern half of Nebraska (Harris et al, 1987). They utilized periodic regression 
(see also §2.7) and observed up to 3 peaks in each of the 9 locations studied (Seattle, 
Nebraska, Iowa, Detroit, Connecticut, San Francisco, Utah, New Mexico and 
Atlanta). They stratified 9 locations by latitude using a cut off of 40°. Their analysis 
revealed a significant effect of latitude in the seasonal pattern observed. 
 
5.4 Meta analysis of published data 
In addition to the variability of the findings, the methodology used to detect 
seasonality varies from study to study (Tables 5.3 to 5.6). To provide a common 
standard for comparison I have applied the angular methods detailed in Chapter 3 to 
these studies for which the monthly data are provided. For two studies these were 
extracted from text figures rather than from tables and so may be in error by a few 
cases in some of the bins. Analyses by covariates (age and gender) have been 
conducted whenever data is also available. The data from 15 of the 20 studies are 
detailed in Appendix I7. Five studies do not provide monthly data, these are: 
Fraumeni (1963), Lanzkowsky (1964), Mainwaring (1966), Thorne et al (1998), 
Sorensen et al (2001). The report from Karimi and Yarmohammadi (2003) provide 
data on the date of first symptom, not of diagnosis. 
Although the majority of the methodology of Chapter 3 is applicable to 
grouped data, the ‘bootstrap’ method of calculation for CI’s requires individual dates 
for each subject within the study. To provide these, the corrected monthly counts 
(rounded to the nearest integer), fg, were assumed to be distributed uniformly over the 
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bin size of 30° (The apparent total number of cases may vary a little from the true 
total because of this rounding) and a random sample of size, fg, drawn from that bin. 
These provided the ‘individual’ data for the calculations and (to avoid some 
inconsistencies) these were also used for the calculations for the SEER data 
summarised in §5.5. 
However, we noted in doing this that the peak of the (simulated) data differed 
from that of the original data quite markedly for some studies. This may be because 
all cases in each month are assigned to the middle of the month in the original data. 
We noted this more frequently happens in studies where R is very small. As a 
consequence, when the peak from the newly created sample differed greatly from 
original one (we restrict that difference to be less than 15°), random sampling was 
continued until a peak from an additional sample was close to the original one.     
The results of these calculations are in Tables 5.7 to 5.10. For ‘start’ as onset 
a significant peak (July) was detected only in England and Wales (Lee, 1963) and this 
was more prominent in the cases aged 0 – 19 years. Although no statistically 
significant peak was detected in children of 3 ages groups (0 – 4, 5 – 9, 10 – 14) in 
Eastern Nebraska, USA, the amplitude of the peak, R, is increasing as age increasing. 
No studies on symptom showed any strong seasonal variation.  
Some studies that examined diagnosis showed a significant peak. Thus a peak 
of late March was reported for cases aged 0 – 78 year in Winston-Salem, North 
Carolina, USA (Hayes, 1961). In contrast, a peak of early July for cases aged 0 – 19 
reported in the USA (Ross et al, 1999). Similarly a peak of July was noted for all ages 
in England (Badrinath et al, 1997) and which is more obvious in children (0 – 14). In 
adults aged 50 – 69 a peak of early October was noted in the USA (Walker and van 
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Noord, 1982) and in late January for adults (16 +) in Northern Finland (Timonen, 
1999). 
The only study based on registration revealed a peak in early August for all 
ages in England (Gilman et al, 1998) and a peak in early September for children (0 – 
14).  
However, the amplitude, R, of the ‘significant’ peaks so identified varies from 
0.029 to 0.259 and the wide 95% CIs for the peak dates provide little support for 
significant seasonality.   
The peak and the corresponding 95% CI of onset, symptom and diagnosis for 
children aged within 0 – 19 years are displayed in the forest plots in Figures 5.1 and 
5.2. The box represents the corresponding peak. The size of the box is related to the 
concentration parameter κ (= 15κ × 15κ) (The multiplier is arbitrarily chosen to fit the 
scale of the plots). The peak is labelled as ‘|’ if κ is very small (κ = 0.01). The length 
of each horizontal line corresponding to each study represents the 95% CI of the peak 
date. The lower limit of the 95% CI is represented by ‘D’ and upper limit by ‘E’. 
Because the CIs may ‘wrap around’ 31 December and 01 January, the different 
markers are used to make it clear which is the lower and which the upper confidence 
limit. The studies are ranked by their latitude and then longitude. 
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Table 5.7 Angular analysis of published studies of ALL – onset 
 
Study Age (yr) N R κ Peak
µ°
 Date of 
Peak 





      
Harris (1984) 0 – 4 61 0.092 0.185 69.33  Mar 12  Oct 13 to Jul 20 1.033 0.567
Eastern Nebraska, USA 5 – 9 26 0.146 0.295 170.24  Jun 22  Feb 02 to Oct 31 1.105 0.576
 10 – 14 14 0.402 0.877 119.58  May 02  Mar 23 to Jul 23 4.519 0.104
 Total  101 0.116 0.234 112.80  Apr 25  Jan 18 to Jul 08 2.739 0.254
      
      
Meighan (1965) 0 – 14 214 0.060 0.120 177.38  Jun 29  Apr 04 to Oct 18 1.543 0.462
Oregon, USA      
      
Lee (1963) 0 – 19 506 0.101 0.203 197.69  Jul 20  Jun 12 to Aug 24 10.331 0.006
England and Wales 20 – 44 168 0.054 0.109 190.30  Jul 12  Feb 21 to Dec 03 0.987 0.611
 Total  674 0.089 0.179 196.57  Jul 19  Jun 11 to Aug 26 10.740 0.005
      
a Calculation for this (and subsequent) analysis is based on the ‘simulated’ individual dates from the corresponding months.
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Table 5.8 Angular analysis of published studies of ALL – symptom 
 
Study Age (yr) N R κ Peak
µ°
 Date of 
Peak 





      
Karimi (2003) 0 – 15 211 0.052 0.104 298.97  Oct 31  Jun 27 to Mar 15 1.142 0.565
Shiraz, Iran      
      
Till (1967) 0 – 9 372 0.003 0.006 338.55  Dec 10  Jun 11 to May 25 0.007 0.997
Greater London, England      
      
Westerbeek (1998) 1.5 – 8 719 0.042 0.084 74.37  Mar 17  Dec 23 to Jul 20 2.558 0.278
Greater Manchester and  9 – 14 264 0.052 0.103 21.78  Jan 23  Sep 22 to May 24 1.408 0.495
Lancashire, England 0 – 14 1055 0.033 0.066 66.58  Mar 09  Nov 23 to Jun 05 2.303 0.316



















Table 5.9 Angular analysis of published studies of ALL – diagnosis 
 
Study Covariate a N R κ Peak
µ°
 Date of 
Peak 





      
Harris (1987) 0 – 19     
Atlanta, USA – 60 0.121 0.244 331.09  Dec 02  Aug 08 to Apr 23 1.760 0.415
New Mexico, USA – 73 0.109 0.220 132.02  May 14  Feb 02 to Sep 09 1.743 0.418
      
Hayes (1961) 0 – 78 86 0.211 0.431 84.44  Mar 28  Feb 15 to May 08 7.623 0.022
Winston-Salem, North 
Carolina, USA 
     
      
Harris (1987) 0 – 19 184 0.027 0.055 212.59  Aug 04  Feb 18 to Jan 07 0.277 0.871
San Francisco, USA      
      
Walker (1982) 0 – 19  1196 0.035 0.069 83.00  Mar 26  Dec 20 to Jun 16 2.859 0.239
USA 0 – 2 243 0.064 0.128 357.22  Dec 29  Sep 25 to Apr 02 1.988 0.370
 3 – 9 607 0.063 0.127 106.13  Apr 18  Jan 22 to Jun 12 4.891 0.087
 10 – 19 346 0.014 0.028 87.44  Mar 30  Oct 16 to Sep 09 0.133 0.936
 20 + 587 0.039 0.078 268.50  Sep 30  May 21 to Jan 14 1.770 0.413
 20 – 49 207 0.060 0.120 258.86  Sep 20  May 22 to Jan 17 1.481 0.477
 50 – 69 172 0.174 0.354 272.14  Oct 03  Aug 30 to Nov 12 10.442 0.005
 70 + 208 0.093 0.186 87.95  Mar 31  Jan 21 to Jun 08 3.579 0.167
 Total  1783 0.011 0.021 76.33  Mar 19  Oct 12 to Aug 23 0.397 0.820
      
Ross (1999) 0 – 19 5532 0.029 0.058 186.62  Jul 09  May 24 to Aug 12 9.397 0.009
USA      
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(Continued)      
Study Covariate a N R κ Peak
µ°
 Date of 
Peak 





      
Harris (1987) 0 – 19     
Utah, USA –  114 0.063 0.126 218.93  Aug 10  Apr 12 to Dec 29 0.897 0.639
Nebraska, USA –  89 0.119 0.240 114.34  Apr 26  Dec 17 to Aug 22 2.528 0.283
Iowa, USA –  211 0.034 0.068 61.45  Mar 04  Sep 28 to Aug 23 0.483 0.786
Connecticut, USA –  191 0.078 0.157 32.05  Feb 02  Nov 01 to Jun 26 2.334 0.311
Detroit, USA –  172 0.100 0.201 46.30  Feb 16  Dec 02 to Apr 25 3.439 0.179
Seattle, USA –  127 0.087 0.174 46.96  Feb 17  Oct 23 to May 14 1.909 0.385
      
Douglas (1999) 0 – 14 789 0.019 0.038 145.28  May 28  Dec 23 to Nov 16 0.555 0.758
England and Wales Male 423 0.050 0.101 79.25  Mar 22  Dec 07 to Jun 26 2.157 0.340
 Female 366 0.056 0.112 217.89  Aug 09  Mar 27 to Nov 27 2.291 0.318
 15 – 79 580 0.029 0.058 30.87  Feb 01  Aug 25 to Jun 03 0.968 0.616
 Male 370 0.057 0.115 77.59  Mar 20  Jan 01 to Jun 11 2.442 0.295
 Female 210 0.074 0.149 308.92  Nov 10  Aug 17 to Feb 06 2.322 0.313
 Total  1369 0.013 0.025 82.66  Mar 25  Oct 25 to Aug 25 0.430 0.806
 Male 793 0.054 0.108 78.42  Mar 21  Jan 15 to May 25 4.578 0.101
 Female 576 0.044 0.089 255.58  Sep 17  May 31 to Dec 21 2.263 0.323
      
von Steensel-Moll (1983) 0 – 14 233 0.038 0.076 9.12  Jan 10  Aug 22 to May 15 0.672 0.715
The Netherlands      
      
Badrinath (1997) 0 – 14  271 0.118 0.237 191.02  Jul 13  May 24 to Sep 03 7.500 0.024
East Anglia, England 15 + 244 0.094 0.189 222.28  Aug 14  May 12 to Nov 13 4.306 0.116
 Total  515 0.103 0.206 204.05  Jul 26  Jun 23 to Aug 30 0.835 0.004
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(Continued)      
Study Covariate a N R κ Peak
µ°
 Date of 
Peak 





      
Westerbeek (1998) b 1.5 – 8 730 0.056 0.111 170.51  Jun 22  Apr 03 to Sep 04 4.520 0.104
Greater Manchester and 9 – 14 266 0.014 0.029 55.29  Feb 26  Sep 18 to Aug 21 0.109 0.947
Lancashire, England 0 – 14 1070 0.042 0.085 181.32  Jul 03  Apr 11 to Sep 11 3.849 0.146
      
Timonen (1999) 16 + 64 0.259 0.537 27.72  Jan 29  Dec 23 to Mar 14 8.611 0.014
Northern Finland      
      
a Age (yr) and gender (Male, Female). 





Table 5.10 Angular analysis of published studies of ALL – registration 
 
Study Age (yr) N R κ Peak
µ°







     
Gilman (1998) 0 – 14 805 0.050 0.100 248.10  Sep 09 Jul 11 to Nov 23 4.047 0.132
West Midlands, England 15 + 535 0.092 0.185 184.65  Jul 07 May 28 to Aug 10 9.099 0.011
 Total 1340 0.057 0.114 212.83  Aug 04 Jun 16 to Sep 17 8.722 0.013
     







Figure 5.1 Peak dates of onset, symptom and diagnosis of ALL for children (0 – 19 
years unless otherwise indicated) from published studies ordered by latitude (one 
year time-scale). 
(see over for keys) 
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Keys for Figure 5.1:   
a 1. Harris (1984) (aged 0 – 14) 3. Lee (1963) (aged 0 – 19) 
 2. Meighan (1965) (aged 0 – 14)   
     
b 1. Karimi (2003) (aged 0 – 15) 3. Westerbeek (1998) (aged 0 – 14) 
 2. Till (1967) (aged 0 – 9)   
     
c 1. Harris (1987) (Atlanta, USA) 9. Harris (1987) (Connecticut, USA) 
 2. Harris (1987) (New Mexico, 
USA) 
10. Harris (1987) (Detroit, USA) 
 3. Harris (1987) (San Francisco, 
USA) 
11. Harris (1987) (Seattle, USA) 
 4. Walker (1982) 12. Douglas (1999) (aged 0 – 14) 
 5. Ross (1999) 13. von Steensel-Moll (1983) (aged 0 – 14)
 6. Harris (1987) (Utah, USA) 14. Badrinath (1997) (aged 0 – 14) 
 7. Harris (1987) (Nebraska, USA) 15. Westerbeek (1998) (aged 0 – 14) 



















Figure 5.2 Peak dates of onset, symptom and diagnosis of ALL for children (0 – 19 
years unless otherwise indicated) from published studies ordered by latitude (2-year 
time-scale). 
Key: As for Figure 5.1.  
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The time scale for the forest plot of Figure 5.1 covers a single year. As we 
have just indicated, it is somewhat difficult to interpret as some of the CI’s wrap 
around the December/January period. To avoid this one possibility is to extend the 
plot of the results over a 2-year interval as in Figure 5.2 (as the repeated histogram of 
Figure 3.2). However, although such a plot displays a clear picture of the 
corresponding 95% CI for the peak dates, any trend in estimated peak dates becomes 
distorted. For example, the peak for study 14 and that for study 7 (Figure 5.2c) seem 
far apart but both are only separated by 3 months.   
Only studies reporting cases on age groups younger than 19 years are included 
in Figures 5.1 and 5.2.  
These graphs indicate substantial heterogeneity between the studies. One 
possible explanation for the differences in peaks could be that the studies were 
conducted at different latitudes from the equator. However, no clear association 
between day of peak and latitude is observed. 
 
5.5 Individual data − Singapore, USA and Central Sweden 
Data 
Singapore 
Individual dates of diagnosis of patients with ALL were made available through the 
Singapore Cancer Registry which includes all cases of cancer occurring in permanent 
residents of the island (population 3.5 million) over the period 1968 – 1999. The 
disease classification follows the International Classification of Diseases, 9th Revision 
(ICD-9) (World Health Organization, 1977). We restrict our analysis to the cases ever 
diagnosed with ALL (ICD9 = 204.0). In addition, age, gender, ethnic group, date of 
birth, place of birth and date of diagnosis are available on an individual case basis. 
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United States of America 
The basic data for analysis were obtained from the SEER program of the National 
Cancer Institute, USA which furnished data in text format from eleven geographical 
areas in the USA for the time period 1973 – 1999. The SEER locations included the 
following metropolitan areas: Metropolitan Atlanta, Connecticut, Metropolitan 
Detroit, Hawaii, Iowa, New Mexico, San Francisco-Oakland SMSA, Seattle, Utah, 
Los Angeles and San Jose-Monterey. Seattle contributed data for the years 1974 – 
1999, Metropolitan Atlanta contributed data for the years 1975 – 1999 and Los 
Angeles and San Jose-Monterey contributed data only for the years 1992 – 1999.  
The SEER program collects patient specific information on tumour site, 
histology, gender, age, ethnicity and date (month and year only) of diagnosis data 
from all residents who are diagnosed with cancer in collaborating states or localities. 
We restrict our analysis to ALL (ICD-9 = 204.0). Because precise dates of diagnosis 
are not given, for calculation purposes (95%CI and angular regression only), we 
randomly assign to each case a day from their corresponding month of diagnosis.  
 
Central Sweden 
Individual dates of each arrival for any diseases at hospital are available from the 
Skövde region of Central Sweden from 1977 to 1994 (population 32,100 at 1995). 
The disease classification follows a Swedish version of the International 
Classification of Diseases, 8th Revision (ICD-8) (World Health Organization, 1967) 
before 1987 and a Swedish version of ICD-9 from 1987 onwards. We restrict our 
analysis to the cases ever diagnosed with ALL (ICD-8 = 204.00 or ICD-9 = 204.0). 
The date of admission to the hospital was considered to be the onset of the disease. In 
addition age and gender are available on an individual case basis.  
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A total of 81 cases are ever diagnosed with ALL in the period 1977 to 1994. 
We reviewed the diagnoses noted at each visit for these 81 cases. In consequence two 
cases are excluded as on most occasions their diagnoses were recorded as 
lymphosarcoma or reticulosarcoma and only once with ALL. Corrections to the date 
of presentation of ALL were made for 7 cases. These cases were initially diagnosed 
with another type of leukaemia or other malignant neoplasma of the lymphoids, but 
subsequently they are recorded as ALL on most occasions. 
Table 5.11 Geographic locations in Singapore, 11 distinct registries in the USA and 
Central Sweden 
 
Location   Period Latitude Longitude 
    
Singapore  1968 – 99 1.16N 103.51E
    
USA    
    
(Honolulu) *, Hawaii  1973 – 99 21.18N 157.52W
    
Metropolitan Atlanta, Georgia   1975 – 99 33.45N 84.23W
    
Los Angeles, California  1992 – 99 34.03N 118.15W
    
(Albuquerque), New Mexico  1973 – 99 35.05N  106.39W
    
San Jose-Monterey, California   1992 – 99 36.78N 121.54W
    
San Francisco-Oakland  1973 – 99 37.48N 122.21W
    
(Salt Lake City), Utah   1973 – 99 40.46N      111.53W 
    
(Iowa City), Iowa  1973 – 99 41.40N 91.32W 
    
(Hartford), Connecticut  1973 – 99 41.46N 72.41W 
    
Metropolitan Detroit, Michigan  1973 – 99 42.20N 83.03W 
    
Seattle, Washington State  1974 – 99 47.36N 122.20W
    
(Skövde), Central Sweden  1977 – 94 58.24N 13.50E 
    
* Locations in (.) refer to state capitals. 
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Geographic variation 
Table 5.11 summaries the geographic details from the three countries and study 
locations ordered by latitude. In some locations, the capital city (of state) is taken to 
define the latitude and longitude. The latitudes range from 1.16° to 58.24°N and the 
longitudes from 157.52°W to 103.51°E. The latitude of Singapore is the smallest 
(very close to the equator of 0°) among the 13 study locations while Central Sweden 
has the greatest latitude. 
 
Patients’ characteristics 
The annual numbers of ALL cases reported in the three countries are given in 
Appendix F. A breakdown (usually by state registry) of these from the USA is given 
in Appendix G. On a per population basis the number of the cases are very similar 
across regions although there is a suggestion of rising numbers in Singapore. The 
apparent increase in the number in the USA is due to information being available 
from more registries in later years. The variation in the annual number of cases is 
considerable. 
Table 5.12 Distribution of age and gender of ALL cases by country 
 
Characteristics   Singapore USA Sweden 
     
Number of cases  939 9581 79 
     
Age (years)     
 Mean  16.99* 22.45 18.62 
 Range  0.09 – 88.32 0 – 102 1 – 90 
     
Gender     
 Male 548 (58.4%) 5517 (57.6%) 49 (62.0%) 
 Female 391 4064 30 
     
* Two cases are excluded from this (and subsequent) analysis because one does not 
have month and day of birth and one is diagnosed at 25 June 1969, which is a few 
days earlier than their recorded birth (30 June 1969). 
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The average age of presentation is similar among three countries and more 
males (approximately 1.5:1) are diagnosed (Table 5.12). This is consistent with the 
finding of Parkin et al (1988), which has reported a ratio of ALL incidence rates for 




The number of cases presenting on a monthly basis (bin size 30º) is given in Figure 
5.3. The segments are ordered from January to December (clockwise) starting due 
North. Although no single peak seems to occur in Singapore and the USA, Central 
Sweden suggests a peak over the interval between 300º through 0º to 45º. 
For the total of ALL cases, the peak in mid August in Singapore is not strong 
(R = 0.040, 95% CI May 01 to October 29) (Table 5.13). Also a peak in May 15 is 
observed in the USA, but it is not strong (R = 0.031, 95% CI Apr 19 to Jun 08). This 
peak estimate is based on the summary statistics provided at each of 11 locations in 
the USA assuming a particular unimodal seasonal pattern is captured in some 
locations (Fisher, 1993). Among these locations the di differ substantially (δmax / δmin 
= 95490.37/164.95 = 578.9). The details of the calculation are summarized in Chapter 
3 (see §3.5). In contrast, a statistically significant peak is apparent in early January (p 
= 0.02) with moderate amplitude of R = 0.223 in Central Sweden. However, the 
sample (N = 79) is small and the 95% CI from November 17 to February 10 rather 
wide. 
   144
 
 
   145
 
 







   146
Gender 
Table 5.14 shows the seasonal pattern in males and females in each location. The 
only statistically significant peak is that observed in males in Central Sweden on 
December 22 with moderate amplitude of R = 0.348 (p = 0.003). However, the 95% 
CI is rather wide from November 16 to January 16 as the sample is small (N = 49). 
The corresponding females peaked on March 22 (p = 0.575). No statistically 
significant peak in either gender is observed in Singapore and the USA.    
The angular regression on gender in each location does not reveal any 
statistically significant difference between the two genders although the estimated 
difference in peak dates between them varies from location to location (Table 5.17). 
Using angular regression a difference of 40 days between males and females is 
estimated in Singapore (Table 5.17). This estimated difference is similar to the 
difference between July 19 (female) and August 29 (male) estimated using the more 
descriptive analysis (Table 5.14).  
However, a difficulty with the iteration process appeared. Thus for the Central 
Sweden data, the plot of L (Figure 5.4) as a function of β, for the binary variable 
gender, reached the same maximum of 5.75618470 at two points. These corresponded 
to estimates of β = 0.8200 (starting value β = 0) and –5.1773 (starting value –2). The 
former led to a difference of 80 days in the estimated difference between male 
(January 25) and female (April 15) peaks (Table 5.17). This corresponds closely to 
that observed using the rose diagram plots of the male and female data (Figure 5.5). 
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Figure 5.4 Plot of the log likelihood surface as a function of the angular coefficient 
(β) for the comparison of gender in Central Sweden. 
 
 
Figure 5.5 Circular plot of the dates of arrival to the hospitals of ALL by gender in 
Central Sweden.  
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The example illustrates two difficulties, the first is to ensure that the maximum 
likelihood estimate of β is indeed the appropriate one, and the second is the 
difficulties intrinsic in the methodology if the distribution (here the females) is 
essentially uniform over the whole year. So the situation parallels that discussed 
earlier (see §3.3), when R = 0 and one cannot be sure if this corresponds to a perfectly 
uniform distribution or 2 distinct peaks 180° apart.  
The angular regression of gender in each location in the USA is performed on 
the simulated data (Table 5.17). The largest difference of 112 days between the two 
genders is observed in San Jose-Monterey, California while the smallest of 4 days is 
found in Los Angeles, California. However, the regression results do not always 
appear to agree well with the descriptive analysis. This divergence appears to be 
partially caused by the smoothing effect of the imputation (spreading the data over the 
month rather than confining it to the mid point), partially by groups with relatively 
few cases, and most importantly the seasonality being almost absent in any event. As 
a consequence of this combination, multiple regression analysis of the SEER data is 
not reported. This difficulty underlines our later emphasis on the need for fully 
individualised data sets. 
 
Age 
In the previously published studies various cuts for age, such as 14, 15, 19 years to 
define children and adults have been used. I used 19 years in this study. In general no 
strong peak is observed in either children (– 19) or adults (20 +) except perhaps for 
children in Central Sweden who showed a marginally strong peak on January 14 with 
moderate amplitude R = 0.223 (p = 0.043) (Table 5.15). The corresponding adults 
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peaked on November 29, but this peak is not statistically significant (R = 0.290, p = 
0.260). 
 The only statistically significant difference between children and adults is 
observed in Atlanta, Georgia using angular regression on the binary age cut (Table 
5.18). This difference is estimated to be 122 days (p = 0.016). A difference of 91 days 
is observed in Singapore and 45 days in Central Sweden (Table 5.18) although they 
are not statistically significant.  
When continuous age is used in the regression, a significant age effect is 
observed in Singapore (β = 0.0508 per year, p = 0.030) and San Jose-Monterey, 
California (β = −0.0799 per year, p = 0.034) (Table 5.19). The difference between 
children and adults in these two locations is 6 and 9 days, respectively. However, in 
Central Sweden, the age (continuous) is not statistically significant (β = −0.0069 per 
year, p = 0.265) and the peak date differs by only 1 day when age increases by 1 year.   
 
Multiple regression 
Table 5.20 gives the results of the circle multiple regression analysis by gender and 
age. The results of the descriptive analysis by gender and age are given in Table 5.16. 
From the descriptive analysis a strong peak of early August for female adults is 
observed in San Jose-Monterey, California (R = 0.354, 95% CI June 26 to September 
22). Similarly, a strong peak of late December is noted for the male children in 
Central Sweden (R = 0.414, 95% CI December 01 to January 22). However, these two 
significant peaks are observed based on small samples, N = 27 in San Jose-Monterey, 
California and 39 in Central Sweden (Table 5.16).  
The multiple regression on gender (Male, Female) and age (– 19, 20 +) is 
performed only in Singapore and Central Sweden. No significant gender and age 
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effect is observed in Singapore (Table 5.20). The difference in presentation of 
children and adults in Singapore is marginally significant (p = 0.080) after adjustment 
for gender. In contrast, a significant effect in Central Sweden for both gender (p = 
0.002) and age (p = 0.018) is observed. The surface plots of the log likelihood as a 
function of the angular regression coefficient (β) in Singapore and in Central Sweden 
were shown in Figures 4.3 and 4.4, respectively. 
 
Ethnicity  
The seasonal variation among Chinese, Malay and Indian residents of Singapore is 
displayed in Table 5.21. There are no strong peaks observed in these three ethnic 
groups. Chinese presented a marginally significant peak at mid August with small R = 
0.058 and wide 95% CI from June 21 to October 16 (p = 0.085). The peak for the 
Malay in late February is about 6 months earlier than the peak for Chinese, while the 
peak for Indians is in early December.  
 Table 5.22 shows the ethnic difference in the USA. The distribution of ethnic 
groups (White non-Hispanic, White Hispanic, Black, American Indians, Chinese, 
Japanese, Filipino, Hawaiian and others) differed among these 11 locations. Among 
‘Others’ group the major nationalities include: Korean (N = 38); Asian Indian and 
Pakistani (N = 38); Vietnamese (N = 38). More cases were observed in White non-
Hispanics in most locations except Los Angeles and New Mexico where more White 
Hispanic cases were observed. More Black Americans were observed in San 
Francisco-Oakland, Connecticut and Detroit. More than 10 American Indian cases 
were observed only in New Mexico (N = 61). While the highest number of Chinese 
cases is observed in San Francisco-Oakland. For those groups with a small number of 
cases, the interpretation of the results must be made with due caution. For 
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completeness I also performed circular analysis with sample size of N < 8, but the 
95% CIs are not generated. For N = 1, the month of diagnosis of the case is taken as 
the peak.    
Two groups present with a statistically significant peak. These are Black 
Americans in Metropolitan Detroit (North), Michigan who presented with a peak at 
early December (N = 170, p = 0.026, R = 0.146, 95% CI October 26 to January 29) 
and ‘others’ in Seattle (South), Washington State who presented with a peak at mid 
July (N = 37, p = 0.011, R = 0.351, 95% CI June 09 to Aug 27). The Black Americans 
in Metropolitan Atlanta, Georgia also presented with a marginally significant peak at 
mid April (N = 126, p = 0.071, R = 0.145, 95% CI February 06 to June 06).  
Presentation differs amongst some ethnic groups. For example, the pattern of 
peak presentation in each of the 11 locations in Black Americans differs from that in 
White non-Hispanics (Figure 5.6) although not in a systematic way and variation is 
considerable. 
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Singapore 939  0.040 0.080 0.338 317.78 222.61  Aug 14 May 01 to Oct 29 2.993 0.224 
           
USA (Pooled) 9543 a  0.031 0.063 0.044 421.62 131.54  May 15 Apr 19 to Jun 08   
           
Hawaii   393  0.056 0.112 0.420 164.95 92.98  Apr 05 Dec 21 to Jul 20 2.457 0.293 
            
Metropolitan Atlanta 570  0.012 0.024 5.844 3330.81 168.75  Jun 21 Nov 07 to Oct 03 0.158 0.924 
            
Los Angeles 1363  0.035 0.070 0.288 391.87 118.34  Apr 30 Jan 21 to Jul 17 3.298 0.192 
           
New Mexico 587  0.047 0.093 0.368 215.75 172.48  Jun 24 Jan 30 to Aug 30 2.546 0.280 
            
San Jose-Monterey  320  0.002 0.004 298.41 95490.37 291.33  Oct 23 Jul 12 to Jun 10 0.003 0.999 
           
San Francisco-Oakland 1236  0.032 0.064 0.412 509.43 218.75  Aug 10 May 29 to Nov 16 2.493 0.288 
           
Utah 693  0.019 0.039 1.970 1365.26 45.22  Feb 15 Sep 03 to Jul 13 0.517 0.772 
           
Iowa 1082  0.019 0.038 1.255 1357.70 44.33  Feb 14 Aug 23 to Jul 07 0.788 0.674 
           
Connecticut 1063  0.014 0.028 2.309 2454.48 49.70  Feb 20 Sep 27 to Jul 31 0.429 0.807 
           
Metropolitan Detroit 1173  0.027 0.054 0.586 687.96 4.04  Jan 05 Aug 16 to May 03 1.719 0.423 
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Seattle 1063  0.023 0.047 0.860 913.79 196.43  Jul 19 Mar 08 to Dec 07 1.164 0.559 
           
Central Sweden 79  0.223 0.458 0.094 7.448 2.78  Jan 03 Nov 17 to Feb 10 7.875 0.020 
           
a 38 cases are excluded from this (and subsequent) analysis because their month of diagnosis is not available. 
b Calculation for the USA for this (and subsequent) analysis is based on the ‘simulated’ individual dates from the corresponding months. 
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Table 5.14 Circular analysis of ALL cases by gender from Singapore, USA and Central Sweden 
 
 















          
Singapore Male 548  0.046 0.092 237.08  Aug 29 May 25 to Nov 30 2.328 0.312 
 Female 391  0.037 0.074 196.79  Jul 19 Feb 20 to Dec 04 1.073 0.585 
          
USA          
           
Hawaii Male 220  0.054 0.108 85.40  Mar 28 Nov 14 to Aug 31 1.284 0.526 
 Female 173  0.060 0.120 101.73  Apr 14 Nov 26 to Aug 24 1.229 0.541 
          
Metropolitan Atlanta Male 339  0.003 0.007 277.84  Oct 09 Jul 30 to Jul 10 0.008 0.996 
 Female 231  0.031 0.062 160.14  Jun 12 Nov 26 to Oct 18 0.445 0.801 
          
Los Angeles Male 767  0.026 0.052 128.23  May 11 Dec 13 to Sep 29 1.051 0.591 
 Female 596  0.047 0.094 111.21  Apr 23 Jan 13 to Aug 18 2.605 0.272 
          
New Mexico Male 340  0.079 0.159 180.07  Jul 02 Apr 25 to Sep 03 4.291 0.117 
 Female 247  0.015 0.029 91.72  Apr 03 Oct 27 to Sep 23 0.105 0.949 
          
San Jose-Monterey Male 200  0.029 0.059 118.51  May 01 Oct 19 to Sep 06 0.346 0.841 
 Female 120  0.055 0.110 297.74  Oct 29 Jun 26 to Mar 23 0.723 0.697 
          
San Francisco-Oakland Male 723  0.037 0.075 229.17  Aug 21 May 08 to Nov 15 2.019 0.365 
 Female 513  0.027 0.053 197.70  Jul 20 Feb 19 to Dec 15 0.721 0.698 
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(Continued)          
 















           
Utah Male 375  0.006 0.012 348.76  Dec 20 Aug 08 to Jul 16 0.028 0.986 
 Female 318  0.038 0.077 54.22  Feb 24 Sep 17 to Jun 24 0.942 0.625 
           
Iowa Male 644  0.028 0.055 102.52  Apr 14 Oct 27 to Sep 06 0.991 0.609 
 Female 438  0.043 0.086 350.83  Dec 22 Jul 22 to May 07 1.628 0.443 
          
Connecticut Male 585  0.006 0.013 6.657  Jan 07 Sep 14 to Aug 22 0.047 0.977 
 Female 478  0.026 0.053 61.24  Mar 04 Sep 06 to Jun 30 0.668 0.716 
          
Metropolitan Detroit Male 669  0.025 0.050 338.26  Dec 09 Jul 29 to May 14 0.835 0.659 
 Female 504  0.036 0.072 27.51  Jan 28 Sep 05 to Jul 07 1.315 0.518 
          
Seattle Male 638  0.016 0.032 210.99  Aug 02 Feb 02 to Dec 26 0.331 0.848 
 Female 425  0.036 0.071 186.59  Jul 09 Mar 21 to Dec 21 1.083 0.582 
          
Central Sweden Male 49  0.348 0.742 349.42  Dec 22 Nov 16 to Jan 16 11.871 0.003 
 Female 30  0.136 0.274 77.94  Mar 22 Nov 19 to Aug 08 1.107 0.575 
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Table 5.15 Circular analysis of ALL cases by age from Singapore, USA and Central Sweden 
 
 















         
Singapore – 19 684  0.055 0.111 201.56  Jul 24 May 30 to Oct 20 4.188 0.123 
 20 + 253  0.055 0.109 303.45  Nov 04 Jul 15 to Mar 17 1.506 0.471 
          
USA         
          
Hawaii – 19 263  0.073 0.147 117.36  Apr 29 Feb 08 to Jul 28 2.836 0.242 
 20 + 130  0.070 0.140 31.88  Feb 02 Sep 17 to Jun 16 1.270 0.530 
            
Metropolitan Atlanta – 19 358  0.046 0.091 9.25  Jan 10 Oct 12 to May 24 1.492 0.474 
 20 + 212  0.107 0.216 183.32  Jul 05 Apr 23 to Sep 04 4.898 0.086 
         
Los Angeles – 19 907  0.050 0.100 131.92  May 14 Mar 09 to Jul 24 4.494 0.106 
 20 + 456  0.025 0.049 46.72  Feb 17 Sep 11 to Jul 13 0.548 0.760 
         
New Mexico – 19 376  0.066 0.132 162.34  Jun 14 Mar 25 to Aug 22 3.260 0.196 
 20 + 211  0.025 0.050 228.45  Aug 20 Mar 05 to Feb 04 0.263 0.877 
            
San Jose-Monterey CA – 19 226  0.039 0.079 22.67  Jan 23 Sep 08 to May 15 0.697 0.706 
 20 + 94  0.096 0.192 207.19  Jul 30 Apr 13 to Dec 18 1.715 0.424 
         
San Francisco-Oakland – 19 761  0.046 0.093 211.14  Aug 03 May 18 to Oct 28 3.269 0.195 
 20 + 475  0.013 0.027 266.22  Sep 27 Apr 20 to Feb 27 0.169 0.919 
         
         
   157
(Continued)         
 















         
Utah – 19 499  0.035 0.070 85.94  Mar 29 Nov 21 to Aug 08 1.212 0.546 
 20 + 194  0.058 0.117 316.32  Nov 17 Jun 11 to Feb 13 1.319 0.517 
         
Iowa – 19 674  0.037 0.074 42.33  Feb 12 Oct 01 to May 28 1.861 0.394 
 20 + 408  0.011 0.022 212.97  Aug 04 Mar 19 to Feb 07 0.096 0.953 
         
Connecticut – 19 653  0.024 0.048 42.37  Feb 12 Sep 14 to Jul 20 0.766 0.682 
 20 + 410  0.005 0.010 155.79  Jun 07 Nov 04 to Oct 05 0.021 0.989 
         
Metropolitan Detroit – 19 768  0.045 0.089 25.51  Jan 26 Oct 28 to Apr 20 3.045 0.218 
 20 + 405  0.031 0.062 273.77  Oct 05 May 20 to Feb 21 0.772 0.680 
         
Seattle – 19 696  0.033 0.066 256.61  Sep 18 Jun 01 to Jan 22 1.523 0.467 
 20 + 367  0.065 0.131 140.37  May 23 Mar 16 to Oct 09 3.146 0.208 
         
Central Sweden – 19 63  0.223 0.458 13.56  Jan 14 Dec 08 to Mar 27 6.278 0.043 
 20 + 16  0.290 0.606 328.23  Nov 29 Sep 07 to Feb 12 2.692 0.260 
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Singapore Male – 19 402  0.070 0.141 217.99  Aug 10 May 14 to Oct 13 3.958  0.138 
  20 + 144  0.065 0.130 335.47  Dec 07 Jul 13 to Apr 19 1.213  0.545 
 Female – 19 282  0.048 0.095 165.09  Jun 17 Feb 08 to Nov 01 1.278  0.528 
  20 + 109  0.071 0.141 263.32  Sep 24 May 25 to Feb 02 1.085  0.581 
           
USA           
            
Hawaii Male – 19 144  0.083 0.166 121.06  May 03 Jan 11 to Aug 06 1.973  0.373 
  20 + 76  0.096 0.193 12.85  Jan 14 Aug 24 to May 25 1.407  0.495 
 Female – 19 119  0.063 0.125 111.40  May 03 Dec 18 to Oct 04 0.933  0.627 
  20 + 54  0.060 0.119 79.08  Mar 22 Oct 02 to Aug 13 0.383  0.826 
              
Metropolitan Atlanta Male – 19 218  0.072 0.145 359.86  Dec 31 Sep 12 to Mar 23 2.266  0.322 
  20 + 121  0.129 0.260 184.00  Jul 06 Apr 19 to Sep 12 4.029  0.133 
 Female – 19 140  0.019 0.039 81.03  Mar 24 Oct 18 to Aug 17 0.104  0.949 
  20 + 91  0.079 0.158 181.82  Jul 04 Jan 26 to Dec 02 1.132  0.568 
           
Los Angeles Male – 19 517  0.055 0.111 157.45  Jun 06 Mar 06 to Sep 04 3.160  0.206 
  20 + 250  0.059 0.119 18.96  Jan 20 Sep 22 to Apr 29 1.751  0.417 
 Female – 19 390  0.059 0.118 99.40  Apr 11 Dec 29 to Jul 28 2.702  0.259 
  20 + 206  0.035 0.070 152.25  Jun 04 Jan 15 to Dec 03 0.497  0.780 
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New Mexico Male – 19 219  0.111 0.224 165.09  Jun 17 Apr 20 to Aug 04 5.440  0.066 
  20 + 121  0.059 0.119 241.46  Sep 02 Apr 17 to Jan 30 0.852  0.653 
 Female – 19 157  0.008 0.016 92.14  Apr 04 Oct 20 to Sep 22 0.020  0.990 
  20 + 90  0.026 0.053 91.50  Apr 03 Nov 03 to Sep 30 0.125  0.939 
            
San Jose-Monterey Male – 19 133  0.035 0.069 125.58  May 08 Oct 24 to Sep 24 0.318  0.853 
  20 + 67  0.021 0.043 95.04  Apr 07 Aug 16 to Jul 23 0.062  0.970 
 Female – 19 93  0.117 0.236 358.30  Dec 30 Oct 10 to Mar 24 2.554  0.279 
  20 + 27  0.354 0.757 215.13  Aug 07 Jun 26 to Sep 22 6.771  0.034 
           
San Francisco-Oakland Male – 19 436  0.054 0.108 232.61  Aug 24 May 22 to Nov 28 2.532  0.282 
  20 + 287  0.013 0.027 207.58  Jul 30 Mar 05 to Jan 26 0.102  0.950 
 Female – 19 325  0.049 0.098 178.50  Jun 30 Feb 27 to Nov 06 1.560  0.458 
  20 + 188  0.029 0.058 303.17  Nov 04 May 15 to Mar 27 0.315  0.854 
           
Utah Male – 19 264  0.023 0.046 22.94  Jan 24 Sep 07 to Jul 24 0.283  0.868 
  20 + 111  0.039 0.079 220.09  Aug 12 Mar 23 to Jan 20 0.344  0.842 
 Female – 19 235  0.066 0.133 106.30  Apr 18 Dec 28 to Aug 21 2.056  0.358 
  20 + 83  0.151 0.306 336.56  Dec 08 Oct 13 to Feb 07 3.803  0.149 
           
Iowa Male – 19 393  0.039 0.077 84.17  Mar 27 Oct 19 to Aug 04 1.177  0.555 
  20 + 251  0.023 0.047 156.63  Jun 08 Jan 14 to Dec 14 0.276  0.871 
 Female – 19 281  0.061 0.122 5.86  Jan 06 Sep 08 to May 02 2.069  0.355 
  20 + 157  0.032 0.064 289.68  Oct 21 May 02 to Feb 26 0.324  0.851 
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Connecticut Male – 19 362  0.015 0.030 54.15  Feb 24 Oct 15 to Sep 14 0.167  0.922 
  20 + 223  0.018 0.036 277.47  Oct 09 May 09 to Apr 16 0.142  0.932 
 Female – 19 291  0.036 0.073 36.39  Feb 06 Sep 19 to Jun 14 0.769  0.681 
  20 + 187  0.029 0.058 116.81  Apr 29 Nov 21 to Sep 23 0.310  0.857 
            
Metropolitan Detroit Male – 19 446  0.055 0.110 20.42  Jan 21 Nov 12 to May 05 2.711  0.258 
  20 + 223  0.074 0.149 243.05  Sep 04 May 10 to Dec 06 2.457  0.293 
 Female – 19 322  0.031 0.062 38.11  Feb 08 Sep 11 to Jul 29 0.616  0.735 
  20 + 182  0.047 0.095 15.22  Jan 16 Aug 01 to Jun 09 0.815  0.665 
           
Seattle Male – 19 410  0.048 0.097 275.86  Oct 07 Jun 17 to Feb 02 1.906  0.386 
  20 + 228  0.079 0.158 127.00  May 09 Feb 16 to Jul 22 2.839  0.242 
 Female – 19 286  0.027 0.055 200.14  Jul 22 Mar 20 to Jan 30 0.432  0.806 
  20 + 139  0.056 0.112 172.89  Jun 25 Mar 03 to Dec 14 0.861  0.650 
           
Central Sweden Male – 19 39  0.414 0.910 356.64  Dec 28 Dec 01 to Jan 22 13.382  0.001 
  20 + 10  0.227 0.467 286.31  Oct 18 Jul 01 to May 01 1.034  0.596 
 Female – 19 24  0.204 0.418 120.04  May 02 Jan 30 to Sep 01 2.005  0.367 
  20 + 6  0.553 1.330 355.48  Dec 27 – 3.669  0.160 
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Table 5.17 Regression coefficients of gender following angular regression 
 




    
Difference 
Location  α°  R κ β  (β) 95% CI of β  p-value (days) 
           
Singapore 220.24  0.042 0.085 –0.3556  0.5717 –1.9507 to 1.3060  0.543 40 
           
USA (imputed dates of diagnosis)           
           
Hawaii  100.14  0.049 0.099 0.0479  0.7290 –1.8881 to 1.9511  0.947 6 
           
Metropolitan Atlanta  59.94  0.016 0.033 1.0629  2.4111 –2.6086 to 2.7995  0.711 95 
           
Los Angeles 118.19  0.033 0.066 –0.0382  0.5844 –1.7386 to 1.6725  0.948 4 
           
New Mexico 144.75  0.055 0.110 –0.7291  0.6149 –2.1873 to 0.8887  0.403 73 
           
San Jose-Monterey 22.49  0.043 0.086 –1.4382  1.4951 –2.6915 to 1.9608  0.312 112 
           
San Francisco-Oakland 217.75  0.035 0.071 –0.3150  0.5944 –1.9532 to 1.4090  0.609 35 
           
Utah  29.50  0.019 0.038 0.1508  1.4177 –2.4144 to 2.4837  0.958 17 
           
Iowa  42.51  0.025 0.050 –1.0321  1.1349 –2.5457 to 1.7458  0.352 93 
           
Connecticut 57.51  0.017 0.033 –0.0484  1.3188 –2.4157  to 2.3905  0.980  6 
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(Continued)           




    
Difference 
 α°  R κ β  (β) 95% CI of β  p-value (days) 
           
Metropolitan Detroit 2.88  0.027 0.054 0.3309  0.7984 –1.7795 to 2.1747  0.677 37 
           
Seattle  199.29  0.022 0.044 0.2083  1.0107 –2.1144 to 2.2846  0.840 24 
           
Central Sweden 24.02  0.267 0.555 0.8200  0.3586 0.2332 to 1.9795  0.060 80 
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Table 5.18 Regression coefficients of age (– 19, 20 +) following angular regression 
 




   
Difference 
Locations  α°  R κ β  (β) 95% CI of β p-value (days) 
          
Singapore 231.58  0.055 0.110 0.9929  0.6456 –0.5320 to 2.3079 0.101 91 
         
USA (imputed dates of diagnosis)          
         
Hawaii  91.00  0.072 0.144 –0.9865  0.6901 –2.3336 to 0.7019 0.143 90 
         
Metropolitan Atlanta  84.15  0.072 0.145 1.7426  0.7746 0.4415 to 2.5465 0.016 122 
         
Los Angeles 99.17  0.040 0.080 –0.8544  0.6252 –2.2452 to 0.7105 0.240 82 
          
New Mexico 185.59  0.054 0.108 0.6173  0.6292 –1.1041 to 2.1507 0.447 64 
         
San Jose-Monterey 322.76  0.063 0.127 –1.8265  1.3920 –2.7094 to 1.4676 0.122 124 
         
San Francisco-Oakland 228.56  0.036 0.072 0.4186  0.6063 –1.3120 to 2.0283 0.549 46 
         
Utah  42.78  0.043 0.087 –1.3623  1.1294 –2.5962 to 1.4105 0.148 109 
         
Iowa  327.58  0.028 0.055 –1.7159  1.4431 –2.7084 to 1.6773 0.277 121 
         
Connecticut 67.06  0.019 0.038 0.6299  1.3054 –2.1849 to 2.5338 0.666 65 
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(Continued)         
 
 




   
Difference 
Location α°  R κ β  (β) 95% CI of β p-value (days) 
         
Metropolitan Detroit 348.04  0.039 0.078 –1.0830  0.7508 –2.3954 to 0.7412 0.150 96 
          
Seattle  218.72  0.044 0.089 –1.2028  0.7337 –2.4176 to 0.4621 0.073 102 
         
Central Sweden 4.15  0.237 0.487 –0.4064  0.4465 –1.8164 to 0.8767 0.315 45 
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Difference 
Location α°  R κ β  (β) 95% CI of β p-value (days) 
         
Singapore 240.81  0.064 0.128 0.0508  0.0252 0.0028 to 0.1997 0.030 6 
         
USA (imputed dates of diagnosis)         
         
Hawaii  101.87  0.080 0.160 –0.0176  0.0130 –0.0861 to 0.0158 0.078 2 
         
Metropolitan Atlanta  93.38  0.052 0.104 0.0283  0.0227 –0.0324 to 0.1453 0.087 3 
         
Los Angeles 117.70  0.033 0.066 0.0002  0.0121 –0.0470 to 0.0478 0.990 0 
         
New Mexico 163.74  0.050 0.100 –0.0063  0.0130 –0.0635 to 0.0384 0.787 73 
         
San Jose-Monterey 307.68  0.085 0.171 –0.0799  0.0488 –0.3476 to 0.0315 0.034 9 
         
San Francisco-Oakland 230.54  0.036 0.071 0.0097  0.0129 –0.0312 to 0.0699 0.583 1 
         
Utah  55.62  0.028 0.057 –0.0347  0.0479 –0.2558 to 0.1182 0.436 4 
         
Iowa  50.75  0.021 0.041 0.0037  0.0310 –0.1140 to 0.1287 0.505 0 
         
Connecticut 58.45  0.017 0.035 0.0049  0.0250 –0.0881 to 0.1077 0.801 1 
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(Continued)         
 
 




   
Difference 
Location α°  R κ β  (β) 95% CI of β p-value (days) 
         
Metropolitan Detroit 344.95  0.046 0.092 –0.0328  0.0192 –0.1406 to 0.0097 0.063 4 
         
Seattle  221.31  0.039 0.078 –0.0232  0.0189 –0.1203 to 0.0277 0.137 3 
         
Central Sweden 7.67  0.240 0.494 –0.0069  0.0075 –0.0432 to 0.0156 0.265 1 
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Location  α° R κ β  (β) 95% CI of β p-value 
          
Singapore Gender (Male, Female)    –0.6188  0.5116 –2.0364 to 0.7332 0.226 
  226.89 0.062 0.124      
 Age (– 19, 20 +)    1.1234  0.6408 –0.2636 to 2.3459 0.080 
          
          
Central Sweden Gender (Male, Female)    1.2901  0.4229 0.8643 to 2.2597 0.002 
  24.52 0.336 0.714      
 Age (– 19, 20 +)    –1.2720  0.5366 –2.3288 to –0.4336 0.018 




















           
Chinese  729  0.058 0.116 218.34  Aug 10 Jun 21 to Oct 16 4.925 0.085 
Malay 139  0.015 0.029 51.86  Feb 22 Sep 01 to Aug 09 0.060 0.970 
Indian 61  0.104 0.209 334.37  Dec 06 Aug 14 to Apr 29 1.321 0.517 
Others  10  0.244 0.503 123.33  May 06 Jan 08 to Aug 23 1.190 0.552 
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Hawaii           
White non-Hispanic 101  0.050 0.100 342.20  Dec 13 Jun 22 to Apr 23 0.505 0.777 
White Hispanic 4  0.559 1.352 129.20  May 11 – 2.499 0.287 
Black 6  0.441 0.983 158.72  Jun 10 – 2.338 0.311 
American Indian –  – – –  – – – – 
Chinese 15  0.231 0.476 68.23  Mar 11 Nov 25 to Aug 11 1.605 0.448 
Japanese  85  0.089 0.179 46.87  Feb 17 Oct 02 to Jul 11  1.349 0.509 
Filipino 58  0.129 0.259 171.33  Jun 23 Mar 11 to Sep 27 1.916 0.384 
Hawaiian  88  0.082 0.164 137.19  May 20 Jan 20 to Oct 10 1.178 0.555 
Others  33  0.242 0.498 64.88  Mar 07 Dec 24 to May 20 3.858 0.145 
Unknown  3  0.482 1.098 300.34  Nov 01 – 1.396 0.498 
           
Metropolitan Atlanta           
White non-Hispanic 403  0.040 0.081 247.08  Sep 08 Mar 22 to Jan 22 1.320 0.517 
White Hispanic 18  0.220 0.450 45.21  Feb 15 Nov 02 to May 15 1.737 0.420 
Black 126  0.145 0.293 102.05  Apr 14 Feb 06 to Jun 06 5.292 0.071 
American Indian 1  – – –  August  – – – 
Chinese 2  0.715 2.105 270.94  Oct 02 – 2.047 0.359 
Japanese  1  – – –  April  – – – 
Filipino –  – – –  – – – – 
Hawaiian  –  – – –  – – – – 
Others  15  0.158 0.320 320.59  Nov 22 Jun 26 to May 03 0.747 0.688 
Unknown  4  0.423 0.934 267.63  Sep 29 – 1.434 0.488 
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Los Angeles           
White non-Hispanic 374  0.050 0.101 122.12  May 04 Dec 23 to Aug 28 1.908 0.385 
White Hispanic 791  0.052 0.105 120.00  May 02 Mar 01 to Jul 17 4.319 0.115 
Black 80  0.090 0.181 270.06  Oct 01 May 19 to Feb 13 1.297 0.523 
American Indian –  – – –  – – – – 
Chinese 26  0.122 0.245 341.89  Dec 13 Jul 14 to May 08 0.771 0.680 
Japanese  11  0.215 0.440 139.10  May 22 Nov 30 to Aug 11 1.013 0.603 
Filipino 28  0.051 0.101 3.360  Jan 04 May 14 to Apr 23 0.143 0.931 
Hawaiian  1  – – –  October  – – – 
Others 50  0.105 0.212 321.38  Nov 22 Aug 02 to Apr 11 1.110 0.574 
Unknown  2  0.715 2.104 30.00  Jan 31 – 2.046 0.360 
           
New Mexico           
White non-Hispanic 255  0.044 0.089 217.84  Aug 09 Mar 06 to Dec 26 1.004 0.605 
White Hispanic 261  0.058 0.116 115.40  Apr 28 Jan 09 to Aug 06 1.760 0.415 
Black 7  0.210 0.430 118.15  Apr 30 – 0.618 0.734 
American Indian 61  0.187 0.381 199.36  Jul 22 May 01 to Sep 18 4.280 0.118 
Chinese –  – – –  – – – – 
Japanese  –  – – –  – – – – 
Filipino –  – – –  – – – – 
Hawaiian  –  – – –  – – – – 
Others 3  0.247 0.509 255.00  Sep 16 – 0.366 0.833 
Unknown  –  – – –  – – – – 
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San Jose-Monterey           
White non-Hispanic 140  0.022 0.043 256.54  Sep 18 May 01 to Apr 01 0.132 0.936 
White Hispanic 129  0.061 0.123 24.27  Jan 25 Oct 05 to May 06 0.976 0.614 
Black 2  0.262 0.544 93.50  Apr 05 – 0.275 0.872 
American Indian –  – – –  – – – – 
Chinese 10  0.054 0.107 309.34  Nov 10 May 22 to Apr 26 0.058 0.972 
Japanese  2  0.262 0.543 60.00  Mar 02 – 0.274 0.872 
Filipino 7  0.549 1.316 213.60  Aug 05 – 4.215 0.122 
Hawaiian  0  – – –  – – – – 
Others 27  0.220 0.451 159.76  Jun 11 Mar 26 to Aug 22 2.611 0.271 
Unknown  3  0.809 2.981 323.67  Nov 25 – 3.930 0.140 
           
San Francisco-Oakland           
White non-Hispanic 721  0.015 0.030 136.47  May 19 Dec 12 to Nov 12 0.324 0.851 
White Hispanic 211  0.103 0.208 207.40  Jul 30 May 29 to Oct 10 4.495 0.106 
Black 109  0.080 0.161 283.96  Oct 15 Jun 06 to Mar 03 1.399 0.497 
American Indian 3  0.334 0.708 76.91  Mar 19 – 0.668 0.716 
Chinese 67  0.145 0.292 285.66  Oct 17 Jul 10 to Jan 19 2.801 0.247 
Japanese  8  0.459 1.031 91.74  Apr 04 Feb 26 to Feb 13 3.366 0.189 
Filipino 64  0.144 0.292 256.81  Sep 18 Jul 06 to Jan 30 2.667 0.264 
Hawaiian  –  – – –  – – – – 
Others 44  0.087 0.174 142.05  May 25 Dec 29 to Nov 03 0.664 0.718 
Unknown  9  0.430 0.952 213.92  Aug 05 Jun 05 to Feb 16 3.331 0.189 
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Utah           
White non-Hispanic 614  0.023 0.045 43.04  Feb 13 Sep 10 to Jul 13 0.628 0.731 
White Hispanic 62  0.053 0.106 98.92  Apr 11 Oct 21 to Aug 28 0.348 0.840 
Black 2  0.977 22.05 300.25  Nov 01 – 3.819 0.148 
American Indian 5  0.586 1.451 173.67  Jun 26 – 3.428 0.180 
Chinese 2  0.715 2.105 60.94  Mar 03 – 2.047 0.359 
Japanese  –  – – –  – – – – 
Filipino 1  – – –  November – – – 
Hawaiian  1  – – –  August  – – – 
Others 6  0.329 0.697 300.25  Nov 01  1.301 0.522 
Unknown  –  – – –  – – – – 
           
Iowa           
White non-Hispanic 1040  0.024 0.048 31.88  Feb 02 Aug 15 to Jun 10 1.207 0.547 
White Hispanic 14  0.133 0.268 103.27  Apr 15 Oct 16 to Sep 06 0.495 0.781 
Black 15  0.231 0.474 169.90  Jun 22 Mar 06 to Oct 21 1.597 0.450 
American Indian 1  – – –  April  – – – 
Chinese –  – – –  – – – – 
Japanese  –  – – –  – – – – 
Filipino –  – – –  – – – – 
Hawaiian  –  – – –  – – – – 
Others 12  0.275 0.571 222.24  Aug 14 Jun 14 to Feb 25 1.809 0.405 
Unknown  –  – – –  – – – – 
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Connecticut           
White non-Hispanic 889  0.030 0.059 38.27  Feb 08 Oct 08 to Jun 10 1.569 0.456 
White Hispanic 83  0.049 0.097 209.53  Aug 01 Jan 27 to Dec 27 0.392 0.822 
Black 61  0.144 0.290 178.85  Jul 01 Mar 29 to Oct 04 2.516 0.284 
American Indian 3  0.175 0.355 150.00  Jun 02 – 0.183 0.913 
Chinese 1  – – –  July  – – – 
Japanese  –  – – –  – – – – 
Filipino 1  – – –  December  – – – 
Hawaiian  –  – – –  – – – – 
Others 16  0.177 0.359 255.16  Sep 16 Apr 25 to Mar 04 1.000 0.607 
Unknown  9  0.275 0.572 358.70  Dec 30 Sep 23 to Apr 01 1.361 0.506 
           
Metropolitan Detroit           
White non-Hispanic 960  0.014 0.027 58.64  Mar 01 Oct 06 to Aug 25 0.362 0.834 
White Hispanic 14  0.252 0.521 141.22  May 24 Nov 23 to Sep 08 1.780 0.411 
Black 170  0.146 0.296 331.39  Dec 02 Oct 26 to Jan 29 7.278 0.026 
American Indian 3  0.334 0.708 343.09  Dec 14 – 0.668 0.716 
Chinese 4  0.228 0.469 193.75  Jul 16 – 0.416 0.812 
Japanese  –  – – –  – – – – 
Filipino 1  – – –  February  – – – 
Hawaiian  –  – – –  – – – – 
Others 16  0.387 0.840 352.35  Dec 24 Nov 07 to Feb 15 4.805 0.091 
Unknown  5  0.348 0.743 135.00  May 17 – 1.214 0.545 
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Seattle           
White non-Hispanic 923  0.005 0.010 179.87  Jul 02 Mar 10 to Feb 13 0.044 0.978 
White Hispanic 26  0.152 0.307 186.26  Jul 08 Feb 23 to Oct 25 1.198 0.550 
Black 36  0.058 0.116 133.31  May 16 Oct 25 to Oct 04 0.241 0.887 
American Indian 10  0.116 0.233 337.71  Dec 09 Jul 21 to Jun 21 0.268 0.875 
Chinese 4  0.694 1.967 255.00  Sep 16 – 3.848 0.146 
Japanese  9  0.371 0.800 149.23  Jun 01 – 2.482 0.289 
Filipino 11  0.272 0.566 316.70  Nov 18 Jul 23 to Mar 28 1.630 0.443 
Hawaiian  –  – – –  – – – – 
Others 37  0.351 0.750 191.39  Jul 14 Jun 09 to Aug 27 9.122 0.011 
Unknown  7  0.331 0.702 247.20  Sep 08 – 1.537 0.464 
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Figure 5.6 Peak dates in ALL cases for Black American and White non-Hispanic from 
the 11 locations of the USA (locations ordered by latitude as in Table 5.22).  
' not proportional to κ. 
* Note: If CI’s not shown – sample too small for the calculation. 
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Influence of latitude and longitude 
For ease of comparison I also used the same cut of as the one used in Harris et al 
(1987). For the places with latitude < 40° from Singapore to San Francisco, USA, the 
estimated peaks are from April to October (Table 5.13). For the locations with 
latitude ≥ 40° from Utah, USA to Central Sweden, the estimated peaks are from 
January to February (Winter) except in Seattle, Washington State, where the latitude 
is 47.36°N, and the estimated peak is at July 19. No association between peak date 
and longitude is observed.   
Figure 5.7 is the angular plot of the 13 estimated peaks from each location 
generated using S-PLUS codes. The peaks are numbered following the order of the 
location in Table 5.11. All the peaks for the location in the USA are presented using  
‘O’. In contrast, the peaks in Singapore and central Sweden are presented differently 
using “/” and “Q”, respectively.  This plot shows that all estimated peaks from the 
USA except one from San Jose-Monterey, California are between the corresponding 
peaks for Singapore and Sweden.  
 The forest plots of the estimated peaks and corresponding 95% CI following 
increasing latitude and longitude are given in Figures 5.8 and 5.9. The box size is 
proportional to κ (= 15 × κ). The peak is labelled as ‘−’ if κ is very small (κ < 0.01). 
To linearize latitude I also transformed them with a sine function. In Figures 5.8 all 
studies are ordered by the latitude. While in Figures 5.9 all studies are ordered by the 
longitude from the West (Hawaii, USA) to the East (Singapore). These plots 
suggested that there is a tendency of a peak towards winter (December) with the 
increasing latitude, but there is no apparent effect of longitude. 
The regression of the 13 peaks observed from each location on the latitude (< 
40° vs ≥ 40°) shows a strong difference in the presentation between South and North 
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(β = 2.673, SE(β) = 0.880, p = 0.004). The difference between South and North is 
141days, which is about 5 months (Table 5.23). However, the effect of the sine 
transformed latitude (continuous) is not statistically significant (β = −3.471 per year, 
SE(β) = 3.147, p = 0.083).   
 
Figure 5.7 Peaks in ALL cases from Singapore, the USA and Central Sweden (study 
numbered following the sequences of Table 5.11).  
1. Singapore 8. Utah  
2. Hawaii 9. Iowa 
3. Metropolitan Atlanta, Georgia  10. Connecticut 
4. Los Angeles, California 11. Metropolitan Detroit, Michigan 
5. New Mexico 12. Seattle, Washington State 
6. San Jose-Monterey, California  13. Central Sweden 
7. San Francisco-Oakland   
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Figure 5.8 Peak dates (95% CI) in ALL cases from Singapore, the USA and Central 
Sweden (locations ordered by latitudes). 
Key: As for Table 5.11.  
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Figure 5.9 Peak dates (95% CI) in ALL cases from Singapore, the USA and Central 
Sweden (locations ordered by longitude). 
Keys for Figure 5.8    
Location Longitude (°E) Location Longitude (°E) 
Hawaii -157.52 Iowa -91.32 
Oakland -122.25 Atlanta -84.23 
Seattle -122.2 Detroit -83.03 
San Jose-Monterey -121.54 Connecticut -72.41 
Los Angeles -118.15 Sweden 13.5 
Utah -111.53 Singapore 103.51 
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Table 5.23 Regression coefficients of latitude following angular regression 
 




   
Difference 
 α°  R κ β  (β) 95% CI of β p-value (days) 
          
Latitude 281.74  0.565 1.375 2.673  0.880 1.5176 to 2.6944 0.004 141 
(< 40°, ≥ 40°N)          
          
sin(latitude) 94.16  0.368 0.792 –3.471  3.147 –2.9348 to 2.4315 0.083 150 
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Mardia and Jupp (2000, page 252) and Fisher (1993, page 146 – 50) described 
a general model for association between two circular variables. I have used this 
method in the calculation of the correlation between the latitude and the 
corresponding peaks. The details of the calculation are given in §4.7. The estimated 
correlation is r = –0.0466 and the test statistic |(l – 1) r| = 2.2834, thus 0.1 > p > 0.05. 




A total of 34 articles, which reported on the seasonal variation in the presentation of 
leukaemia, were identified through a literature search. Among them, 20 examined the 
presentation of ALL and hence, are studied in detail in this Chapter. These studies are 
arranged according to the ‘start’ measure utilised and further by their latitude and 
longitude. The results reported, such as sample size, study period, location, statistical 
test used and their abbreviated conclusions are summarised. Despite investigation of 
seasonal patterns in the presentation of ALL over a range of latitudes from 35.05°S to 
65.01°N, because of somewhat contradictory findings, there is no clear message with 
respect to their interpretation. Thus, for example, although it has been suggested that 
if a seasonal infective agent were acting during childhood (with a short incubation 
period from infection to clinical disease), then this would become apparent by 
examination of onset date, we find no evidence to support this type of hypothesis. 
There are a number of possible reasons why inconsistent results may have 
occurred. These include the different ‘start’ measures used, such as date of onset, 
symptom, diagnosis or registration. Westerbeek et al (1998) found significant 
seasonal variation for Hodgkin’s disease only in date of first symptom and not in date 
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of diagnosis. Thus they suggest that date of first symptom more closely reflects the 
event that precipitates the clinical onset of disease than does the date of diagnosis. A 
similar argument in this respect can also be found in Higgins et al (2001) and Gao et 
al (2001). The publications reviewed also include studies based on a small number of 
cases and hence of little statistical power (Lanzkowsky, 1964; Mainwaring, 1966). 
Finally, a variety of statistical techniques have been used to search for seasonality, 
and these different approaches may also contribute to the different findings. 
In Chapter 2, I applied the statistical tests commonly used when the monthly 
data are reported and this suggested that the conclusions drawn were very dependent 
on the test used. Therefore, to provide a common standard for comparison of the 
published studies of ALL, I applied the angular methodology to each of these in this 
Chapter. A forest plot format (used in the meta analysis of clinical trials) is adopted to 
show the variation in estimated date of the peak and the 95% CI. Two methods of 
presentation of the plot, one using a single-year time-scale and one a 2-year time-
scale, are explored. Whereas the 2-year time-scale displays a clear picture of the 
corresponding 95% CI of the peak dates, any trend in the estimated peak dates is 
obscured. As a consequence the 1-year plot is recommended. The synthesis, using 
angular methods, indicates that seasonal patterns in the presentation of ALL are not 
marked, although there remains some inconsistency. Variation by geographical area 
persists but the forest plots suggest, for example, no clear association between day of 
peak and latitude. 
However, this reanalysis was still based on grouped data so that it is difficult 
to exclude the possibility that differences in the peak presentation of ALL depend on 
geographical variation. The individually based data from Singapore, the USA and 
(Central) Sweden within latitudes ranging from 1.16° to 58.24°N enabled this to be 
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examined in greater detail. Again no clear seasonal pattern (all ages) is found in 
Singapore, which is close to the equator nor in the USA across a wide range of 
latitudes. This is consistent with the report of Walker and van Noord (1982), who 
concluded that there was no seasonality in the USA across all ages. In contrast, Ross 
et al (1999) found a summer peak in the diagnosis of ALL in the children defined as 0 
− 19 years. However, in a re-analysis of the data from Walker and van Noord (1982) 
by Harris et al (1987), up to 3 peaks were reported in each of the 9 locations studied 
for ages 0 – 19. 
In contrast for Central Sweden, a significant peak in winter (early January) is 
observed. This is close to the peak of onset (Winter: June to August) reported from 
Capetown, South Africa (Lanzkowsky, 1964) and the peak of symptoms (Winter: 
October) in Shiraz, Iran (Karimi and Yarmohammadi, 2003). However, this differs 
from the summer peak onset reported in England and Wales (Lee, 1962; 1963) and 
summer peak of diagnosis in England (Badrinath et al, 1997). These contrasting 
results for ALL may be due to the different statistical approaches that have been used, 
the different age groups chosen or the different date of ‘start’ considered although, the 
delay between clinical symptom in children and diagnosis is not likely to be great 
(Greaves, 1993). 
The apparent difference in peak presentation between Singapore, the USA and 
Central Sweden will be partly due to the ‘start’ measure in each country differing. For 
example, the date of arrival to the hospitals is used in Central Sweden, but date of 
diagnosis is used in Singapore and the USA. Some other non aetiological factors, such 
as the occurrence of the major public holidays may also affect the presentation in each 
country, for example, the close proximity of the Western and Chinese New Year 
festivals in Singapore.       
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For many exposures, seasonal variation will depend on climate and a range of 
population characteristics (Little and Elwood, 1992). Thus I have also examined the 
seasonal pattern of ALL presentation by gender and age groups (− 19, 20 +) in each 
location. In these data ALL occurs more frequently in males than females in each 
location, but there is little evidence of a seasonal component. Only males in Central 
Sweden presented with a moderate peak at mid December (R = 0.348, p = 0.003). 
However, the sample is very small (N = 49) and the 95% CI rather wide from 
November 16 to January 16. The analysis by age (− 19, 20 +) also did not reveal any 
significant peak in Singapore and the USA. Only children in Central Sweden showed 
a moderate peak at mid January (R = 0.223, p = 0.043). Again the sample is small (N 
= 63) and the 95% CI rather wide from December 08 to March 27. Further analysis of 
gender by age groups showed a strong peak at late December for male children in 
(Central) Sweden (R = 0.414, p = 0.001) and a moderate peak at early August for 
female adults in San Jose-Monterey, California (R = 0.354, p = 0.034).   
Although no strong peak is observed in either children or adults in each 
location, the difference in peak presentation between children and adults appears to 
vary from location to location as does that between male and female. However, 
univariate angular regression found no statistically significant gender effect in any 
location. A significant effect of (binary) age is observed in Atlanta, Georgia. In 
contrast, using age as continuous the effect in the seasonal variation is statistically 
significant in Singapore and San Jose-Monterey, California. Multiple regressions 
confined to Central Sweden alone show a significant effect of gender and age. 
However this is not the case in Singapore. 
Although, to my knowledge, seasonal variation in the presentation of ALL by 
ethnic group has not been investigated in the literature, substantial variation in the 
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frequency of ALL between ethnic groups has been noted. For example, Linet and 
Devesa (1991) has shown that in the USA the highest rates of ALL are evident among 
Hispanic populations, Filipinos and Chinese. Rates among Whites are moderate to 
high by international standards, while those for American Indians are somewhat 
lower. The lowest rates are among Blacks, with the ALL incidence rate ratio 
approximately 0.5 for Blacks compared to Whites.  
This Chapter appears to be the first attempt to examine the seasonality with 
this focus. In Singapore, there are three major ethnic groups: Chinese, Malay and 
Indian. Although no peaks are statistically significant (Table 5.21), Malays peaked 
early in the year (end February), Chinese peaked mid - year (August), while Indians 
peaked at the end (early December). The seasonal variation was also examined in 
White non-Hispanic, White Hispanic, Black Americans, American Indian, Chinese, 
Japanese, Filipino and Hawaiian in each of the 11 locations in the USA (Table 5.22). 
No strong peak is observed in any ethnic group except for Black Americans in 
Metropolitan Detroit, Michigan, who presented with a significant peak in early 
December (Winter) and ‘Others’ in Seattle, Washington State in mid July (Summer). 
In addition the peak for each ethnic group varies from location to location. For 
example, the peak for Chinese from Honolulu, Hawaii (latitude 21.18°N) to Seattle, 
Washington State (latitude 58.24°N) varies from March to December. No clear 
association between peak in date and latitude is observed in any ethnic group. 
The risk of ALL has been associated with socio-economic status and some 
environmental factors (Stiller and Parkin, 1996; Hjalmars and Gustafsson, 1999), but I 
was not able to examine their impact on seasonal variation as, for example, socio-
economic status of the individuals is not included in the available data.  
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The latitude and longitude effect is also examined in a preliminary manner in 
this Chapter. The 13 peaks estimated from each location are examined and grouped by 
the latitude using a cut off of 40°. Angular regression was suggestive that the peak 
presentation of ALL depended on latitude; presenting in the South (latitude < 40°) (in 
October) 7 months later than in the North (p = 0.004).  
In summary, the multiple angular regression analysis was not able to identify 
an effect of either gender or age on the seasonal presentation of ALL, although there 
were some indications from the (Central) Sweden data that both of these may play a 
role. There are also indications of differences between at least some ethnic groups but 
again the evidence is not substantial. However, there is a firmer suggestion that those 
from more Northern latitudes present earlier than those from the South.  
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6 Conclusion  
 
This thesis sets out to accomplish several objectives. Firstly, it aims at defining an 
appropriate statistical methodology for situations where seasonality of disease can be 
summarised by either a single peak or by different peaks that are possibly determined 
by patient characteristics or external influences. Secondly, it evaluates the application 
of angular regression methods to the medical literature. A computer program for 
angular regression was developed to enable clinical researchers to make use of the 
method. Finally, the above objectives were brought together in a study to identify 
seasonal components contributing to the incidence of acute lymphoblastic leukaemia 
(ALL) in various populations using primary data.  
For count data accumulated into months over a year, a variety of statistical 
tests have been devised. They include the Pearson χ2 test, the Edwards test, the 
summer to winter ratio test, and the periodic regression (cosinor analysis) method. 
These tests (and others) have been described in detail in Chapter 2. Although some of 
these tests have been extensively used, this application was not the primary purpose 
for their development (for example, the Pearson χ2 test). As a result, their 
performance is not always satisfactory in seasonality analyses. 
The angular (circular) method that is described in Chapters 3 and 4 provides 
an alternative. This method utilizes individual dates of presentation and replaces the 
Normal distribution appropriate for linear data with the von Mises distribution. It 
considers the calendar year as a circle and identifies each date of onset as a point on 
that circle. Under the assumption of a peak onset for a disease, a point, 0θ , on the 
circle corresponding to this (single) peak is then identified, and its magnitude, R, is 
estimated. The confidence interval (CI) of the peak can also be calculated even though 
the calculation is not always straightforward.  
   187
Although the focus is on seasonal variation over a year, the angular method is 
also applicable to other time-frames. Furthermore, the angular method has been 
extended to include angular regression, which also utilizes individual dates of disease 
onset. Angular regression can be used to compare seasonal patterns of different 
patient subgroups with the disease in question. But no standard computer software is 
available for implementing this method.  
In order to enable clinical researchers to make use of the full angular and 
angular regression methodology a computer program for these methods has been 
developed using S-PLUS (2001, version 6). This program has been extensively tested, 
and is used for all the calculations in the thesis.  
Some of the preliminary methodological work associated with angular 
regression has been published (Gao et al, 2002). The angular method has also been 
used by us to investigate suicides in Singapore (Parker et al, 2001), presentation of 
childhood cancers in the United States of American (USA) (Machin and Gao, 2000), 
breast cancer in Singapore (Gao et al, 2001) and methicillin-resistant staphylococcus 
aureus (MRSA) in Spain (Gao and Machin, 2004). To date Machin and Gao (2000), 
Gao et al (2001) and Gao and Machin (2004) remain, to the best of my knowledge, 
the only published examples of using angular regression models in a medical context.  
The use of the angular method has been explored in this thesis in a meta-
analysis of seasonality with respect to ALL. A total of 34 studies of seasonality of 
leukaemia were identified, of these twenty studied seasonality of ALL and were re-
examined in detail. These studies range in location from latitude 35.05°S to 65.01°N, 
but have used different ‘start’ measures (onset, symptom, diagnosis and registration) 
and a mixture of analytical methods. Most studies have analysed data by months and 
none have used individual date of ‘start’ in the analysis. No clear consensus with 
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respect to the seasonal variation of ALL presentation has been drawn from these 
collective reports.  
The angular method was used to reanalyse these data, but most studies show 
little evidence of marked seasonality. To display the variation of the observed peaks 
across the studies, a forest plot similar to that used in the meta analysis of clinical 
trials is adopted (probably for the first time in a review of seasonality). These graphs 
indicate substantial heterogeneity between the studies. One possible explanation for 
the differences in (weak) peaks could be that the studies were conducted at different 
latitudes. However, no clear association between day of peak and latitude is apparent.  
The seasonal component of ALL (both in children and adults) from Singapore, 
the USA and Central Sweden has also been examined using patient specific dates of 
onset of the disease and individualised information on gender, age and ethnicity. As 
anticipated, no clear seasonal pattern is found in Singapore, as it is geographically 
located close to the equator. However, the findings from the USA are also mainly 
negative. But the data from Central Sweden suggested a strong peak in early January. 
Thus this analysis provides no clear evidence that latitude (and hence possibly 
‘climate’) is a factor affecting the presentation of ALL. Nevertheless the sensitivity of 
this analysis would have been greater if full details (rather than month/year) were 
available for data from the Surveillance, Epidemiology, and End Results (SEER) 
Program.    
The seasonal variation in the presentation of ALL by ethnic group in 
Singapore and the USA was also examined. No strong evidence of seasonality was 
observed in any ethnic group although Black Americans in Metropolitan Detroit, 
Michigan who presented a significant peak at early December (Winter) and ‘Others’ 
in Seattle, Washington State at mid July (Summer). 
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The multiple angular regression analysis was not able to identify an effect of 
either gender or age on the seasonal presentation of ALL, although there were some 
indications from the (Central) Sweden data that both of these may play a role. 
Although the extremes of Singapore (latitude 1.16°N) and Central Sweden (latitude 
58.24°N) give a suggestion that latitude may play a role, the patterns within the USA 
do not confirm this. 
In this thesis extensive use of the angular regression model has been made 
with one and two independent variables (ordered categorical with 2 or 3 levels, or 
continuous) and some problems with the method emerged. For example, although the 
coefficients are estimated by the maximum likelihood method, the iterations do not 
always converge and even when they do, they may converge to different estimates 
depending on the starting values chosen. This suggests that plots of the likelihood 
surfaces are an important diagnostic tool in such situations as are basic rose diagram 
plots of the individual data. It is perhaps of no surprise, that the difficulties become 
more apparent for small sample sizes with near uniform distributions over the circle. 
Further work using models with latitude in its full angular form rather than as a binary 
variable would be useful.  
In general, in order to investigate seasonality more effectively, it is 
recommended to fully utilise the date of onset and, if a single peak seems appropriate, 
to estimate the peak onset, its magnitude and the associated CI using angular 
summary and regression methods. Unfortunately, routine databases used by many 
authors are not often able to provide the case-specific information that is required for 
a full evaluation. To overcome these shortcomings in the investigation of the 
seasonality of ALL, a coordinated and prospective study using individual dates of first 
symptom, patient specific (location, age, gender and ethnicity) and health care 
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delivery details encompassing subjects from many latitudes and longitudes is 
required. From this, the true extent of the climatic component in the aetiology of ALL 
may be revealed.  
In summary, this thesis demonstrates that the angular methods allow for a 
more precise analysis by utilising the actual dates of presentation of the patients and a 
more appropriate test for the presence of a single peak and more accurate assessment 
of any effects of patient characteristics or external influences. However, no firm 
conclusion with respect to the seasonality of ALL can be drawn. 
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Appendix A Bootstrap estimate of the mean direction  
 
Fisher (1993, 210 – 211) gave the computing algorithm for the bootstrap estimate of 
the mean direction (see also §3.3). Let θ1, …,θN be an arbitrary sample of N 
directions, and define 
 cos , sini i i ix yθ θ= =  (A.1) 
for i = 1, …, N. 
Algorithm A.1. Mean vector (z) and covariance matrix (u) of (xi, yi). 
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Algorithm A.2. Square root (v) of a positive definite symmetric 2 × 2 matrix (u). 
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Algorithm A.3. Inverse (w) of square root of a positive definite 2 × 2 matrix (u). 
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b b
b b              (A.10) 








−  = = =  +  
b
b  (A.11) 
Algorithm A.4. Estimate of mean direction. 
Given the quantities z0 and v0 from the original sample, and wB and zB from a 
bootstrap sample, calculate CB and SB, from 





z v w z z
s









−   = +      
              (A.13) 
*
Bˆθ  can now be determined from equations (3.1) and (3.3).    
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Appendix B Proof  that the von Mises distribution is approximately 
normal  
 








κ θ µπ κ= −   (B.1) 
Let ( )1/ 2ζ κ θ µ= − , then (B.1) becomes  
 ( ) ( ){ }1/ 20exp( ) exp [1 cos ]2 I κ κ ζπ −−-kk .                               (B.2) 
This probability density function is therefore proportional to 
 1/ 2exp{ [1 cos( )]}.κ κ ζ−− −  (B.3) 
For large κ, using a Taylor series expansion 
 1/ 2 1 2 2 4 31 1cos( ) 1 ( ).
2 4!
Oκ ζ κ ζ κ ζ κ− − − −= − + −  
Consequently 
 
1/ 2 1 2 2 4 3
1 2 2
1 11 cos( ) ( )
2 4!




κ ζ κ ζ κ ζ κ
κ ζ κ
− − − −
− −
− = − +
= +
 (B.4) 
Thus the exponential part of (B.3) is approximately 21 .
2
ζ−  Hence ζ has 
approximately standard Normal distribution N(0, 1). Therefore, since 1/ 2θ = κ ζ µ− +  
and when κ is large, θ is approximately Normal with mean µ and standard deviation 
κ−½. 
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Appendix C Articles identified for reviewing the seasonality of 
presentation of leukaemia 
 
C.1 Studies identified from the list in Allan and Douglas (1994) 
Year Study 
  
1960 Steinberg AG 
 The genetics of acute leukemia in children 
 Cancer 13:985-99 
  
1961 Hayes DM 
 The seasonal incidence of acute leukaemia 
 Cancer 14:1301-5 
  
1963 Fraumeni JF 
  Seasonal variation in leukaemia incidence (letter to the editor) 
 Br Med J 2:1408-9 
  
1963 Lee JAH 
 Seasonal variation in leukaemia incidence. (letter to the editor) 
 Br Med J 2:623 
  
1963 Swan A 
 Seasonal variation in leukaemia incidence 
 Br Med J 4:1063-4 
  
1964 Bjelke E 
 Leukemia in children and young adults in Norway 
 Cancer 17:248-55 
  
1964 Knox G 
 Epidemiology of childhood leukaemia in Northumberland and Durham 
 Br J Prev Soc Med 18:17-24  
  
1964 Lee JAH 
 Seasonal variations in the incidence of the clinical onset of leukaemia  
 Path Microbiol 27:772-6 
  
1964 Lanzkowsky P 
 Variation in leukaemia incidence (letter to the editor) 
 Br Med J 1:910 
  
1965 Janicki K, Gurda M 
 Considerations on seasonal variation in leukemias 








1965 Lee JAH, Gardner MJ 
 Season and malignant disease 
 In Hayhoe FGJ (ed) Current Research in Leukaemia 266-73 Cambridge: 
Univ Press 
  
1965 Meighan SP, Knox G 
 Leukemia in children: Epidemiology in Oregon  
 Cancer 18:811-4 
  
1966 Dowsett EG 
 Leukaemia in Kingston, Surrey, 1958-64 
 Br J Cancer 20:16-31 
  
1966 Mainwaring D 
 Epidemiology of acute leukaemia of childhood in the Liverpool area 
 Br J Prev Soc Med 20:189-94 
  
1967 Till MM, Hardisty RM, Pike MC, Doll R 
 Childhood leukaemia in greater London: a search for evidence of clustering
 Br Med J 3:755-8 
  
1968 Gunz FW, Spears GFS 
 Distribution of acute leukaemia in time and space. Studies in New Zealand 
 Br Med J 4:604-8 
  
1969 Fekety Jr FR, Carey JJH 
 Season and the onset of acute childhood leukemia 
 Md Stat Med J 18:73-7 
  
1982 Walker AM, van Noord PA 
 No seasonality in the diagnosis of acute leukemia in the United States 
 J Natl Cancer Inst 69:1283-7 
  
1984 Harris RE, AL-Rashid RA 
 Seasonal variation in the incidence of childhood acute lymphocytic 
leukemia in Nebraska 
 Nebr Med J 69:192-8 
  
1987 Harris RE, Harrell Jr FE, Patil KD, Al-Rashid R 
 The seasonal risk of pediatric/juvenile acute lymphocytic leukemia in the 
United States 
 J Chronic Dis 40:915-23 
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C.2 Studies identified from PubMed data base 
Year Study 
  
1997 Badrinath P, Day NE, Stockton D 
 Seasonality in the diagnosis of acute lymphocytic leukaemia 
 Br J Cancer 75:1711-3 
  
1998 Gilman EA, Sorahan T, Lancashire RJ, Lawrence GM, Cheng KK 
 Seasonality in the presentation of acute lymphooid leukaemia 
 Br J Cancer 77:677-8 
  
1998 Thorne R, Hunt LP, Mott MG 
 Seasonality in the diagnosis of childhood acute lymphoblastic leukaemia 
 Br J Cancer 77:678 
  
1998 Westerbeek RM, Blair V, Eden OB, Kelsey AM, Stevens RF, Will AM, 
Taylor GM, Birch JM 
 Seasonal variations in the onset of childhood leukaemia and lymphoma 
 Br J Cancer 78:119-24 
  
1999 Douglas S, Cortina-Borja M, Cartwright R 
 A quest for seasonality in presentation of leukaemia and non-Hodgkin's 
lymphoma 
 Leuk Lymphoma 32:523-32 
  
1999 Ross JA, Severson RK, Swensen AR, Pollock BH, Gurney JG, Robison LL 
 Seasonal variations in the diagnosis of childhood cancer in the United 
States 
 Br J Cancer 81:549-53 
  
1999 Timonen TT 
 A hypothesis concerning deficiency of sunlight, cold temperature, and 
influenza epidemics associated with the onset of acute lymphoblastic 
leukemia in northern Finland 
 Ann Hematol 78:408-14 
  
2001 Higgins CD, dos-Santos-Silva I, Stiller CA, Swerdlow AJ 
 Season of birth and diagnosis of children with leukaemia: an analysis of 
over 15 000 UK cases occurring from 1953-95 
 Br J Cancer 84:406-12 
  
2001 Sorensen HT, Pedersen L, Olsen J, Rothman K 
 Seasonal variation in month of birth and diagnosis of early childhood acute 
lymphoblastic leukemia 









2002 Eatough JP 
 Evidence of seasonality in the diagnosis of monocytic leukaemia 
 Br J Cancer 87:509-10 
  
2003 Karimi M, Yarmohammadi H 
 Seasonal variations in the onset of childhood leukemia/lymphoma: April 
1996 to March 2000, Shiraz, Iran 
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C.3 Studies identified from the list in Ross et al (1999, Table 2) 
Year Study 
  
1983 van Steensel-Moll HA, Valkenburg HA, Vandenbroucke JP, van Zanen GE 
 Time space distribution of childhood leukaemia in the Netherlands 
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C.4 Studies identified during review 
Year Study 
  
1968 Browning D, Gross S 
 Epidemiological studies of acute childhood leukaemia  
 Am Dis Child 116:576-85 
  
1968 Paul FM 
 Childhood leukaemia in Singapore children 
 Singapore Med J 9:139-50 
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Appendix D Studies not included in the literature review 
 
Year Study  Reasons 
   
1934 Lambin P, Gerard MJ French 
 Variations de fréquence saisonnières de la 
leucémie aiguë 
 
 Sang 8:730-2  
   
1935 Engelbreth-Holm J German  
 An die jahrezeit gebundene schwankungen im 
vorkommen akuter leukose 
 
 Klin Wsher 14:1677-9  
   
1940 Storti E, Brotto M Italian 
 Studio statistico, clinico-anatomopatologico su 
157 casi di leucemia 
 
 Haematologica 21:37-107  
   
1954 Guasch J French 
 Hérédité des leucémies  
 Sang 25:384-421  
   
1954 Scanu A Italian 
 Frequenza stagionale delle emopatie acute e sub-
acute di tipo leucemico 
 
 Rif Med 68:449-52  
   
1955 Fantuzzi B Italian 
 Sull’incidenza stagionale della leucemia acuta nel 
bambino 
 
 Min Pediatr 7:604-6  
   
1958 Gerola M Italian 
 Contributo statistico sull’andamento stagionale 
delle leucemie 
 
 Aggrior Pediat 9:187-9  
   
1962 Nicola P, Balocco A Italian 
 Aspetti clinico-statistici delle leucemie 
dell’infanzia 
 
 Minerva Pediatr 14:1531-46  
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(Continued)  
Year Study  Reasons 
   
1963 Temesio N, de Ibarreta JL, Garófalo O et al Spanish 
 Leucosis y sindromos seudoleucemicos linfoides 
en la infancia 
 
 In Monografia de Clinica Paediatrica y 
Puericultura, Facultad de Medicina de 
Montevideo. 
 
   
1966 Ambs E, Ströder J, Ferneding M (1966) German 
 Biostatistische probleme akuter leukämien im 
kindesalter 
 
 Arch kinderheilkd 173:149-59  
   
1966 Delaux CA Spanish 
 Frecuencia estacional de la leucemia  
 Medicina 26:335-8  
   
1968 Gurda M, Janicki K Polish 
 Studies of the seasonal incidence of leukaemia – 
II 
 
 Pol Tyg Lek 23:255-7  
   
1965 Janicki K, Gurda M Polish  
 Studies of the seasonal incidence of leukaemia – I  
 Pol Tyg Lek 20:304-6  
   
1965 Radujkov Z, Borota R, Lucic A Serbian  
 Seasonal appearance of acute leucosis  
 Med Pregl 18:19-22  
   
1983 Plotnikov YK  Ukrainian 
 Seasonal morbidity of acute leucosis  
 Vrach Delo 7:53-4  
   
1983 Ramenghi U, Miniero R, Pastore G, Saracco P, 
Madon E 
Italian 
 Variazioni stagionali nell’insorgenza delle 
leucemie acute nel bambino 
 
 Min Pediatr 35:1001-4  
   
1989 Efimov ML, Vasil'eva GS, Kovalenko VR, 
Pozdniakova AP, Griskin Gia 
Russian 
 
 Seasonal variations of first clinical manifestations 
of acute leukemia in humans 
 
 Gematol Transfuziol 34:61-4  
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(Continued)  
Year Study  Reasons 
   
1962 Lee JAH 
 Seasonal variation in the clinical onset of 
leukaemia in young people 
Extended data is 
studied in Lee (1963) 
 Br Med J 1: 1737-8  
   
1986 Harris RE, Patil KD, AL-Rashid RA 
 Seasonal childhood acute lymphocytic leukemia 
in the Midwest 
Extended data is used 
in Harris et al (1987) 
 Iowa Med 76:419-22  
   
1964 Allan TM Review article 
 Seasonal onset of acute leukaemia  
 Br Med J 2:630  
   
1985 Linet MS Review article 
 The Leukemias: Epidemiologic Aspects. page 185 
− 222 
 
 New York: Oxford University Press  
   
1965 Stewart AM, Hewitt D Seasonality of birth 
 Aetiology of childhood leukaemia  
 Lancet ii:789-90  
   
2001 Feltbower RG, Pearce MS, Dickinson HO, Parker 
L, McKinney PA 
Seasonality of birth 
 Seasonality of birth for cancer in Northern 
England, UK 
 
 Paediatr Perinat Epidemiol 15:338-45  
   
1964 Gardner MJ, Lee JAH 
 Seasonal variation in leukaemia incidence. 
 Br Med J 1:57 
A letter reporting the 
preliminary results of 
Lee (1964) 
   
1970 Spiers PS, Quade D 
 On the question of an infectious process in the 
origin of childhood leukemia 
 Biometrics 26:723-37 
Discussing two 
epidemiologic models 
based upon the 
dramatic increase in 
exposure rate to many 
infections of childhood 
that occurs when 
children first enter 
school  
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(Continued)  
Year Study  Reasons 
   
1972 Milne RJ, Logan JW, Logan NE Mortality 
 Trends in some cancer mortalities in New 
Zealand 
 
 NZ Med J 75:149-52  
   
1976 Vianna NJ, Polan AK Not on onset 
 Childhood lymphatic leukemia: prenatal 
seasonality and possible association with 
congenital varicella 
 
 Am J Epidemiol 103:321-32  
   
1989 Manet G, Guilbert X, Roux A, Vuillaume A, 
Parodi AL 
Not on onset 
 Natural mode of horizontal transmission of 
bovine leukemia virus (BLV): the potential role 
of tabanids (Tabanus spp.) 
 
 Vet Immunol Immunopathol 22:255-63  
   
1990 Guerci A, Scheid P, Feugier P, Pierrez J, Frenkiel 
N, Guerci O 
Not on onset 
 Time-variations of pretreatment peripheral blood 
S + G2/M-phase size determined by flow 
cytometry in adult acute myeloid leukaemia 
 
 Eur J Haematol 45:5-10  
   
1996 Meltzer AA, Annegers JF, Spitz MR Not on onset 
 Month-of-birth and incidence of acute 
lymphoblastic leukemia in children 
 
 Leuk Lymphoma 23:85-92  
   
1991 Rhame FS Not on seasonality 
 Prevention of nosocomial aspergillosis  
 J Hosp Infect 18 Suppl A:466-72  
   
1998 Douglas S, Cortina-Borja M, Cartwright R Hodgkin 
 Seasonal variation in the incidence of Hodgkin's 
disease 
 
 Br J Haematol 103:653-62  
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(Continued)  
Year Study  Reasons 
   
2002 Cornet M, Fleury L, Maslo C, Bernard JF, 
Brucker G; Invasive Aspergillosis Surveillance 
Network of the Assistance Publique-Hopitaux de 
Paris 
Not on leukaemia 
 Epidemiology of invasive aspergillosis in France: 
a six-year multicentric survey in the Greater Paris 
area 
 
 J Hosp Infect 51:288-96  
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Appendix E Published studies identified on the seasonality of leukaemia (non ALL) 
 
 
Study   
 













        
Steiberg 
(1960) 
USA Not given Onset  Children’s Cancer Research 
Foundation 
AL 0 – 15  449 






1943 – 58 Onset, Diagnosis   Hospital  AL 
AML 
AMNL 
0 – 78 184 
64 
14 
        
Lee 
(1963) 





0 – 44 4219 
743 
279 
        
Fraumeni 
(1963) 
USA 1958 – 61 Onset  National Co-operative 










        
Swan 
(1963) 
London, England  Not given Onset, Diagnosis Personally observed AL Adults  56 
        
Bjelke 
(1964) 
Norway 1953 – 58 Diagnosis 
Symptom 
Cancer Registry AL 0 – 19 235 
220 
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(Continued)        
 
Study   
 



















1951 – 60 Symptom  Hospitals, cancer registries, 




0 – 14 185 
139 
46 
        
Lee Victoria, Australia 1946 – 59 Onset Anti-Cancer Council L All 987 
(1964) New Zealand 1958 – 61 Onset  General Register  L All 543 





Not given Onset  Paediatric Teaching Unit, 
University of Capetown  
AL 
AML 
0.1 – 13 40 
8 

















        
Lee 
(1965) 
England 1945 – 63 Admission London, Royal Marsden 
Hospitals 
AL All 207 
 England 1958 – 63 Admission  St Bartholomew’s Hospital  AL All 118 
 England and Wales 1946 – 60 Onset   National Cancer Registration 
Scheme  
CLL 45 + 1288 
        
Meighan 
(1965) 
Oregon, USA 1950 – 61 Onset Death certificate and 
University of Oregon Medical 
School Hospital 
L 0 – 14 243 
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(Continued)        
 
Study   
 


















1958 – 64 Onset Retrospective survey AL 0 – 95 117 
        
Mainwaring 
(1966) 
Liverpool, England 1955 – 64 Diagnosis, Symptom Medical charts at Children’s 




0 – 14 74 
18 
3 













        
Browning 
(1968) 
Cuyahoga Aug 1955 – Jul 65 Diagnosis Hospital records AL 0 – 14 168 
        
Gunz 
(1968) 
New Zealand 1953 – 64 Onset Cancer Death Lists  L 
AL 
0 – 14 
15 +  
287 
714 
        
Paul 
(1968) 
Singapore 1963 – 67 Admission  Paediatric Unit, General 
Hospital 
L 0 – 14 100 
        





1950 – 62 Diagnosis, Symptom, Onset Admitted to Johns Hopkins 
Hospital 
L 0 – 19 96 
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(Continued)        
 
Study   
 













        
Walker 
(1982) 






        
Gilman 
(1998) 
Great Britain 1953 – 81 Date when the survey child 
was last perfectly well 




0 – 15 9207 
5312 
















        
Douglas 
(1999) 
England and Wales 1984 – 93 Diagnosis Data Collection Study AML  
CML 
0 – 79 3266 
1100 
        
Ross 
(1999) 
USA 1989 – 91 Diagnosis Children’s Cancer Group, 
Pediatric Oncology Group 
AML 0 – 19 1153 
        
Timonen 
(1999) 
Northern Finland 1972 – 86 Diagnosis  University Hospital, Oulu and 
central hospitals  
AL 
AML 
16 + 300 
236 
        
Higgins 
(2001) 
England, Wales and 
Scotland 




0 – 14 15835 
11591 
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(Continued)        
 
Study   
 













        
Eatough 
(2002) 
England and Wales 1974 – 98  Diagnosis  Office of National Statistics MNL All 2311 
        
Karimi 
(2003) 
Shiraz, Iran Apr 96 – Mar 00 Symptom Hospitals of Shiraz University 
of Medical Sciences 
AML 0 – 15 63 
        
a SEER = Surveillance, Epidemiology, and End Results 
TNCS = Third National Cancer Survey 
CCPDS = Centralized Cancer Patient Data System 
b AL = acute leukaemia, AML = acute myeloblastic leukaemia, acute myeloid leukaemia and acute myelocytic leukaemia, AMNL = acute 
monocytic leukaemia, ANLL = acute non-lymphocytic leukaemia, LL = lymphoblastic leukaemia, lymphocytic leukaemia and lymphatic 
leukaemia, MNL = monocytic leukaemia, ML = myeloblastic leukaemia, CL = Chronic leukaemia, CALL = common acute lymphoblastic 
leukaemia, CGL = chronic granulocytic leukaemia, CML = chronic myeloid leukaemia 
CLL = chronic lymphatic leukaemia 
c Cases with month of onset and cell type are stated.
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Appendix F Annual number of ALL cases registered in Singapore, 
Central Sweden and 11 distinct registries in the USA 
 
Year Singapore Central Sweden USA* Cumulative 
number of 
registries 
     
1968 20 – –  
1969 24 – –  
1970 27 – –  
1971 28 – –  
1972 24 – –  
1973 15 – 181 (7) 
1974 27 – 242 (8) 
1975 21 – 196 (9) 
1976 29 – 229  
1977 20 1 232  
1978 18 4 227  
1979 19 3 223  
1980 30 5 240  
1981 27 4 273  
1982 22 2 268  
1983 40 2 286  
1984 28 5 296  
1985 30 3 294  
1986 22 7 296  
1987 32 3 304  
1988 35 8 327  
1989 25 2 373  
1990 41 12 330  
1991 33 3 337  
1992 48 2 530 (11) 
1993 45 3 517  
1994 32 10 505  
1995 32 – 587  
1996 39 – 579  
1997 37 – 559  
1998 34 – 626  
1999 35 – 524  
     
Total 939 79 9581  
     
* Note – the apparent increase in the number is due to information being available 
from more registries in later years. 
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Appendix G Annual number of ALL cases collected by each registry in the USA 
 












Utah Iowa Connecticut Metropolitan 
Detroit 
Seattle 
            
1973 12 – – 13 – 39 13 38 41 25 – 
1974 11 – – 15 – 57 17 48 44 20 30 
1975 7 18 – 12 – 27 18 47 32 15 20 
1976 16 16 – 16 – 31 15 35 41 31 28 
1977 16 12 – 17 – 36 21 43 28 36 23 
1978 8 17 – 13 – 25 22 37 39 41 25 
1979 15 11 – 12 – 28 23 41 33 35 25 
            
1980 15 17 – 19 – 31 20 35 28 38 37 
1981 12 17 – 19 – 37 30 38 35 50 35 
1982 16 10 – 25 – 38 21 46 35 47 30 
1983 8 12 – 24 – 37 24 41 51 47 42 
1984 19 28 – 16 – 53 21 35 44 48 32 
1985 21 19 – 16 – 36 39 42 36 36 49 
1986 15 23 – 30 – 49 26 32 32 45 44 
1987 13 24 – 27 – 48 32 35 49 42 34 
1988 16 24 – 21 – 72 25 28 41 59 41 
1989 17 34 – 28 – 61 38 50 50 48 47 
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(Continued)           












Utah Iowa Connecticut Metropolitan 
Detroit 
Seattle 
            
1990 9 22 – 26 – 58 25 41 42 51 56 
1991 14 25 – 37 – 53 28 37 33 63 47 
1992 19 26 164 27 34 47 36 34 39 55 49 
1993 10 25 158 16 44 54 24 50 33 62 41 
1994 18 20 170 26 35 51 27 32 32 45 49 
1995 14 34 173 31 37 55 30 56 42 48 67 
1996 19 33 186 21 41 50 30 38 44 57 60 
1997 15 29 165 31 47 61 24 38 43 45 61 
1998 23 36 200 19 47 57 34 51 56 54 49 
1999 18 38 151 30 36 52 31 35 50 41 42 
            
            
Total 396 570 1367 587 321 1243 694 1083 1073 1184 1063 
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Appendix H Using S-PLUS to implement seasonality analysis 
 
The methods we described in Chapters 2 to 4 could be programmed in most computer 
languages. However, the bootstrap and angular regression are not tools that are used 
in isolation but rather are applied to other statistical techniques. They need to call 
other procedures with different sets of inputs (data) and then collect them together and 
analyze the results. For example, the Reg.fit function is called internally and 
automatically by Reg to do the actual model fitting in the angular regression. This 
function Reg.fit is the work-horse for Reg, and is named as the default method in the 
definition of Reg. It receives x and y data rather than a formula. For this reason, they 
are most effectively used in an integrated environment for data analysis. S-PLUS 
(2001, version 6) is one of the examples of integrated environments and that have 
built-in facilities for vectors, matrices and lists to deal with complicated data 
structures (Efron and Tibshirani, 1993).  
This section documents S-PLUS code for the functions used to perform 
seasonal variation analysis. The structure of the functions is arranged according the 
Figure H1. All functions are given in Programs 1 to 6. In the S-PLUS programming 
language, the arguments to a function in (.) specify the data to be operated on, and 
also pass processing parameters to the functions. Each function may have a number of 
arguments. The formal name ‘…’ (three dots) is used to pass arbitrary arguments to a 
function; I discuss this in Program 5. A line beginning with ‘#’ indicates a comment. 
The code for each function is preceded by a list describing what it does, the input 
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Summer to Winter ratio
Ratio
Lorenz curve and Gini index
Gini
Grouped and non-parametric methods
Program 2
Data summary






Date, K, I0, Dvm, Dcard, Newton
Angular methods
Programs 3 − 6
Conversion of date to angle
Program 1 (Theta, Fs)
 
 
Sample data set 
When using these functions one should first construct a vector (f) of monthly counts 
ordered from January to December or a vector of observed individual dates of disease 
onset (dat). For example, one can construct a vector with the name edwards.dat for 
the data of Table 2.1 with the built-in function c and type in data from the keyboard.  
 
> edwards.dat <- c(10, 19, 18, 15, 11, 13, 7, 10, 13, 23, 15, 22) 
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However, a data frame should be constructed when covariates of each individual 
subject are available. One can construct data frames in several ways in S-PLUS. One 
easy method of getting data into S-PLUS for plotting and analysis is to import the 
data file. For acute primary angle-closure glaucoma (APACG) data (Appendix I1), 
one can type in Microsoft Excel from the keyboard, then import to S-PLUS. 
Assuming a data frame aacg containing information on patients with APACG in 
Singapore is already built in. This data set has four columns representing four 
variables: Date of attack, patients’ age, sex and side of eye attacked. The following 
displays the first three subject records. 
 
> aacg[1:3, ] 
 
   ATT.DATE AGE    SEX W.EYE   
1 1/1/1995   50 Female  Left  
2 2/1/1995   56 Female Right  
3 2/1/1995   59   Male  Left       
… 
 
To run the examples in this section, one will need to create functions with an 
editor. There are many different approaches to editing functions in S-PLUS, but the 
simplest way to get started is with the Edit function. The built-in function Edit 
creates a function template with the proper structure when called with a name that 
does not correspond to an existing S-PLUS object. Thus, to create a new function 
called Edwards, call Edit as follows: 
 
> Edit (EDWARDS) 
 
Edit the template as desired in the Script window that appears. To source in the 
function, select Script f Run from menu, press the F10 key, or use the Run button on 
the Script toolbar. All the function written in S-PLUS can be modified for other 
situations by minor coding changes. 
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Conversion of date to angle 
In general, the seasonal data is presented as either grouped (monthly) or individual 
date of onset. Regardless of the data type the adjustments for unequal month length 
(and often leap-years) is always required (see §2.8) and should be implemented first 
except for some non-parametric methods (see §2.6). These can be done by two 
functions Theta for individual date of onset and Fs for grouped data in Programs 1. 
Theta transforms an individual date (dat) within a year to an angle on a complete 
circle. Fs adjusts observed monthly counts (f) of unequal month and leap years to the 
average number of days per ‘standard’ month taken over the duration of the study. It 
can be applied to seasonal or half yearly counts. Two more input required are the total 
number of years (n.yr) covered during the study period and the total number of leap 
years (n.lp) (contain February 29) and covered during the study period. For example, 
Table 2.1 are monthly births of anencephalics to primiparous women in Birmingham 
(1940 – 1947) collected over n.yr = 8 complete years which contains n.lp = 2 leap 
years. To adjust the data of Table 2.1 one call Fs created with f = edwards.dat and 
n.yr = 8 and n.lp = 2: 
 
> FS(edwards.dat, 2, 8) 
 
[1] 9.7932 20.4184 17.6278 15.1795 10.7725 13.1556 6.8553 9.7932  
 
[9] 13.1556 22.5244 15.1795 21.5451 
 
Note the output is the same as the final frequency in Method II of Table 2.6.  
 
Grouped and non-parametric methods 
Data arising from studies investigating the pattern of disease onset within a calendar 
year have been traditionally summarised into monthly counts summated over the 
complete years studied. The seasonal patterns are often examined by use of Pearson 
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chi-squared tests with 11 degrees of freedom and Edwards test. These tests (and 
others) have been described in Chapter 2. In general, Pearson chi-squared test is for 
the heterogeneity and only tests for departures from a uniform distribution of cases 
throughout the year and not specifically for the presence of a single peak or any other 
pattern. While Edwards test may be more appropriate for grouped data, it gives a poor 
approximation to the χ2 distributions under the null hypothesis when sample sizes are 
small.   
 Program 2 lists eight functions to implement seasonality analysis for grouped 
(monthly) data. These functions do not correct the frequencies themselves (this is 
done through Fs as required). Except Gini, which produces Gini index and Lorenz 
curve (Figure 2.5), these functions explicitly calculate the associated statistics and the 
associated p-values. In addition, Pearson also performs Tp on quarterly or biannual 
totals of presentation of disease. Edwards can further estimate the peak angle, 0θ  in 
degrees and also the amplitude, a. Ratio performs the summer to winter ratio on 
biannual counts ordered by summer: May – October and winter: November – April. 
The exact 95% CI for the ratio based on the binomial distribution or by a normal 
approximation are also given.  
 For example, the following command tests whether there is a peak in monthly 





N-total amplitude    peak Edwards  p-value  
    176    0.2815 0.53189  6.9734 0.030601 
 
In addition, for the adjusted frequencies the Edwards function returns a similar result:  
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> EDWARDS(FS(edwards.dat, 2, 8)) 
 
 N-total amplitude   peak Edwards p-value  





If individual data of onset is available, angular methods are recommended. However, 
these methods (descriptive) can also be applied to grouped data. There are four 
components of the programs; data summary, graphical presentation, regression and 
others. Because some functions are used by other functions it is better to construct all 
functions listed in the Programs 3 to 6 first.  
 All the calculations described in Chapter 3 can be obtained by running Peak 
(individual date) or Peakgp (monthly data) on the uncorrected data as the Theta or Fs 
will be called internally to do the corresponding adjustments. Boots provides 
bootstrap CI for the peak. However, Matrix and Date should be built in first. For 
example, the following command tests whether there is a peak in monthly births of 
anencephalics to primiparous women in Birmingham (1940 – 1947) using Peakgp. 
 
> PEAKGP(Edwards.dat, 2, 8) 
 
 Seasonality analysis 
 
data:  Edwards.dat  
 
Mardia = 7.0534, df = 2, p-value = 0.0294  
 
sample estimates: 
   N       S      C       R Kappa  Delta  sigma2 peak.degree peak.day  
 176 0.21121 24.629 0.14156 0.286 27.076 0.15384     0.49134  0.49816 
 
 LCI.degree UCI.degree LCI.day UCI.day  
     310.25     50.735  314.56  51.439 
 
To convert peak in degree (0.49134) or peak in day (0.49816) calculated, call Date as 
follows. 




[1] 01 Jan  
 
Because the individual dates of onset of APACG is available, Attach data aacg first 






 Seasonality analysis 
 
data:  ATT.DATE  
 
Mardia = 14.862, df = 2, p-value = 0.0006  
 
sample estimates: 
   N      S       C       R   Kappa  delta peak.degree peak.day  
 132 16.682 -26.507 0.23727 0.48852 9.5244      147.82   149.87 
 
 LCI.degree UCI.degree LCI.day UCI.day  
     116.05     179.58  117.66  182.08 
 
Angular data can be displayed in angular plot, histogram and rose diagram 
(§3.2). These plots can be generated by functions listed in Program 4. For example, 




The legends ‘January’ and ‘July’ are superimposed on the circular plot. 
 To model the onset of APACG ATT.DATE as a function of sex, use built in 
function options to change the default choice of contrasts for all factors, as in the 
following example:  
 
> options(contrasts = c(factor = "contr.treatment",  
+  ordered = "contr.poly")) 
 
then call Reg as follows (female as reference group): 
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> REG(THETA(ATT.DATE) ~ as.factor(ifelse(SEX == "Female", 1, 0)),  
+  data = Aacg.work, 
+  init = 0, 
+  trace = T) 
 
     coef1    peak        R        K          H  
1 0.176081 147.815 0.237268 0.488520 7.53906800  
2 0.223701 145.892 0.240918 0.496495 7.77638060  
3 0.236256 145.387 0.241179 0.497067 7.79349970  
4 0.239521 145.254 0.241197 0.497106 7.79467380  
5 0.240367 145.219 0.241198 0.497108 7.79475280  
6 0.240585 145.21 0.241198 0.497109 7.79475810  
7 0.240642 145.208 0.241198 0.497109 7.79475850  
8 0.240657 145.207 0.241198 0.497109 7.79475850  
9 0.24066 145.207 0.241198 0.497109 7.79475850  
10 0.240661 145.207 0.241198 0.497109 7.79475850  
11 0.240662 145.207 0.241198 0.497109 7.79475850  
12 0.240662 145.207 0.241198 0.497109 7.79475850  
13 0.240662 145.207 0.241198 0.497109 7.79475850  
14 0.240662 145.207 0.241198 0.497109 7.79475850  
15 0.240662 145.207 0.241198 0.497109 7.79475850  
16 0.240662 145.207 0.241198 0.497109 7.79475850  
17 0.240662 145.207 0.241198 0.497109 7.79475850  
18 0.240662 145.207 0.241198 0.497109 7.79475850  
19 0.240662 145.207 0.241198 0.497109 7.79475850  
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A vector of observed individual dates of disease onset (for any pre-
specified date format). 
  




THETA <- function(dat) 
{ 
 d <- yeardays(dat)  
 
 theta <- ifelse(leap.year(as.numeric(format(years(dat))))==F, 
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Function Fs 
  
Description Adjusts observed monthly counts (f) of unequal month length and leap 
years to the average number of days per ‘standard’ month taken over the 











• A vector of observed monthly counts ordered from January to 
December.  
• A vector of quarterly counts in a sequence of December – February, 
March – May, June – August, and September – November. 
• A vector of half yearly counts ordered by summer: May – October 
and winter: November – April. 
n.lp 
 
The total number of leap years contains February and covered during the 
study period (study period is not necessarily starting from January).   
n.yr The total number of years covered during the study period. 
  




FS <- function(f, n.lp, n.yr) 
{ 
 n.nlp <- n.yr - n.lp 
  
 # Duration of interval # 
 d <- (366*n.lp + 365*n.nlp)/n.yr/length(f) 
  
a12 <- d*c(1/31, n.yr/(n.lp*29 + n.nlp*28), 1/31, 1/30, 1/31, 
1/30, 1/31, 1/31, 1/30, 1/31, 1/30, 1/31) 
  
 a4 <- d*c(n.yr/(n.yr*62 + n.lp*29 + n.nlp*28), 1/92, 1/92,  
1/91) 
 
a2 <- d*c(1/184, n.yr/(n.nlp*181 + n.lp*182)) 
  
 # Adjustment factor # 
 if (length(f) == 12) {adjust <- a12}  
  else if (length(f) == 4) {adjust <- a4} 
   else if (length(f) == 2) {adjust <- a2}  
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PROGRAM.2 Grouped and non parametric methods 
 
This section describes the codes to implement the grouped and non-parametric tests 
contained in Chapter 2. All the function built in this section does not correct the 




Description Performs Tp on monthly, quarterly or biannual totals of presentation of 




f (see Fs) 
  
Value Vector with the following components: 
  
N–total Sample size. 
X–square The value of the test statistic, Tp. 




PEARSON <- function(f) 
{ 
 if (length(f) == 12) {E <- sum(f)/12} 
  else if (length(f) == 4) {E <- sum(f)/4} 
   else if (length(f) == 2) {E <- sum(f)/2}  
 
 stat <- sum((f - E) ^ 2 / E) 
 
 # Organize results # 
 estimate <- c(sum(f), stat, 1 - pchisq(stat, length(f) - 1)) 
  







   235
Function Edwards 
  
Description Performs TE on monthly counts (f) of the presentation of disease. Note 




f (see Fs) 
  
Value Vector with the following components: 
  
N–total Sample size. 
amplitude  The amplitude, a, of the peak 0θ . 
peak 0θ  in degree. 
Edwards The value of the test statistic, TE. 




EDWARDS <- function(f) 
{ 
 N <- sum(f) 
  
 theta <- seq(15, 345, 30) 
  
 W <- sum(sqrt(f)) 
  
 PI <- pi/180 
  
 S <- sum(sqrt(f)*sin(theta*PI)) 
  
 C <- sum(sqrt(f)*cos(theta*PI)) 
  
 d <- sqrt(S^2 + C^2)/W 
  
 E <- 8*N*d^2 
 
 if (S > 0 & C > 0) {chi0 <- atan(S/C)/PI}  
  else if (C < 0) {chi0 <- atan(S/C)/PI + 180} 
   else {chi0 <- atan(S/C)/PI + 360} 
 chi0 
 
 # Organize results # 
 estimate <- c(N, 4*d, chi0, E, 1-pchisq(E, 2)) 
  
 names(estimate) <- c("N-total", "amplitude", "peak", "Edwards", 
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Function Roger 
  
Description Performs TR on monthly counts (f) of the presentation of disease. Note 




f (see Fs) 
  
Value Vector with the following components: 
  
N–total Sample size. 
Roger The value of the test statistic, TR. 




ROGER <- function(f) 
{ 
 N <- sum(f) 
  
 theta <- seq(15, 345, 30) 
 
 PI <- pi/180 
  
 S <- sum(f*sin(theta*PI)) 
  
 C <- sum(f*cos(theta*PI)) 
  
 R <- 2*(S^2 + C^2)/N 
 
 # Organize results # 
 estimate <- c(N, R, 1 - pchisq(R, 2)) 
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Function Dn 
  




f (see Fs) 
j Number of division, default is j = 6. 
  
Value Vector with the following components: 
  
N–total Sample size. 




DN <- function(f, j = 6) 
{ 
 N <- sum(f) 
  
 f <- rep(f, 12) 
 S <- rep(0, 12) 
 for (i in 1:12){  




 D <- rep(0, 12) 
 for (i in 1:12){  




 stat <- max(D, na.rm = T) / sqrt(N) 
 
 # Organize results # 
 estimate <- c(N, stat) 
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Function Hewitt 
  




f (see Fs) 
  
Value Vector with the following components: 
  
N–total Sample size. 
Hewitt The value of the test statistic, TH. 
  
Note This function is only used in the situation when there is no prior 
hypothesis which specifies a 6-month period of higher expected 




HEWITT <- function(f) 
{ 
 r <- rank(f) 
  
 S <- rep(0, 12) 
 for (i in 1:12){  




 stat <- max(S) 
 
 # Organize results # 
 estimate <- c(sum(f), stat) 
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Function Kuiper 
  




f (see Fs) 
n.lp (see Fs) 
n.yr (see Fs) 
  
Value List with the following components: 
  
N–total Sample size. 
FN Sample cumulative probability distribution function FN. 
F 
 
Cumulative probability distribution function F under a uniform 
distribution.  
FN-F The difference between FN − F. 
Kuiper The value of the test statistic, KT N . 
  




KUIPER <- function(f, n.lp, n.yr) 
{ 
 n.nlp <- n.yr - n.lp 
  
 # cumulative days at end of each month # 
 day <- n.lp*c(31, 29, 31, 30, 31, 30, 31, 31, 30, 31, 30, 31) + 
    n.nlp*c(31, 28, 31, 30, 31, 30, 31, 31, 30, 31, 30, 31) 
  
 F.day <- cumsum(day/(n.lp*366 + n.nlp*365)) 
  
 F.N <- cumsum(f/sum(f)) 
  
 D.N <- F.N - F.day 
  
 V.N <- max(D.N) + abs(min(D.N)) 
  
 stat <- V.N * sqrt(sum(f)) 
  
 ret <- list("N-total" = sum(f),  
     "FN" = F.N, 
     "F" = F.day, 
     "FN-F" = D.N,  
#     "TK" = V.N, 
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Function Ratio 
  




f (see Fs) 
  
Value List with the following components: 
 
N–total Sample size. 
ratio 1st count in f to 2nd count ratio. 
X-square The value of the test statistic, Tp.  
p–value The p-value for the test under the null hypothesis.   
LCI-normal Lower limit of 95% CI for ratio by normal approximation. 
UCI-normal Upper limit of 95% CI for ratio by normal approximation. 
LCI-binomial Lower limit of 95% CI for ratio by binomial approximation. 




RATIO <- function(f) 
{ 
 N <- sum(f) 
  
 S1 <- f[1] 
 S2 <- f[2] 
  
 p <- S1/N 
 q <- S2/N 
  
 # 95% CI for p by normal approximation # 
 L.normal <- p - 1.96*sqrt(p*q/N) 
 U.normal <- p + 1.96*sqrt(p*q/N) 
 
 # exact 95%CI based on binomial distribution # 
 # qf(0.75, 1, 1) = F0.25, 1, 1 # 
 L.exact <- S1/(S1 + (S2 + 1)*qf(1 - 0.025, 2*S2 + 2, 2*S1)) 
 U.exact <- (S1 + 1)/(S1 + 1 + S2/qf(1 - 0.025, 2*S1 + 2, 2*N - 
2*S1)) 
 
 estimate <- c(N, S1/S2, PEARSON(f)[2], PEARSON(f)[3],  
     L.normal/(1 - L.normal), U.normal/(1 - U.normal),  
     L.exact/(1 - L.exact), U.exact/(1 - U.exact)) 
  
 names(estimate) <- c("N-total", "ratio", "X-square", "p-value",  
       "LCI-normal", "UCI-normal", "LCI-binomial",  
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Function Gini 
  




f (see Fs) 
n.lp (see Fs) 
n.yr (see Fs) 
  
Value Vector with the following component: 
  
G The value of the Gini index, G. 
  
Note No correction of the monthly counts is required.  
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Code 
_____________________________________________________________________ 
GINI <- function(f, n.lp, n.yr) 
{ 
 # number of days in Feb #  
 day2 <- 29*n.lp + 28*(n.yr - n.lp) 
  
 # number of days in each month # 
 daym <- c(n.yr*31, day2, n.yr*31, n.yr*30, n.yr*31, n.yr*30, 
n.yr*31, n.yr*31, n.yr*30, n.yr*31, n.yr*30, n.yr*31) 
  
 gini <- cbind("Day" = daym, "Incidence" = f/daym) 
 row.names(gini) <- month.abb  
  
 gini <- sort.col(gini,  
      columns.to.sort = "@ALL",  
      columns.to.sort.by = "Incidence") 
  
 # cumulative percentage of days # 
 x <- cumsum(gini$Day)/sum(daym) 
  
 # cumulative percentage of cases # 
 y <- cumsum(gini$Incidence)/sum(gini$Incidence) 
 
 # Lorenz Curve # 
 par(pty = "s") 
 plot(c(0, x), c(0, y), 
   xlab = "Cumulative percentage of days", 
   ylab = "Cumulative percentage of cases", 
   type = "o", 
   lty = 1, 
   lwd = 3) 
 lines(c(0, 1), c(0, 1), lty = 2, lwd = 3) 
   
 y1 <- c(0, y[-12]) 
  
 G <- 2*(0.5 - sum((y1 + y)*gini$Day/sum(daym)/2)) 
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dat (see Theta). 
  
Value A list containing the following components: 
  
Mardia The value of the test statistic, 2Mardiaχ  
df 
 
The degrees of freedom of the asymptotic χ2 distribution associated with 
Mardia statistic (= 2). 






N, S, C, R,  
Kappa (= κ),  
delta (= δ),  
peak.degree (= 0θ ),  
peak.day (= peak in days),  
LCI.degree (= lower limit of 95% CI in degree),  
UCI.degree (= upper limit of 95% CI in degree),  
LCI.day (= lower limit of 95% CI in day),  
UCI.day (= upper limit of 95% CI in day) 
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Code 
_____________________________________________________________________ 
PEAK <- function(dat) 
{ 
 # Number of individual cases # 
 N <- length(dat) 
 
 theta <- THETA(dat) 
  
 # mean direction (chi0) # 
 PI <- pi/180 
  
 S <- sum(sin(PI*theta))  
 
 C <- sum(cos(PI*theta)) 
  
 if (S > 0 & C > 0) {chi0 <- atan(S/C)/PI}  
  else if (C < 0) {chi0 <- atan(S/C)/PI + 180} 
   else {chi0 <- atan(S/C)/PI + 360} 
 chi0 
 
 # magnitude of the peak (R) # 
 R <- sqrt(S^2 + C^2)/N 
 
 # confidence interval #   
 rho2 <- sum(cos(2*PI*(theta - chi0)))/N   
 delta <- (1 - rho2)/(2*R^2)  
 se <- sqrt((1 - rho2)/(2*N*R^2)) 
  
 # Lower limit of 95% confidence interval. 
 LCI <- (chi0 - asin(1.96*se)/PI)%%360 
 
 # Upper limit of 95% confidence interval. 
 UCI <- (chi0 + asin(1.96*se)/PI)%%360 
  
 # Organize results 
 ret <- list( 
  data.name = deparse(substitute(dat)), 
  method = "Seasonality analysis",  
  statistics = 2*N*R^2, 
  parameters = 2, 
  estimate = c(N, S, C, R, K(R), delta, chi0, chi0*365/360, 
      LCI, UCI, LCI*365/360, UCI*365/360)) 
 ret$p.value <- 1 - pchisq(ret$statistics, ret$parameters) 
 names(ret$statistics) <- "Mardia" 
 names(ret$parameters) <- "df" 
 names(ret$estimate) <- c("N", "S", "C", "R", "Kappa", "delta", 
  "peak.degree", "peak.day", "LCI.degree", "UCI.degree", 
  "LCI.day", "UCI.day") 
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Function Peakgp 
  





f (see Fs). 
n.lp (see Fs). 
n.yr (see Fs). 
  
Value (see Peak).   
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Code 
_____________________________________________________________________ 
PEAKGP <- function(f, n.lp, n.yr) 
{ 
 # total number of cases # 
 N <- sum(f)  
  
 # Final frequence # 
 f <- FS(f, n.lp, n.yr) 
 
 # theta is the same as that grouped annually # 
 # we need to adjust only theta or frequency # 
 if (length(f) == 12) {theta <- seq(15, 345, 30)}  
  else if (length(f) == 4) {theta <- c(15, 105, 195, 285)} 
   else if (length(f) == 2) {theta <- c(30, 210)} 
  
 # mean direction (chi0) # 
 PI <- pi/180 
 C <- sum(f*cos(PI*theta)) 
 S <- sum(f*sin(PI*theta))  
  
 if (S > 0 & C > 0) {chi0 <- atan(S/C)/PI}  
  else if (C < 0) {chi0 <- atan(S/C)/PI + 180}  
   else {chi0 <- atan(S/C)/PI + 360} 
 chi0 
    
 # magnitude of the peak (R) # 
 if (length(f) == 12) {h <- 30}  
  else if (length(f) == 4) {h <- 90} 
   else if (length(f) == 2) {h <- 180} 
  
 R <- PI*h/(2*sin(PI*h/2))*sqrt(S^2 + C^2)/N 
  
 # confidence interval #   
 rho2 <- sum(f*cos(2*PI*(theta - chi0)))/N   
 
 delta <- (1 - rho2)/(2*R^2)  
  
 se <- sqrt(delta/N) 
 
 # Lower limit and upper limit of 95% confidence interval # 
 LCI <- (chi0 - asin(1.96*se)/PI)%%360 
 UCI <- (chi0 + asin(1.96*se)/PI)%%360 
  
 # Organize results # 
 ret <- list( 
  data.name = deparse(substitute(f)), 
  method = "Seasonality analysis",  
  statistics = 2*N*R^2, 
  parameters = 2, 
  estimate = c(N, S, C, R, K(R), delta, chi0, chi0*365/360,   
    LCI, UCI, LCI*365/360, UCI*365/360)) 
 ret$p.value <- 1 - pchisq(ret$statistics, ret$parameters) 
 names(ret$statistics) <- "Mardia" 
 names(ret$parameters) <- "df" 
 names(ret$estimate) <- c("N", "S", "C", "R", "Kappa", "delta",  
  "peak.degree", "peak.day", "LCI.degree", "UCI.degree",  
  "LCI.day", "UCI.day") 
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Function Matrix 
  
Description Calculates vector Z, matrix V and W used in the calculation of bootstrap 






A vector of angles on a complete circle (360°) corresponding to the 
observed individual dates of onset. 
  
Value Vector with the following components: 
  
Z1 1st element of Z. 
Z2 2nd element of Z. 
V11 1st diagonal element of V(2 × 2). 
V12 Off diagonal elements of V. 
V22 2nd diagonal element of V. 
W11 1st diagonal element of W (2 × 2). 
W12 Off diagonal element of W. 
W22 2nd diagonal element of W. 
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Code 
_____________________________________________________________________ 
MATRIX <- function(theta) 
{ 
 PI <- pi/180 
 # Vector x and y # 
 x <- cos(PI*theta) 
 y <- sin(PI*theta) 
  
 # Mean vector(z) 
 N <- length(theta) 
 z1 <- sum(x)/N 
 z2 <- sum(y)/N 
   
 # Covariance matrix (u) 
 u11 <- sum((x - z1)^2)/N 
 u22 <- sum((y - z2)^2)/N 
 u12 <- sum((x - z1)*(y - z2))/N 
  
 # Square root (v) 
 beta <- (u11 - u22) / (2*u12) - sqrt((u11 - u22)^2/(4*u12^2) + 1)  
 t1 <- sqrt((beta^2*u11 + 2*beta*u12 + u22)/(1 + beta^2)) 
 t2 <- sqrt((u11 - 2*beta*u12 + beta^2*u22)/(1 + beta^2)) 
 v11 <- (beta^2*t1 + t2)/(1 + beta^2) 
 v22 <- (t1 + beta^2*t2)/(1 + beta^2) 
 v12 <- beta*(t1 - t2)/(1 + beta^2) 
 
 # Inverse (w) 
 int1 <- 1/t1 
 int2 <- 1/t2 
 w11 <- (beta^2*int1 + int2)/(1 + beta^2) 
 w22 <- (int1 + beta^2*int2)/(1 + beta^2) 
 w12 <- beta*(int1 - int2)/(1 + beta^2) 
 
 c(Z1 = z1, Z2 = z2, V11 = v11, V12 = v12, V22 = v22, W11 = w11, 
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Function Boots 
  




theta (see Matrix).  
 
Optional input  
 
B Number of bootstrap samples, the default is B = 2000. 
alpha The significance level α, the default is α = 0.05. 
  
Value The iteration details and a list with the following components: 
  
peak.degree Estimated peak of original sample in degree.  
CI.degree (1 − α)% CI in degree. 
CI.date (1 − α)% CI in date. 
  
Note  Matrix, Date must be built in first. 
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Code 
_____________________________________________________________________ 
BOOTS <- function(theta, B = 2000, alpha = 0.05) 
{ 
 PI <- pi/180 
  
 # Estimate of z, v, w from the original sample # 
 z10 <- MATRIX(theta)[1] 
 z20 <- MATRIX(theta)[2] 
 v110 <- MATRIX(theta)[3] 
 v120 <- MATRIX(theta)[4] 
 v220 <- MATRIX(theta)[5] 
 
 # Replicates of MATRIX after bootstrap # 
 repli <- bootstrap(theta, MATRIX, B, sampler = 
samp.boot.bal)$replicates 
 
 Z1 <- repli[ , 1] 
 Z2 <- repli[ , 2] 
 W11 <- repli[ , 6] 
 W12 <- repli[ , 7] 
 W22 <- repli[ , 8] 
  
 # Bootstrap estimates of mean direction # 
 Cb <- z10 + (v110*W11 + v120*W12)*(Z1 - z10) + (v110*W12 + 
v120*W22)*(Z2 - z20) 
 Sb <- z20 + (v120*W11 + v220*W12)*(Z1 - z10) + (v120*W12 + 
v220*W22)*(Z2 - z20) 
 C <- Cb / sqrt(Cb^2 + Sb^2) 
 S <- Sb / sqrt(Cb^2 + Sb^2) 
  
 mub <- function(S, C) 
 {  
  PI <- pi/180 
  ifelse (S > 0 & C > 0, atan(S/C)/PI,  
   ifelse (C < 0, atan(S/C)/PI + 180, atan(S/C)/PI + 
360))  
 } 
 mub(S, C) 
  
 # Estimate of mean direction (degree) from the original sample 
# 
 S0 <- sum(sin(PI*theta)) 
 C0 <- sum(cos(PI*theta)) 
 mu0 <- mub(S0, C0) 
 
 # put all peaks together #  
 add.mu0 <- c(mub(S, C), mu0) 
 # put mu0 in the centre #  
 centre.mu0 <- sort(add.mu0) 
 names(centre.mu0) <- 1:(B+1) 
  
 # find position of mu0 # 
 i <- as.numeric(names(centre.mu0[centre.mu0 == add.mu0[B + 
1]])) 
 i <- median(i) 
 
 if (i > B/2 + 1) { 
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   cut.point <- i - B/2 # left end point # 
   
   # Rearrange replicates and mean direction of 
original sample # 
   # from lower cut point to upper cut point # 
   CI.dat <- c(centre.mu0[cut.point:(B + 1)], 
centre.mu0[1:(cut.point - 1)])  
    
   # Confidence Interval 
   LCI <- CI.dat[ceiling(B*alpha/2 + 1)] 
   UCI <- CI.dat[B + 1 - floor(B*alpha/2)] 
  } 
   
 else if (i < B/2 + 1) { 
 
   cut.point <- B/2 + i + 1 # Right end point # 
 
   # Rearrange replicates and mean direction of 
original sample # 
   # from lower cut point to upper cut point # 
   CI.dat <- c(centre.mu0[cut.point:(B + 1)], 
centre.mu0[1:(cut.point - 1)])  
 
   # Confidence Interval # 
   LCI <- CI.dat[ceiling(B*alpha/2 + 1)] 
   UCI <- CI.dat[B + 1 - floor(B*alpha/2)] 
  }  
 else { 
   # Confidence Interval # 
   CI.dat <- centre.mu0 
   LCI <- CI.dat[ceiling(B*alpha/2 + 1)] 
   UCI <- CI.dat[B + 1 - floor(B*alpha/2)] 
  } 
 
  list( 
   "peak.degree" = mu0, 
   "CI.degree" = c(LCI, UCI), 
   "CI.date" = c(DATE(LCI*365/360), DATE(UCI*365/360))) 
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dat (see Theta). 
 
Optional input  
 
bin The size of the bin, the default is bin = 5°. 
h The distance of points within the same bin, the default is h = 0.1. 
peak If TRUE, then an arrow which indicates the estimated peak and the 
amplitude of the peak is added to the existing plot. 
  
Value Angular plot. 
  
Note  Theta, Peak must be built in first. 
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Code 
_____________________________________________________________________ 
ANGULAR <- function(dat, bin = 5, h = 0.1, peak = F) 
{ 
 cir <- sort(THETA(dat))  
 
 f.bin <- table(cut(cir, seq(0, 360, bin))) 
 
 theta <- seq(bin, 360, bin) 
 
 PI <- pi/180 
  
 par(pty = "s") 
 symbols(0, 0, circles = 1, add = F, inches = F, lty = 1, lwd = 3,  
   axes = F,  
   xlim = c(-(1 + h*max(f.bin)), (1 + h*max(f.bin))),  
   ylim = c(-(1 + h*max(f.bin)), (1 + h*max(f.bin))))  
    
 for (i in 1:max(f.bin)){  
   
  p.x <- sin(PI*theta)*(1 + i*h) 
   
  p.y <- cos(PI*theta)*(1 + i*h) 
   




 if (peak == T) 
 {arrows(0, 0, 
   sin(PEAK(dat)$estimate[[7]]*PI)*PEAK(dat)$estimate[[4]],  
   cos(PEAK(dat)$estimate[[7]]*PI)*PEAK(dat)$estimate[[4]], 
   lwd = 3, 
   open = T) 
  
 lines(c(0, sin(PEAK(dat)$estimate[[7]]*PI)),  
   c(0, cos(PEAK(dat)$estimate[[7]]*PI)), 
   lty = 2)} 
 
 text(0, 0.9, "0", cex = 1.0)  
 text(0, -0.9, "180", cex = 1.0)  
 text(0.9, 0, "90", cex = 1.0)  
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Function Hist 
  





f (see Fs). 
n.lp (see Fs). 
n.yr (see Fs). 
fit 
 
If TRUE, the fitted von Mises and Cardioid distribution is added to the 
existing plot.    
  
Value Repeated histogram. 
  





HIST <- function(f, n.lp, n.yr, fit = F) 
{ 
 f <- FS(f, n.lp, n.yr) 
  
 barplot(c(f, f), 
   width = 30,  
   histo = T, 
   axes = F,  
     col = 0,   
     xlab = "Month", 
      ylab = "Number of cases", 
     names = rep(substring(month.abb, 1, 1), 2)) 
  
 axis(2, pos = 0) 
  
 # fit von Mises distribution # 
 if (fit == T){ 
  R <- PEAKGP(f, n.lp, n.yr)$estimate[[4]] 
  K <- PEAKGP(f, n.lp, n.yr)$estimate[[5]] 
  mu0 <- PEAKGP(f, n.lp, n.yr)$estimate[[7]] 
  
  theta <- seq(30, 390, length = 360) 
  vM <- sum(f) * pi/6 * DVM(theta - 30, K, mu0) 
  card <- sum(f) * pi/6 * DCARD(theta - 30, R, mu0) 
 
  lines(c(theta, theta + 360), c(vM, vM), lty = 1) 
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Function Rosegp 
  
Description Produce rose diagram for the monthly counts (f) of the presentation of 




f (see Fs). 
n.lp (see Fs). 
n.yr (see Fs). 
  
Value Angular plot. 
  
Note  Fs must be built in first. 
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Code 
_____________________________________________________________________ 
ROSEGP <- function(f, n.lp, n.yr) 
{ 
 # Monthly frequency is adjusted # 
 f <- FS(f, n.lp, n.yr) 
  
 f.vec <- rep(f, each = 31) 
      
 PI <- pi/180 
  
 theta <- rep(1:360, rep(c(rep(1, 29), 2), 12)) 
 
 x <- sin(c(0, theta[-372])*PI)*sqrt(f.vec) 
    
 y <- cos(c(0, theta[-372])*PI)*sqrt(f.vec) 
   
 par(pty = "s") 
 plot(x, y,  
  type = "l",  
  xlim = c(-max(abs(x), abs(y)), max(abs(x), abs(y))), 
  ylim = c(-max(abs(x), abs(y)), max(abs(x), abs(y))), 
  xlab = "",  
  ylab = "",  
  axes = F) 
 
 symbols(0, 0, circles = sum(sqrt(f))/12,  
     add = T,  
     inches = F,  
     lty = 8,  
     lwd = 2) 
  
 lines(c(0, x[1]), c(0, y[1])) 
 
 for (i in 1:12){  
   
  lines(c(0, x[31*i]), c(0, y[31*i])) 
 } 
  
 text(max(sqrt(f))*sin(seq(15, 345, 30)*PI) +  
   max(sqrt(f))*sin(seq(15, 345, 30)*PI)/10,  
  max(sqrt(f))*cos(seq(15, 345, 30)*PI) +  
   max(sqrt(f))*cos(seq(15, 345, 30)*PI)/10, 
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Description Fits an angular regression Reg model, without computing the model 




x A model matrix (design matrix).  
y A response vector. 
init A vector of initial values on the scale of the linear predictor. 
  
Optional input  
 
maxit Maximum number of iterations (default is 20) 
trace If TRUE, iterations details are printed while Reg is fitting the model.  
  
Value The iteration details on regression coefficient, peak, R, κ and L and a 
list containing the following components:  
  
LLH ratio The likelihood ratio statistic.  
p-value The asymptotic p-value based on the likelihood ratio statistics. 
variance Variance or covariances of the regression coefficient estimates. 
SE Vector of standard error of the regression coefficient estimates. 
t The t-statistic. 
p-value-t The p-value based on the t-statistic. 
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Code 
______________________________________________________  
REG.FIT <- function(x, y, init, maxit = 20, trace = F,...) 
{ 
 if(!is.numeric(x))  
   stop("model matrix must be numeric") 
 
 if(!is.numeric(y))  
   stop("response must be numeric") 
 
 if(!is.null(nrow(x))) if(nrow(x) < ncol(x)) 
   stop(paste(ncol(x), "parameters but only", nrow(x), 
"observations"))  
 
 theta <- y 
  
 N <- length(theta) 
 
 init <- as.matrix(init) 
  
  # standardize variables before model fitting # 
 x <- t(t(x) - colMeans(x))  
  
 n <- dim(x)[2] 
  
 # Calculate LLH under null hypothsis (beta = 0) #  
  
 PI <- pi/180 
  
 S0 <- sum(sin(PI*theta))/N  
   
 C0 <- sum(cos(PI*theta))/N 
 
 R0 <- sqrt(S0^2 + C0^2) 
   
 if (S0 > 0 & C0 > 0) {mu0 <- atan(S0/C0)/PI}  
  else if (C0 < 0) {mu0 <- atan(S0/C0)/PI + 180} 
   else {mu0 <- atan(S0/C0)/PI + 360} 
 mu0 # mu0 is from 0 to 360 degree # 
   
 u0 <- sin(PI*(theta - mu0)) 
 
 # log likelihood equation # 
 LLH0 <- - N*log(I0(K(R0))) + K(R0)*sum(cos(PI*(theta - mu0))) 
 
 if (trace) 
 cat(for (i in 1:n) cat("      coef", i, sep=""),  
  "    peak",  
  "        R",  
  "        K",  
  "         H", "\n") 
 
 # Start with init # 
 iter <- 0 
   
 while ((iter <- iter + 1) <= maxit) { 
  # Linear combination of all factors # 
  z <- t(init)%*%t(x) 
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  S <- sum(sin(PI*theta - 2*atan(z)))/N  
   
  C <- sum(cos(PI*theta - 2*atan(z)))/N 
 
  R <- sqrt(S^2 + C^2) 
   
  if (S > 0 & C > 0) {mu <- atan(S/C)/PI}  
   else if (C < 0) {mu <- atan(S/C)/PI + 180}  
    else {mu <- atan(S/C) / PI + 360} 
  mu # mu is from 0 to 360 degree # 
   
  u <- sin(PI*(theta - mu) - 2*atan(z)) 
 
  # log likelihood equation # 
  LLH <- - N*log(I0(K(R))) + K(R)*sum(cos(PI*(theta - mu) - 
2*atan(z))) 
    
  # Solve equation (6.61) 
  left <- matrix(0, nrow = n, ncol = n) 
  for (i in 1:n) 
  { 
   for (j in 1:n) 
   { 
    if (i == j) {left[i, j] <-  
         4*sum(x[ , j]^2/(1 + z^2)^2)}  
     else {left[i, j] <-  
         4*sum(x[ , i]*x[ , j]/(1 + z^2)^2)} 
    left[i, j] 
   }  
  }  
  left 
   
  right <- matrix(0, nrow = n, ncol = 1) 
  for (i in 1:n) 
  { 
   right[i, 1] <- 2*sum(x[ , i]*u/(1 + z^2))/R 
  }  
  right 
   
  del <- solve(left, right)    
   
  init <- init + del 
   
  if (trace) 
  cat(format(iter),  
    format(init, digits = 6), 
    format(mu, nsmall = 2, digits = 6), 
    format(R, digits = 6, nsmall = 6), 
    format(K(R), digits = 6, nsmall = 6), 
    format(LLH, digits = 8, nsmall = 8), "\n")  
  } 
  
 # Variance of regression coefficient # 
 g <- matrix(2/(1 + z^2), N, 1) 
 inv <- solve(left) 
 Var.init <- (inv +  
      inv%*%t(x)%*%g%*%t(g)%*%x%*%inv/ 
      as.numeric(N - t(g)%*%x%*%inv%*%t(x)%*%g))/K(R)/R 
 
 list("LLH ratio" = - 2*(LLH0 - LLH), 
  "p-value-LLH" = 1 - pchisq(- 2*(LLH0 - LLH), length(init)), 
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  "variance" = Var.init, 
  "SE" = diag(sqrt(Var.init)), 
  "t" = init/diag(sqrt(Var.init)), 
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Function Reg.control 
  
Description Allows users to set parameters (maxit, trace) for Reg. 
  
Optional input  
 
maxit (see Reg.fit) 
trace (see Reg.fit) 
  
Value A list is returned, consisting of the two parameters, conveniently 
packaged to supply the control input to Reg. The values for 
Reg.control can be supplied directly in a call to Reg. These values 




REG.CONTROL <- function(maxit = 20, trace = F, ...) 
{ 
 if(maxit < 1) { 
  warning("the value of maxit supplied is zero or negative; the 
default value of 20 was used 
      instead") 
  maxit <- 20 
 } 
 
 list(maxit = maxit,  
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Function Reg 
  






A formula object, with the response on the left of a `~' operator and 
the terms, separated by + operators, on the right. The response is a 
single angular variable on a complete circle (360°) corresponding to 
the observed individual dates of onset. 
 
Optional Input  
 
data Data frame in which to interpret the variables named in the formula 
and subset arguments.  
subset An expression defining which subset of the rows in the data to use in 
the fit. This can be a logical vector, which is replicated to have length 
equal to the number of observations, a numeric vector indicating 
which observation numbers to include, or a character vector of the 
row names to include. By default, all observations are included.  
na.action A function to filter missing data.  
control
 
A list of iteration and algorithmic constants. See Reg.control for their 
names and default values. These can also be given directly as input  
to Reg itself, instead of through control.  
method The method to use in fitting the model. By default, the function 
Reg.fit is used and the model is fit iteratively. However, other fitting 
methods can be defined if there is any.   
model  logical flag: if TRUE, then the model frame is returned in the model 
component of the fitted object. 
x A logical flag. If x=TRUE, the model.matrix is returned. By default, 
x=FALSE. 
y A logical flag. If TRUE, then the response is returned in the y 
component of the fitted object.  
Contrasts A list giving contrasts for some or all of the factors appearing in the 
model formula. The names of the list should be the names of the 
corresponding variables. The elements of the list should be either 
contrast-type matrices (matrices with as many rows as levels of the 
factor, and with columns linearly independent of each other and of a 
column of ones), or else they should be functions that compute such 
contrast matrices. 
... Additional arguments for the fitting routines; see Reg.fit and the 
functions it calls.  
  
Value (see Reg.fit)  
 
 




REG <- function(formula, data, subset, na.action,  
     control = REG.CONTROL(...),  
     method = "REG.FIT", model = F, 
     x = F, y = F, contrasts = NULL,...) 
{ 
 call <- match.call() 
  
 m <- match.call(expand = F) 
  
 m$method <- m$model <- m$x <- m$y <- m$control <- m$contrasts <- 
m$... <- NULL 
  
 m$drop.unused.levels <- T 
  
 m[[1]] <- as.name("model.frame") 
  
 m <- eval(m, local = F) 
 
 if(method == "model.frame") 
  return(m) 
  
 Terms <- attr(m, "terms") 
  
 xvars <- as.character(attr(Terms, "variables")) 
  
 if((yvar <- attr(Terms, "response")) > 0) 
  
  xvars <- xvars[ - yvar] 
  
 if(length(xvars) > 0) { 
  
  xlevels <- lapply(m[xvars], levels) 
  
  xlevels <- xlevels[!sapply(xlevels, is.null)] 
  
  if(length(xlevels) == 0) 
  
  xlevels <- NULL 
 } 
 else xlevels <- NULL 
  
 Y <- model.extract(m, response) 
  
 X <- model.matrix(Terms, m, contrasts)[ , -1] 
  
 Reg.fitter <- get(method) 
  
 fit <- Reg.fitter(x = X, y = Y, init, maxit = control$maxit, 
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Description Generates a date in non-leap year from a positive number (day of year) 




day A positive number. 
  




DATE <- function(day) 
{ 
 dates(ceiling(day-1), out = "day mon ", origin = c(month = 1,  
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Function K 
  




R R.    
  




K <- function(R) 
{ 
 ifelse (R < 0.53, 2*R + R^3 + 5*R^5/6, 
  ifelse (R < 0.85 & R >= 0.53, - 0.4 + 1.39*R + 0.43/(1 - R),  
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Function I0 
  










I0 <- function(K) 
{ 
 integrand <- function(y, K){exp(K*cos(y))} 
   
 integrate(integrand,  
    lower = 0,  
    upper = 2*pi,  
    subdivision = 10000, 
    K = K)$integral/(2*pi)  
}  
_____________________________________________________________________
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Function Dvm 
  






A vector of angles on a complete circle (360°) corresponding to the 
observed individual dates of onset.    
K Estimate of the concentration parameter of von Mises distribution. 
mu0 Estimate of peak in degree, 0θ . 
  




DVM <- function(theta, K, mu0) 
{ 
 PI <- pi/180 
 
 exp(K*cos(pi/180*(theta - mu0)))/(2*pi*I0(K)) 
}  
_____________________________________________________________________ 
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Function Dcard 
  






A vector of angles on a complete circle (360°) corresponding to the 
observed individual dates of onset.    
R The estimated amplitude of the peak. 
mu0 Estimate of peak in degree, 0θ . 
  




DCARD <- function(theta, R, mu0) 
{ 
 PI <- pi/180 
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Function Newton  
  




R R    
 
Optional input  
 
K Initial given value of concentration parameter, κ (default = 1). 
maxit Maximum number of iterations (default = 20). 
  





NEWTON <- function(R, K = 1, maxit = 20) 
{ 
 # Use Newton's method to find the K # 
 I1 <- function(p) 
 { 
  integrand <- function(y, p){cos(y)*exp(p*cos(y))} 
  
  integrate(integrand,  
     lower = 0,  
     upper = 2*pi,  
     subdivision = 10000, 
     p = p)$integral/(2*pi)  
 } 
 
 # Start with init # 
 iter <- 0 
 
 while ((iter <- iter + 1) <= maxit) { 
  del <- - (I1(K)/I0(K) - R)/(1 - I1(K)/I0(K)/K - (I1(K)/I0(K))^2)  
  K <- K + del  
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Appendix I Data sets 
 
















Side of  
eye 
        
01-Jan-95 50 Female Left 05-Jun-95 79 Female Left 
01-Feb-95 56 Female Right 06-Jun-95 69 Male Left 
01-Feb-95 59 Male Left 07-Jun-95 42 Female Left 
06-Feb-95 62 Female Right 07-Jun-95 63 Female Right 
18-Feb-95 80 Female Right 09-Jun-95 67 Female Left 
21-Feb-95 63 Female Right 11-Jun-95 59 Female Right 
23-Feb-95 74 Female Left 12-Jun-95 61 Male Right 
23-Feb-95 64 Male Right 13-Jun-95 41 Male Left 
23-Feb-95 75 Female Left 14-Jun-95 70 Female Right 
24-Feb-95 61 Female Left 15-Jun-95 67 Female Right 
27-Feb-95 82 Male Left 16-Jun-95 53 Female Left 
27-Feb-95 65 Male Right 19-Jun-95 52 Male Left 
28-Feb-95 66 Female Left 01-Jul-95 53 Female Left 
01-Mar-95 47 Male Right 02-Jul-95 66 Male Right 
01-Mar-95 47 Female Left 02-Jul-95 68 Female Left 
01-Mar-95 66 Male Left 03-Jul-95 46 Female Right 
04-Mar-95 51 Female Right 06-Jul-95 63 Female Left 
07-Mar-95 51 Male Left 16-Jul-95 70 Female Left 
08-Mar-95 58 Female Right 17-Jul-95 62 Female Left 
11-Mar-95 65 Female Left 21-Jul-95 67 Male Left 
12-Mar-95 83 Female Left 23-Jul-95 77 Female Right 
13-Mar-95 60 Female Right 24-Jul-95 56 Female Left 
14-Mar-95 44 Male Right 24-Jul-95 56 Female Right 
14-Mar-95 50 Female Right 29-Jul-95 76 Male Left 
14-Mar-95 68 Female Right 01-Aug-95 79 Female Left 
16-Mar-95 61 Female Right 06-Aug-95 55 Female Left 
17-Mar-95 61 Male Left 13-Aug-95 67 Female Right 
17-Mar-95 56 Female Left 17-Aug-95 66 Female Left 
19-Mar-95 49 Male Left 04-Sep-95 71 Female Left 
21-Mar-95 45 Female Left 06-Sep-95 50 Male Left 
21-Mar-95 67 Male Left 10-Sep-95 68 Female Right 
23-Mar-95 57 Female Left 10-Sep-95 77 Female Right 
26-Mar-95 72 Female Right 10-Sep-95 63 Female Left 
30-Mar-95 42 Male Left 11-Sep-95 74 Male Right 
06-Apr-95 76 Male Right 11-Sep-95 57 Male Right 
07-Apr-95 61 Male Left 11-Sep-95 71 Female Left 
07-Apr-95 64 Male Right 16-Sep-95 49 Female Right 
14-Apr-95 57 Female Left 18-Sep-95 70 Male Right 
16-Apr-95 50 Female Left 20-Sep-95 51 Female Left 
21-Apr-95 38 Female Left 21-Sep-95 73 Female Right 
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Side of  
eye 
        
21-Apr-95 73 Female Right 21-Sep-95 61 Female Left 
22-Apr-95 65 Female Right 22-Sep-95 60 Female Right 
26-Apr-95 73 Female Left 29-Sep-95 60 Female Left 
30-Apr-95 58 Female Right 29-Sep-95 65 Female Left 
01-May-95 68 Female Left 30-Sep-95 58 Male Right 
02-May-95 77 Female Right 02-Oct-95 73 Female Left 
03-May-95 81 Female Left 03-Oct-95 60 Female Left 
08-May-95 62 Female Right 03-Oct-95 64 Female Right 
11-May-95 58 Female Right 08-Oct-95 78 Male Left 
11-May-95 70 Female Left 08-Oct-95 58 Female Left 
11-May-95 72 Female Left 09-Oct-95 52 Male Right 
16-May-95 60 Female Left 10-Oct-95 64 Female Left 
16-May-95 74 Female Right 12-Oct-95 75 Female Left 
16-May-95 46 Female Right 14-Oct-95 56 Male Right 
17-May-95 71 Female Right 16-Oct-95 71 Male Right 
20-May-95 50 Female Right 16-Oct-95 68 Female Left 
21-May-95 65 Female Left 18-Oct-95 75 Female Right 
25-May-95 84 Female Left 23-Oct-95 56 Female Right 
26-May-95 77 Female Left 26-Oct-95 62 Female Left 
27-May-95 59 Male Left 26-Oct-95 72 Female Left 
28-May-95 76 Female Right 27-Oct-95 81 Male Left 
30-May-95 40 Female Left 31-Oct-95 69 Male Right 
31-May-95 62 Female Left 01-Nov-95 63 Female Right 
31-May-95 77 Female Right 04-Nov-95 78 Female Right 
02-Jun-95 66 Female Right 24-Nov-95 58 Female Right 
03-Jun-95 80 Male Right 01-Dec-95 66 Female Right 
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I.2 Deep vein thrombosis (Bounameaux et al, 1996) 
 
Month Year  
 1989 1990 1991 1992 1993 1994
  
Confirmed cases:  
  
Jan 29 31 36 37 27 32
Feb 13 29 27 29 17 27
Mar 28 23 26 33 23 26
Apr 27 29 23 16 24 23
May 22 28 17 16 38 26
Jun 31 36 20 21 24 22
Jul 23 39 23 14 27 18
Aug 32 36 19 23 40 18
Sep 29 24 28 31 32 27
Oct 26 22 25 32 23 27
Nov 25 27 28 21 26 31
Dec 28 24 31 37 29 24
   
Suspected cases:   
   
Jan 100 104 116 131 119 97
Feb 69 99 98 97 97 95
Mar 95 103 117 131 115 102
Apr 75 101 113 92 104 91
May 86 112 99 69 108 104
Jun 80 119 103 97 86 85
Jul 87 114 130 80 95 118
Aug 109 114 102 99 131 96
Sep 89 95 87 113 132 96
Oct 96 99 104 105 86 103
Nov 80 107 99 104 99 115
Dec 79 85 123 119 108 96
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I.3 Sleep related vehicular accidents (Horne and Reyner, 1995) 
 




0000 – 0059 31
0100 – 0159 30
0200 – 0259 40
0300 – 0359 27
0400 – 0459 25
0500 – 0559 38
0600 – 0659 40
0700 – 0759 37
0800 – 0859 23
0900 – 0959 13
1000 – 1059 9
1100 – 1159 19
1200 – 1259 19
1300 – 1359 16
1400 – 1459 27
1500 – 1559 34
1600 – 1659 40
1700 – 1759 34
1800 – 1859 18
1900 – 1959 12
2000 – 2059 14
2100 – 2159 13
2200 – 2259 24
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I.4 Testicular torsion (Kirkham and Machin, 1983) 
 
   
10-Feb-76 23-Feb-76 24-Feb-76 26-May-76 08-Aug-76 11-Sep-76
01-Nov-76 24-Nov-76 09-Jan-77 08-Mar-77 13-Sep-77 29-Nov-77
09-Feb-78 08-May-78 31-Jul-78 03-Aug-78 23-Aug-78 12-Oct-78
13-Nov-78 25-Nov-78 12-Jan-79 17-Jan-79 23-Feb-79 15-Mar-79
17-Oct-79 26-Oct-79 31-Jan-80 25-Mar-80 12-Apr-80 14-May-80
30-May-80 30-Aug-80 13-Sep-80 18-May-81 06-Aug-81 28-Aug-81
04-Oct-81 05-Oct-81 01-Apr-82 01-May-82 02-May-82 21-Jul-82
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   277
I.6 Thyroid cancer (Machin and Chong, 1999) 
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I.7 Acute lymphoblastic leukaemia (ALL) 
Study  Covariate b Jan Feb Apr May Jun Jul Aug Sep Oct Nov Dec Total
   
Onset    
   
Lee (1963) 0 – 19 40 34 44 39 58 51 55 36 48 33 38 506
(England and Wales) 20 – 44 14 14 7 22 22 8 18 13 13 12 16 168
   
Meighan (1965) 0 – 14 15 12 25 22 15 22 13 24 17 16 18 214
(Oregon, USA)   
   
Harris (1984) 0 – 4 4 4 11 4 4 0 6 6 7 3 5 61
(Eastern Nebraska, USA) 5 – 9 2 2 3 1 1 4 5 2 0 2 1 26
 10 –14 0 3 3 2 1 1 1 2 0 0 0 14
   
Symptom    
   
Till (1967) 0 – 9 25 26 36 27 36 31 29 22 40 31 38 372
(Greater London, England)   
   
Westerbeek (1998) 1.5 – 8 58 56 76 70 48 55 69 45 56 57 72 719
(Greater Manchester and  9 – 14 25 19 24 28 20 15 18 21 28 17 29 264
Lancashire, England) 0 – 14 89 79 107 104 77 75 95 73 89 80 106 1055
   
Karimi (2003) 0 – 15 18 20 18 20 11 17 20 12 33 16 13 211
(Shiraz, Iran)   
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(Continued)   
Study  Covariate b Jan Feb Apr May Jun Jul Aug Sep Oct Nov Dec Total
   
Diagnosis   
   




   
   
Walker (1982) – 2 21 22 16 14 26 23 11 15 29 17 28 243
(USA) 3 – 9 61 46 56 52 64 56 42 38 47 48 45 607
 10 – 19 34 31 29 28 24 31 32 32 26 25 24 346
 20 – 49 14 19 15 15 18 18 15 23 23 17 14 207
 50 – 69 14 6 10 11 12 16 17 22 14 20 18 172
 70 + 26 17 17 18 17 21 18 11 13 15 13 208
   
van Steensel-Moll (1983) 0 – 14 17 23 16 19 18 20 20 15 17 29 17 233
(The Netherlands)   
   
Harris (1987)   
Atlanta, USA 0 – 19 6 6 4 1 7 7 1 4 8 6 6 60
New Mexico, USA – 5 9 8 4 11 7 2 6 9 5 1 73
Utah, USA – 12 5 6 12 15 11 5 7 17 8 8 114
San Francisco, USA – 15 14 16 15 22 17 9 14 20 18 13 184
Nebraska, USA – 6 8 14 8 5 5 10 10 5 2 8 89
Iowa, USA – 16 11 22 20 14 18 16 15 18 14 27 211
Detroit, USA – 18 9 21 15 14 11 12 7 13 18 19 172
Seattle, USA – 14 5 16 11 8 7 10 7 13 10 12 127
Connecticut, USA – 18 19 15 12 17 16 11 16 14 16 18 191
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(Continued)   
Study  Covariate b Jan Feb Apr May Jun Jul Aug Sep Oct Nov Dec Total
   
Badrinath (1997) 0 – 14 21 19 23 24 25 25 32 25 27 17 10 271
(East Anglia, England) 15 + 18 23 15 26 20 21 29 27 19 15 20 244
    
Westerbeek (1998) a 1.5 – 8 61 60 60 74 70 57 73 59 60 59 44 730
(Greater Manchester and  9 – 14 26 24 23 27 18 23 19 22 28 20 17 266
Lancashire, England) 0 – 14 92 87 88 106 97 87 101 89 94 85 69 1070
   
Douglas (1999) 0 – 14 60 69 63 59 77 69 55 71 73 65 52 789
(England and Wales) Male 28 41 35 35 36 32 33 35 31 38 32 423
 Female 32 28 28 24 41 37 22 36 42 27 20 366
 15 – 79 53 43 53 50 45 42 38 45 68 49 37 580
 Male 32 27 36 36 27 31 20 30 36 28 28 370
 Female 21 16 17 14 18 11 18 15 32 21 9 210
   
Ross (1999) 0 – 19 452 398 478 492 467 496 495 460 456 467 424 5532
(USA)   
   
Timonen (1999) 16 + 8 10 5 4 2 3 3 4 6 8 2 64
(Northern Finland)   
   
Registration   
   
Gilman (1998) 0 – 14 84 64 55 65 71 78 74 75 69 63 59 805
(West Midlands, England) 15 + 45 30 57 47 62 48 45 48 42 47 33 535
   
a ‘Symptom’ is given above. 
b Ages (years) or Gender. 
